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ABSTRACT
Oocyte Quality: Molecular Constituents Altered in the Oocyte Due to Various
Environmental Factors
by
Lindsay Cox, Doctor of Philosophy
Utah State University, 2016

Major Professor: Dr. S. Clay Isom
Department: Animal, Dairy, and Veterinary Sciences
An estimated 1.6 million American couples struggle with infertility. Some causes
for poor fertility can be clearly defined but in many instances, subfertility is unexplained.
Poor oocyte quality is now considered to be a main contributing factor for many causes
of infertility. Good oocyte quality is crucial for many processes including embryo
development and maintaining pregnancy. There is a possibility that any alterations to the
oocyte can have long lasting effects on embryo development and the health of the
offspring. The oocyte is very sensitive to any perturbations to its surrounding
environment. Transcripts for apoptosis inhibitors and epigenetic modifiers were found to
be significantly more abundant in in vivo-matured oocytes compared to oocytes that were
matured in vitro. RNA degradation and chromatin remodeling pathways may also be
perturbed in in vitro-matured oocytes. While examining the effects of maternal age on the
oocyte, there are age-related differences in gene expression in equine cumulus-oocyte
complexes. Differences in gene expression may lead to a decrease in oocyte
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developmental competence. Age related alterations to gene expression in the equine
cumulus-oocyte complexes might be caused by increased rates of oxidative stress and
subsequent DNA damage. These alterations could directly impact many processes within
the oocyte. Higher incidences of apoptosis may be possible in the cumulus cells from
aged mares, which would directly impact the developmental competence of the oocyte.
Lastly, oocyte quality may be impacted by western dietary consumption patterns, which
could lead to many genes being differentially expressed in oocytes. Alterations to the
abundance of these genes have been shown to lead to effects that are commonly seen
with metabolic syndrome, such as glucose intolerance, insulin resistance, obesity and
diabetes. The results of this work will ultimately provide insight into the effects
environmental influences have on the oocyte at the molecular level.
(268 pages)
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PUBLIC ABSTRACT
Oocyte Quality: Molecular Constituents Altered in the Oocyte Due to Various
Environmental Factors
Lindsay Cox
An estimated 1.6 million American couples struggle with infertility. Some causes

for poor fertility can be clearly defined but in many instances, subfertility is unexplained.
The cause for many of these infertility issues is now thought to be due to defects in the
quality of the woman’s eggs. The egg primarily determines whether a pregnancy will be
achieved and maintained. Any alterations to the egg will have effects on both pregnancy
and possibly the health of the future child. The egg is very sensitive to any alterations to
the environment it is surrounded by in the ovary. Environmental factors, such as
maturation culture conditions, maternal age, and a total western diet that reflects the poor
eating habits of the United States have all been shown to lead to alterations in various
genes. While looking at the effects the environment in which the egg undergoes
maturation has on the quality of the egg, it was demonstrated that genes that are crucial
for proper egg development are affected when maturation occurs in the laboratory, rather
than within the body. Another study demonstrated that maternal age does lead to agerelated alterations to genes, which could explain for the decrease in egg quality due to
age. Lastly, it has been shown that poor nutrition can have an impact on many genes
within the eggs. Alterations to these genes have previously been shown to lead to many
similar effects as those seen with obesity and diabetes. We hope these findings will help
to provide insight into the effects environmental influences can have on the oocyte.
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CHAPTER 1
REVIEW OF LITERATURE
Poor oocyte quality is thought to be a main contributing factor for 1.6 million of
American couples that are unable to conceive (Krisher 2004). The quality of the oocyte is
crucial for embryo development, maintaining pregnancy, and ultimately the birth of the
offspring (Combelles and Racowsky 2005; Krisher 2004; Lonergan et al. 2003b; Roberts
2005; Sirard et al. 2006; Wang and Sun 2007). In particular, a good quality oocyte must
be able to resume meiosis after being meiotically quiescent for an extended period of
time, cleave following fertilization, develop to the blastocyst stage of embryo
development, induce a pregnancy and develop to term (Sirard et al. 2006). The inherent
constitution of an oocyte before fertilization is even thought to play a role in determining
disease susceptibility in the adult offspring derived from that oocyte (Krisher 2004).
Alterations within the oocyte can have long lasting effects on development.
Folliculogenesis
The quality of the oocyte is determined during folliculogenesis (Krisher 2004),
defined as the process of the growth and maturation of the ovarian follicles. Each oocyte
is housed inside of one of these follicles within the ovary. As the oocyte grows and
matures, the whole follicle itself goes through a series of changes, beginning as a
primordial follicle. The follicle will later become a primary or preantral follicle before
transitioning to a secondary and antral follicle. Finally, the follicle will transition into a
preovulatory follicle called a Graafian follicle in preparation for ovulation.
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Primordial follicles contain flattened squamous cells that surround the oocyte in a

single layer that are referred to as granulosa cells. As the primordial follicle grows, it will
develop into a more advanced primary follicle. The granulosa cells surrounding the
oocyte are now more cuboidal in nature. The transition to a secondary or preantral follicle
is characterized by an increase in the
diameter of the primordial follicle from
20 µm to between 200 and 400 µm
(Johnson 2003). The oocyte contributes
to much of the increased diameter as it
increases to its final size of 60-120 µm

Figure 1-1. Illustration of follicular development.

(Johnson 2003). As the follicle becomes a secondary follicle, the granulosa cells divide
and become multiple layers thick. The oocyte secretes glycoproteins to make up a
translucent layer called the zona pellucida that surrounds the oocyte and separates the
oocyte from the granulosa cells. Gap junctions between the oocyte and granulosa cells
form an extensive intercellular network that aids in oocyte development: the granulosa
cells produce many growth factors and biosynthetic substrates that are passed into the
oocyte to facilitate proper growth. The stromal cells that surround the preantral follicle
condense to form spindle-shaped cells called thecal cells (Johnson 2003). The transition
from a preantral follicle to an antral follicle begins with the proliferation of the granulosa
cells, which increases the size of the follicle. A viscous fluid is formed called follicular
fluid. The fluid causes a follicular antrum to form in the follicle. As the antrum grows,
the oocyte becomes bathed in the follicular fluid. Antral follicles consist of three layers of
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cells. Dense masses of granulosa cells called the cumulus cells now surround the oocyte.
Further growth and proliferation allows for the thecal cells to form two distinct layers: the
theca interna and the theca externa (Johnson 2003).
The gonadotropin hormones produced by the pituitary gland in response to an
increased secretion of gonadotropin releasing hormone (GnRH) drive and control the
growth of the follicles. The theca interna cells have receptors that bind luteinizing
hormone (LH) and under the influence of LH, produce androgens (Johnson 2003).
Hormonal control of follicular developments is clearly defined by Senger (2012). The
primary role of LH is to promote growth and maturation of the follicles and the oocytes
(Senger 2012). LH is also responsible for ovulation of the oocyte. The granulosa cells
contain receptors that bind follicle stimulating hormone (FSH), the hormone responsible
for stimulating follicle growth (Senger 2012). Once the follicles reach the antral stage,
they are able to produce and secrete increased amounts of estrogen in response to FSH
and LH, if selected for continued growth. Binding of LH to the theca interna cells leads to
the conversion of cholesterol to testosterone. Testosterone produced by the theca interna
cells will then diffuse into the granulosa cells. When FSH binds to the granulosa cells, it
allows for the conversion of testosterone to estradiol (Senger 2012). As the selected
follicles continue to grow, the granulosa cells begin to synthesize LH receptors. These
growing antral follicles will continue to secrete estradiol as well as the hormone inhibin,
which will inhibit further FSH release from the pituitary (Senger 2012). Only those
follicles that have the appropriate number of LH receptors to fully respond to LH will
continue growing, while the rest will undergo atresia. Continued growth of the follicle
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allows it to reach the size of dominance and become a preovulatory or Graafian follicle.
A final surge of LH will induce ovulation with the rupture of the follicle and release of
the oocyte.
Oocyte development
Oocyte development entails a series of processes that include proliferation by
mitosis, genetic reshuffling and reduction by meiosis, and cytodifferentiation during
oocyte maturation (Johnson 2003). In most mammals, the development of the oocyte
occurs over the span of many years and these processes will take place at different time
points throughout a female’s life. The mitosis phase occurs during the fetal period in
humans and domestic livestock species. Once mitosis is completed, the primordial germs
cells will then enter meiosis where they will arrest at the first prophase and become
primary oocytes.
Prenatal oocyte development
Oogenesis is the development of the oocyte from its primordial state to a fully
matured, competent state at which point it is capable of being fertilized. The first part of
oogenesis takes place prenatally. Primordial germ cells develop in the early embryo when
the yolk sac is still present (Senger 2012). The primordial germ cells originate outside of
the embryo from the base of the hindgut and then migrate to the genital ridge, which will
eventually become the ovary.
At the beginning of embryo development, all of the cells that comprise the
embryo are considered somatic cells. As the primordial germ cells originate from the

	
  

	
  
	
  

epiblast cells of the embryo, they must undergo genome reprogramming via various
epigenetic events, including a global demethylation event that erases all of the previous
methylation marks on DNA and histones (Cantone and Fisher 2013). The epigenome is
comprised of multiple chemical modifications to the DNA that inform the genome of
what to do. The epigenome is responsible for altering the phenotype, or the behavior of a
given cell, without actually altering the DNA sequence. Alteration of the phenotype by
the epigenome is typically achieved through modifications to the DNA and chromatin
(Sasaki 2008). Chromatin consists of DNA, RNA, and protein that together help to
regulate gene expression. Some of these modifications include methylation, acetlyation,
phosphorylation, ubiquitilayion, and sumoylation. These modifications can occur on
DNA or histones and are responsible for turning gene expression on or off depending on
the specific modification. Epigenetic modifications are crucial for defining cellular
identity and determining cell fate (Sasaki 2008). Genome reprogramming entails the
remodeling or erasure of these epigenetic marks. Reprogramming is necessary in order to
establish the developmental program of the gametes, turn genes back on that are
necessary for oocyte development, and establish an epigenetic landscape that can later
restore totipotency (Cantone and Fisher 2013). The genome must be completely wiped
clean of DNA methylation patterns and chromatin modifications that are associated with
a somatic genome (Kota and Feil 2010). Various key transcription factors and epigenetic
modifiers control this process. The earliest global chromatin change that occurs is a loss
of dimethylated histone 3 lysine 9 (H3K9me2) and an increase in trimethylated histone 3
lysine 27 (H3K27me3). The increase in H3K27me3 causes the silencing of many
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developmental regulatory genes in order to prevent cell differentiation and maintain the
proper expression of the pluripotency genes (Cantone and Fisher 2013). A decrease in
H3K9me2 is necessary in order for DNA demethylation to occur. Widespread erasure is
thought to protect the transmission of inappropriate information, like epimutations, that
may be detrimental to the next generation (Cantone and Fisher 2013). Complete
demethylation occurs in intergenic regions, including imprinted domains and repeat
elements, which are protected from erasure in the zygote. A cascade of chromatinremodeling events is necessary to complete this global demethylation (Cantone and
Fisher 2013).
De novo methylation will occur later during oocyte development in order to allow
continued differentiation of the oocyte to occur and to turn off pluripotent factors. Sexspecific imprinted DNA will also need to be re-established during oocyte growth.
Typically, two copies of a gene are inherited from the mother and father and both copies
are functional for most genes. Imprinting is the epigenetic phenomenon in which one
copy of a gene is epigenetically silenced in a parent-of-origin dependent manner, leaving
only one copy active and functional. These genes are clustered in domains of several
megabases of DNA. Expression of these gene clusters is controlled by an imprinting
control region (ICR) (Kota and Feil 2010). The ICR of one of the two alleles is marked
by DNA methylation and repressive histone marks. In the oocyte, DNA methylation at
majority of the ICRs is derived from the mother (Kota and Feil 2010).
Once the primordial germ cells migrate to the genital ridge, they undergo mitotic
proliferation forming primordial oocytes. After several rounds of cell division, the
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oocytes will enter meiosis, becoming primary oocytes. Meiosis involves two sequential
divisions in which the chromosomal content is halved and modified through the exchange
of genetic material between homologous chromosomes. In the oocyte, meiosis is
characterized by asymmetrical cell division, with nearly all of the cytoplasm allocated to
the oocyte. Meiosis is initiated prenatally by retinoic acid and stimulated by retinoic acid
8 (STRA8) expression (Bowles, 2006). The oocyte enters prophase I, at which point the
chromosomes condense and the homologous pairs match up at the leptotene stage. At the
zygotene stage, a synaptonemal complex forms between the homologous pairs.
Homologous recombination then occurs at the pachytene stage to ensure genetic
diversity. And finally, during the diplotene stage, synapsis is complete and a chiasmata is
seen, which is important for later chromatid segregation. Development pauses at the
primary oocyte stage shortly after going through the diplotene stage of prophase I of
meiosis. The oocyte is maintained in this arrested state by various meiotic arresting
factors from birth until the time it is recruited for ovulation. Morphologically, the oocyte
is considered to be at the germinal vesicle stage, which is characterized by the germinal
vesicle nucleus that contains a large nucleolus and chromosomes that are partially
condensed (Zhang and Xia 2012).
Meiotic arrest
The mechanism by which the oocyte is maintained in meiotic arrest is described
as follows. Meiosis is driven by maturation promoting factor (MPF), which consists of
cyclin dependent kinase 1 (CDK1) and cyclin B. Prior to meiotic resumption, cyclic
adenosine monophosphate (cAMP) binds and activates protein kinase A (PKA). PKA is
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responsible for phosphorylating the kinase WEE2 and inhibiting the protein tyrosine
phosphatase CDC25. WEE2 phosphorylates CDK1, rendering it inactive. APC-Cdh1 is
responsible for degrading cyclin B during this time, causing MPF to be inactive (Polanski
et al. 2012).
Meiotic arrest is thought to be controlled by a substance produced by the
surrounding granulosa cells that suppresses meiosis and cell cycle progression. When
oocytes are removed from follicles and cultured in vitro, they can spontaneously resume
meiosis without any hormonal stimulation. This demonstrates that a substance produced
by the granulosa cells is responsible for meiotic arrest in the oocyte (Zhang and Xia
2012). These oocyte maturation-inhibiting molecules can diffuse easily from the
granulosa cells into the oocyte via gap junctions. Cyclic AMP is the main molecule that is
thought to be responsible for keeping the oocyte in meiotic arrest and inhibiting
maturation (Zhang and Xia 2012). Cyclic AMP is produced by adenlyl cyclase, which is
controlled by the G protein coupled receptor GPR3. FSH binding to receptors on the
granulosa cells leads to an increased concentration of cAMP, which influences the
prolonged meiotic arrest (Kawamura et al. 2011). Experimental reduction of cAMP levels
within oocytes leads to the resumption of meiosis, independent of gonadotropin
stimulation, and compromises the developmental capabilities of the oocytes (Zhang et al.
2010). Meiotic arrest is thus dependent on a high amount of cAMP in the oocyte (Zhang
and Xia 2012).
In addition to cAMP, granulosa cells produce C-Type Natriuretic Peptide (CNP),
encoded by the Natriuretic Peptide Precursor Type C (NPPC) gene, prior to the
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Luteinizing Hormone (LH) surge. FSH and estrogen can stimulate the expression of
NPPC (Zhang and Xia 2012). Oocyte-derived paracrine factors GDF9, BMP15, and
FGF8B also promote the mRNA expression of the CNP receptor natriuretic peptide
receptor 2 (NPR2). The presence of CNP promotes cyclic guanosine monosphosphate
(cGMP) production in the granulosa cells (Zhang et al. 2010). Cyclic GMP then diffuses
into the oocyte through the gap junctions. Higher amounts of cGMP in the oocyte cause
the inhibition of phosphodiesterase 3A (PDE3A), the enzyme that is responsible for
degrading cAMP. Inhibition of PDE3A allows cAMP levels to remain high and thus
prevents the resumption of meiosis from occurring. CNP and NPPC in granulosa cells
have been shown to be high during follicular growth until the LH surge, when levels
decline due to the down-regulation of NPPC expression by LH, and meiosis subsequently
resumes (Kawamura et al. 2011). Treatment of oocytes with CNP directly prevented
germinal vesicle breakdown in the oocyte and prevented the resumption of meiosis
(Kawamura et al. 2011).
Oocyte growth
The process of oocyte growth begins around the time of the formation of the
primordial follicle and continues up to the development of the Graafian follicle. Oocyte
growth is not dependent on reactivation of meiosis (Johnson 2003). During oocyte
growth, the oocyte produces new mRNAs and organelles as well as modifies and
redistributes existing ones. The oocyte must properly replicate cytoplasmic organelles,
such as the mitochondria, since the early embryo will derive these organelles from the
oocyte upon fertilization (Picton et al. 1998). The majority of the RNAs that are
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synthesized at this time are important for both oocyte growth and maturation. Also, a
large amount of these RNAs are stored for early embryonic development. Transcription
and translation rates vary throughout oogenesis. Even though the oocyte is meiotically
quiescent, transcription is still very active during the growth phase (Picton et al. 1998).
The oocyte also actively produces proteins throughout growth that are essential for
oocyte differentiation, interacting with the surrounding somatic cells, fertilization, and
early embryo development (Picton et al. 1998). The glycoprotein membrane called the
zona pellucida is made up of three glycoproteins that are secreted by the oocyte early in
oocyte growth. Throughout oocyte growth, the cytoplasmic organelles begin to migrate to
the periphery of the cell. The golgi apparatus enlarges and exports glycoproteins to the
zona pellucida as well as utilizes these glycoproteins in order to form the cortical
granules that are necessary for fertilization. The ooplasm accumulates numerous
membrane bound vesicles, glycogen granules, and lipid droplets (Picton et al. 1998). As
the oocyte grows, it will undergo an almost 100-fold increase in volume, which is
achieved by accumulating water, ions, lipids, and the cytoplasmic organelles. Once the
oocyte has completed the growth phase, it will eventually undergo germinal vesicle break
down and meiosis can then resume. Transcription rates decline rapidly once the oocyte
has completed growth. Once meiosis resumes, transcription has almost completely
ceased, requiring the oocyte to rely on stored transcripts (Picton et al. 1998).
Meiotic resumption
Once meiosis arresting factors are removed, development continues with the
resumption of meiosis and further growth of the oocyte in preparation for fertilization.
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The underlying mechanism that drives this process is still not fully established and may
vary among species. The granulosa and theca cells within the ovary are known to be
primarily responsible for relaying the hormonal signals to the oocyte to induce meiotic
resumption and final maturation of the oocyte. Gap junctions between the granulosa cells
and the oocyte provide a biochemical pathway that is responsible for regulating what
hormones and factors will influence the oocyte. Dissociation and closing of these
junctions has been shown to induce oocyte maturation and the resumption of meiosis by
preventing further molecules from diffusing into the oocyte, including those molecules
that work to maintain meiotic arrest in oocytes (Zhang and Xia 2012).
The gonadotropin hormones (LH and FSH) play major roles in the resumption of
meiosis in oocytes. LH is the primary driver of the growth phase between a primary
oocyte and a secondary oocyte, where it is responsible for the removal of meiotic
inhibitors, getting the oocyte to final maturation, and ovulation (Motola et al. 2007).
However, LH does not directly bind to the oocyte due to the absence of functional LH
receptors (Kawamura et al. 2011). The effect LH has on the oocyte is mediated through
the action it has on the theca cells within the follicle and the secretion of paracrine
factors. LH also acts on the granulosa cells where it stimulates a decrease in cGMP in the
granulosa cells and thus, increases PDE3A activity (Zhang and Xia 2012). The LH surge
also leads to the activation of mitogen activated protein kinase (MAPK). MAPK helps to
close the gap junctions between the granulosa cells and the oocytes (Zhang and Xia
2012). The closing of these gap junctions will prevent cGMP from diffusing into the
oocyte, which will allow for PDE3A to subsequently decrease cAMP levels. Inhibition of
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cAMP through phosphodiesterase inhibitors has been shown to induce oocyte maturation
in some species, such as the mouse (Leonardsen et al. 2000).
FSH is widely known for its function in regulating and inducing follicular
development, in part by stimulating the proliferation of granulosa cells. This hormone is
also responsible for regulating the gap junction connections between the granulosa cells
and the oocyte (Combelles et al. 2004). FSH plays a major role in meiosis resumption
through the control of signaling molecules. FSH binding to its receptors on the granulosa
cells induces these cells to produce a factor called hypoxanthine that promotes germinal
vesicle breakdown and subsequent resumption of meiosis (Jin et al. 2006). As previously
mentioned, cAMP is one of the molecules responsible for maintaining the oocyte in
meiotic arrest. A reduction of FSH before ovulation leads to a decrease in cAMP
concentration, which allows oocyte maturation to resume. Desensitization of the oocyte
to cAMP could also play a role in the resumption of oocyte development, since the
oocyte has been routinely exposed to cAMP for an extended period.
Maturation
Once meiosis has been resumed, the oocyte will undergo the maturation process.
For the oocyte to properly and fully achieve maturation, it must undergo the three levels
of oocyte maturation: meiotic maturation, cytoplasmic maturation, and molecular
maturation (Sirard et al. 2006). Meiotic maturation is the cascade of nuclear events that is
induced either by the LH surge that occurs prior to ovulation or by removing the oocyte
from its follicle (Sirard et al. 2006). At the time of the LH surge, cGMP decreases
allowing PDE3A to now be active. Protein Kinase B (AKT) activity also increases at this

	
  

	
  
	
  

time, which is responsible for phosphorylating and activating PDE3A. Once activated,
PDE3A hydrolyzes cAMP and prevents it from binding PKA, rendering PKA inactive.
With PKA inactive, it can no longer phosphorylate WEE2, allowing CDK1 to now be
active. Active CDK1 will then activate CDC25, which will further increase CDK1
activity. Increased activity of CDK1 leads to the inhibition of APC-Cdh1. With APCCdh1 inhibited, it can no longer degrade cyclin B, allowing it to accumulate at high levels
(Polanski et al. 2012). CDK1 and cyclin B combine to make MPF and meiosis resumes
with the breakdown of the germinal vesicle. The oocyte progresses into metaphase and
the homologous chromosome pairs align on the metaphase plate. APC-CDC20 is
activated to promote anaphase. APC-CDC20 targets and degrades a protein called
securin, which allows the previously inactive protein separase to become active. Separase
cleaves the cohesin complex along the arm of the chromatids, allowing the homologous
pairs to separate. At telophase, the sister chromatids migrate to opposite poles. An uneven
cytokinesis occurs in the oocyte in which the chromosomes separate to two cells evenly,
but there is an unequal splitting of cytoplasm. Essentially all the cytoplasm goes to one
cell, which becomes the secondary oocyte, and the other cell with little cytoplasm gets
extruded as the first polar body. The oocyte then enters into meiosis II, where it
eventually arrests again at metaphase II. At this point the oocyte is considered meiotically
mature. The oocyte is held in this arrest by c-mos and Cytostatic Factor (CSF), which
inhibits APC from promoting anaphase (Polanski et al. 2012). Meiotic maturation and the
visualization of the first polar body is typically used as an indicator that the oocyte is
mature (Sirard et al. 2006).
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Many of the events that characterize cytoplasmic maturation are not visible and

because of this, cytoplasmic maturation is not as clearly defined as meiotic maturation.
The first phase of cytoplasmic maturation occurs when the oocyte ceases RNA and
protein synthesis by modifying the transcription and translation machinery through
nucleolus condensation and ribosome depletion (Hyttel et al. 1986; Hyttel et al. 1989).
The second phase of cytoplasmic maturation occurs around the time of the LH surge and
is characterized by the events that occur as the oocyte progresses to metaphase. Also at
this time, organelles, such as the mitochondria and cortical granules, are redistributed
(Assey et al. 1994). The last part of cytoplasmic maturation, which is also considered to
be molecular maturation, includes the accumulation of molecules that will be necessary
to prepare the oocyte for fertilization and sustain early embryo development (Humblot et
al. 2005). In particular, the oocyte must stockpile mRNAs and proteins. The quality of the
oocyte will be influenced by alterations to transcript abundances, which can ultimately
have long lasting effects on embryo development. Because of this, Sirard et al. (2006)
believes that molecular maturation will have the greatest effect on influencing the quality
of the oocyte and its developmental competence.
Oocyte competence/Synthesis of mRNAs and proteins
Oocyte competence is defined as the oocyte’s ability to resume meiosis, cleave
following fertilization, develop to the blastocyst stage, and ultimately induce a pregnancy
that develops to term in good health (Sirard et al. (2006). The oocyte must successfully
complete nuclear, cytoplasmic, and meiotic maturation in order to be developmentally
competent. During the time of oogenesis, oocytes must synthesize, accumulate, and store

	
  

	
  
	
  

a large amount of mRNA transcripts, which are necessary for oocyte maturation and early
embryo development once transcription has ceased. These high rates of transcription and
storage of most transcripts occur during oocyte growth. During this time, mRNAs are
very stable in order to permit accumulation (Medvedev et al. 2008). Transcription is then
silenced as the germinal vesicle breaks down during the first resumption of meiosis.
Oocytes rely on these stored transcripts to continue meiosis, undergo mitotic divisions
following fertilization, and complete maternal zygotic transition during embryo
development (Sirard et al. 2006). In order for the oocyte to acquire developmental
competence, the oocyte must properly synthesize and store these maternal transcripts
prior to the onset of transcriptional silence (Yuan et al. 2011). The health of the early
embryo depends on transcripts and proteins already present in the oocyte, which indicates
that embryo developmental potential is inherent within the oocyte (Sirard et al. 2006).
Differences in mRNA profiles and transcript abundance may influence the oocytes’
potential to produce competent and viable embryos (Jian, 2010). The majority of the
embryos that fail to develop to the blastocyst stage are blocked at or close to the maternal
zygotic transition indicating that the oocytes are incompetent and may be unable to
activate the embryonic genome (Sirard et al. 2006). Activation of the embryonic genome
is reliant on the activation and translation of the maternal transcription factors that are
stored in the oocyte (Vigneault et al. 2004) as well as degradation of oocyte-specific
transcripts (Sirard et al. 2006). Alterations to the abundance of these crucial transcripts
will most likely influence the embryo’s ability to activate the embryonic genome. Since
activation of the embryonic genome is required for further development, the intrinsic

	
  

15	
  

	
  
	
  

16	
  

quality of the oocyte is crucial for maintaining and sustaining proper embryo
development.
mRNA degradation
As the germinal vesicle breaks down, transcription is silenced via epigenetic
mechanisms and the oocyte relies on stored transcripts to continue meiosis and sustain
the early part of embryo development. During oocyte maturation, the degradation of
transcripts also occurs with almost half of the transcripts undergoing some form of
deadenylation and about 30% of total mRNA being degraded (Yuan et al. 2011).
Typical mRNA degradation is achieved by interactions between the structural
components of the mRNA and specific factors. The 5’ cap of the mRNA interacts with
the cytoplasmic protein EIF4E and protects the mRNA transcript from being attacked by
exonucleases aiming to degrade the transcript starting at the 5’ end. The 3’ poly(A) tail of
the mRNA is a series of adenine bases at the end of the mRNA that has many important
roles including mRNA stability. The 3’ protection is in part based on the effect of
poly(A) binding proteins (PABPs) that bind to the poly(A) tail to protect it from
degradation by exonucleases that degrade the transcript from the 3’ end. Cis elements are
located within the 3’ untranslated regions (UTRs) that also play a role in mRNA stability.
In order for normal degradation to occur, one or more of these mechanisms of mRNA
protection must be compromised so that the RNA degradation machinery has access to
the mRNA (Garneau et al. 2007).
The most common pathway of mRNA degradation, especially in the oocyte, is
initiated by a shortening of the poly(A) tail followed by the removal of the 5’ cap and
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subsequent 5’ to 3’ exonucleolytic degradation of the transcript. The CCR4-NOT
complex is the main deadenylase in oocytes that is responsible for shortening the poly(A)
tail. Following deadenylation, the LSM complex will then associate with the 3′ end of the
mRNA transcript, which induces decapping to occur by the DCP1–DCP2 enzymes.
Decapping then leaves the mRNA susceptible to decay by the 5′ to 3′ exoribonuclease
XRN1. Messenger RNA transcripts with short poly(A) tails can also undergo 3’ to 5’
degradation (Garneau et al. 2007).	
  
Degradation of maternal mRNA is crucial for the oocyte to zygote transition to be
completed successfully (Medvedev et al. 2008). Around the time of meiotic resumption,
mRNAs undergo a transition from stable to unstable. At this time, the mRNAs become
more accessible to the RNA degradation machinery due to a decrease in the RNAbinding protein MSY2 (YBX2) (Medvedev et al. 2011). This protein is abundant in germ
cells, comprising about 2% of total oocyte protein, and is responsible for global mRNA
stability (Medvedev et al. 2011). During maturation, MSY2 is phosphorylated by
CDC2A, which triggers the transition from mRNA stability to instability and subsequent
degradation. Messenger RNA degradation will continue until the first few cell divisions
of embryo development (Piko and Clegg 1982). Alterations to the cellular mechanisms or
degradation machinery could lead to alterations to transcript silencing and degradation.
Both aberrant degradation as well as maintenance of transcripts during oocyte maturation
could be deleterious to oocyte quality. Messenger RNA degradation is necessary for
facilitating the loss of oocyte identity and the transition to a totipotent embryo (Ma et al.
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2013). If these transcripts aren’t degraded and properly removed, embryo quality will be
compromised.
Role of cumulus granulosa cells in oocyte quality
The somatic cells that surround the oocyte within the follicle play an essential role
in supporting normal oocyte development. These cells, the granulosa cells (in particular
the granulosa cells immediately surrounding the oocyte, the cumulus granulosa cells),
have been considered as nurse cells to the oocyte. Communication between these cells
and the oocyte is critical for coordinating growth and maturation of the oocyte (Moor and
Dai 2001). These cells have been shown to be responsible for maintaining the oocyte in
meiotic arrest, promoting meiotic resumption, and most importantly, helping the oocyte
acquire developmental competence (Eppig 2001). Granulosa cells have also been shown
to participate in the global suppression of transcription that occurs in the oocyte during
maturation (De La Fuente and Eppig 2001). The interaction between the granulosa cells
and the oocyte most greatly influences the development of the oocyte by providing
communication through paracrine, autocrine, and endocrine factors (Voronina and
Wessel 2003).
Granulosa cells are somatic cells that originate from the ovarian stroma; they
encompass the oocyte beginning at the primary oocyte stage of development and will
maintain this close contact until the oocyte is ovulated. Communication is achieved
through various signaling pathways, including contact-mediated signals, ligand-receptor
interactions, paracrine and autocrine signaling pathways, gap junction interactions, and
receptor tyrosine kinases (McGinnis et al. 2013). The largest communication network is
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achieved through gap junctions between the oocyte and the cumulus cells. A regulatory
loop between the oocyte and the granulosa cells is crucial for communication and aids in
both oocyte and follicular growth. Kit ligand (KL) from the granulosa cells has been
shown to be one of the primary drivers of promoting oocyte growth (Eppig 2001). FSH
has been shown to stimulate the expression of KL. Once the oocyte has reached a specific
size, GDF9 produced from the oocyte then suppresses KL expression in the cumulus cells
to terminate oocyte growth (Eppig 2001). KL is also thought to support oocyte
cytoplasmic maturation (Reynaud et al. 2000). BMP15 in the oocyte has very similar
roles as GDF9 and is essential for oocyte and follicular development. Both GDF9 and
BMP15 have also been shown to regulate granulosa cell development and proliferation
(Otsuka et al. 2000; Vitt et al. 2000). Any alterations to these transcripts could play a
major role in the inadequate development of the oocyte. COX2 produced by the
granulosa cells has been shown to be required for normal ovulation (Lim et al. 1997).
GDF9 has been shown to play a pivotal role in this prostaglandin pathway by stimulating
the production of both COX2 and its receptor (Elvin et al. 2000). Normal differentiation
of the cumulus cells is also crucial for oocyte development. Inappropriate differentiation
has been shown to lead to oocytes that lack proper developmental competence (Eppig et
al. 1998).
Cumulus cell expansion helps to drive the resumption of meiosis and is critical for
normal oocyte development. The LH surge causes the cumulus cells to secrete a
mucinous matrix that contains hyaluronic acid (HA). GDF9 promotes cumulus expansion
by increasing HA synthesis. Cumulus cell expansion is crucial for ovulation, as inhibiting
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expansion and HA synthesis leads to decreased rates of ovulation (Chen et al. 1993).
Cumulus cell expansion also leads to the dissociation of the gap junctions, which is
necessary for meiosis to resume and oocyte maturation to occur.
Steroid intermediates produced by the cumulus cells function to induce meiosis.
Xia et al. (1994) demonstrated that cumulus cells secrete a steroid substance that induces
meiotic resumption and is possibly one of the maturation inducing substances. This
steroid is referred to as meiosis activating sterol (MAS); an intermediate compound in the
cholesterol biosynthesis pathway that is produced by the cumulus cells surrounding the
oocyte. The surge of gonadotropins elevates the concentration of MAS. In porcine
oocytes, it was suggested that FSH might promote meiotic resumption through the
secretion of MAS from the cumulus cells (Jin et al. 2006). MAS has also been found to
induce meiotic resumption in the oocyte in rodents by stimulating germinal vesicle
breakdown (Grondahl et al. 1998). Some labs promote the use of MAS in their in vitro
culture medium to induce meiotic resumption from metaphase I to metaphase II and
increase the quality of oocytes (Marin Bivens et al. 2004).
The cumulus/granulosa cells play a pivotal role in the development of the oocyte.
The communicative network between the oocyte and the cumulus cells is crucial for the
oocyte to develop properly and acquire developmental competence. If this network were
perturbed, the oocyte would be affected.
Fertilization/Oocyte activation
Once the oocyte has reached maturation and is ovulated, it is ready and capable of
being fertilized. When a sperm comes in contact with an oocyte, it will penetrate the zona

	
  

	
  
	
  

pellucida. The plasma membrane of the oocyte will then fuse with the membrane of the
sperm. Fusion of the sperm with the oocyte initiates a signaling cascade in the oocyte
cytoplasm, which leads to the activation of the oocyte and subsequent embryo
development (Amdani et al. 2015). The release of Ca2+ stores from the endoplasmic
reticulum is necessary for oocyte activation. How fusion of the sperm and the oocyte
causes the Ca2+ stores to be released has not been clearly delineated. The general
consensus is that there is a sperm oocyte-activating factor (SOAF) that is released into the
oocyte upon fusion, which initiates the cascade for Ca2+ release (Amdani et al. 2015).
However, this specific factor has yet to be identified. Ca2+ is released via inositol-1,4,5triphosphate receptors (IP3R) in the endoplasmic reticulum membrane after the release of
inositol-1,4,5-triphosphate (IP3 ). Upon fertilization, a protein factor from the sperm, the
SOAF, is incorporated into the oocyte and initiates the generation of IP3 (Amdani et al.
2015). The phospholipase C family is thought to be a likely candidate as being the SOAF
since these proteins catalyze the hydrolysis of phosphatidylinositol 4,5-biphosphate
(PIP2) to generate IP3 and diacylglycerol (DAG). IP3 causes the release of Ca2+ from the
ER membrane while DAG and Ca2+ activate the protein kinase C (PKC) pathway. PKC,
Ca2+/calmodulin-dependent protein kinase II (CaMKII), and mitogen activated protein
kinase (MAPK) all play critical roles in the signaling cascade that ensues from Ca2+
release. This signaling cascade will lead to further events that prepare the oocyte to be
activated, allow the pronucleus to form, and allow meiosis to resume so that embryo
development can occur (Amdani et al. 2015).
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The release of Ca2+ at fusion and activation of subsequent molecules will cause

the oocyte to undergo a series of structural and biochemical changes. The cortical
granules will undergo exocytosis and their contents will be released into the perivitelline
space (the space between the plasma membrane and zona pellucida) (Senger et al. 2012).
Exocytosis of the cortical granules is facilitated by Ca2+ release from the endoplasmic
reticulum. These contents include enzymes that will result in a biochemical change of the
zona pellucida - called the “zona block” - such that no further sperm can penetrate it. The
release of the cortical granules also causes structural and biochemical changes to the
oocyte vitelline, or plasma membrane - the “vitelline block” -, which reduces the ability
of the oocyte plasma membrane to fuse with additional sperm (Bleil et al. 1981; Sun
2003). The sum product of the zona and vitelline blocks is an elaborately redundant
method to prevent polyspermy – or the fertilization of a single egg with multiple sperm –
which results in an inappropriate number of chromosomes and certain embryonic failure.
The release of intracellular Ca2+ triggered by sperm/egg fusion is also necessary
for the second meiotic resumption in the oocyte in order to fully complete meiosis (Xu et
al. 1994). This increase in Ca2+ aids in the degradation of cyclin B, which deactivates
MPF (Lorca et al. 1993). This reduction in MPF activity allows the oocyte to resume
meiosis, resulting in the extrusion of the second polar body and a haploid oocyte.
After the sperm enters the oocyte cytoplasm, the nucleus decondenses and forms
the male pronucleus. The maternal chromatin also forms a pronucleus and the two
pronuclei then migrate to the center of the oocyte. At first mitosis, the pronuclear
envelopes breakdown allowing the chromatin to mix (Prather et al. 2009). After the first
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mitosis, DNA synthesis for the next cell cycle begins immediately without any growth
phase. Once DNA replication is completed, the embryo enters directly into mitosis. As
described previously, the maternal transcripts stored within the oocyte control this early
embryo development until the time the embryonic genome is activated, which timing
varies with each species. In mice, the maternal to zygotic transition occurs around the 2cell stage. In humans and pigs, this occurs at the 4-8 cell stage. And in cow, sheep, and
horse, the maternal to zygotic transition occurs at the 8-cell to compaction stage (Senger
et al. 2012).
At the beginning of embryo development, shortly after fertilization, the maternal
and paternal genome undergo global demethylation (Cantone and Fisher 2013). This
global demethylation occurs asynchronously in the maternal and paternal chromosomes.
Global demethylation is crucial in the early embryo in order to turn on transcriptional
machinery that was previously methylated and silenced in the germ cells in preparation
for embryonic genome activation, restoring pluripotency, establishing imprints that were
previously erased, as well as erasing any epimutations that may have occurred in the
germ cells (Cantone and Fisher 2013). Once the transcription machinery is active,
transcription from the incipient embryonic genome starts to occur. Some of the
transcripts that are initially made are responsible for the degradation of maternal
transcripts that are no longer needed (Stitzel and Seydoux 2007). The majority of these
transcripts must be degraded, since they come from a differentiated cell and could be
harmful to the embryo in establishing pluripotency. Genes that are involved in
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biosynthetic processes and pluripotency are then transcribed for continuing embryo
development.
All of these developmental events mentioned have to occur perfectly in order for
the oocyte to properly acquire developmental competence and be capable of sustaining
embryo development and maintaining pregnancy. Any alterations could lead to a
decrease in oocyte quality and affect the embryo’s ability to thrive, if the oocyte is even
capable of being fertilized. If any of these crucial processes throughout oocyte
development are perturbed, any number of detrimental effects may occur.
Environment and oocyte quality
The environment strongly influences the oocyte’s ability to acquire
developmental competence (Katz-Jaffe et al. 2009). Both the oocyte and embryo are very
sensitive to perturbations to their surrounding environment (Leroy et al. 2011). The fluid
within the follicle that houses the oocyte during development is derived from the blood in
the thecal capillaries. As development progresses, fluid accumulates in the follicle,
bathing the oocyte and providing the environment for oocyte development. The oocyte
microenvironment, in particular the follicular fluid, has been shown to influence the
metabolism, gene expression patterns, and developmental competence of oocytes;
blastocyst quality and implantation efficiency; and, ultimately, pregnancy rates
(Betteridge 2001). Changes that lead to alterations to the follicular fluid and the
microenvironment surrounding the oocyte can have long lasting effects on the quality of
the oocyte and ultimately, the embryo. Numerous examples of how various
environmental factors lead to alterations to the quality of the oocyte have been shown.
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Some of these environmental influences include superovulation, follicle size,
temperature, culture conditions, maternal age, nutrition and toxic chemicals.
Superovulation
Administration of exogenous gonadotropin hormones has been a widely used
method to hyperstimulate the ovary and induce the development and ovulation of a large
number of oocytes. Typically, this is done for embryo production and various assisted
reproductive technologies (ARTs). The quality of oocytes achieved through
superovulation has been shown to be decreased, most likely due to the artificial
stimulation for oocyte growth and ovulation of oocytes that most likely wouldn’t have
normally made it through development (Combelles and Albertini 2003). Superovulation
forces many oocytes to develop at a much quicker rate than normal and prevents the
normal selection process that occurs in vivo, which ensures that only the best oocyte(s)
develops and is ovulated. While superovulation may increase the number of oocytes
available to use, the competence of these oocytes is most likely compromised (Combelles
and Albertini 2003). Superovulation leads to alterations to the microenvironment
surrounding the oocyte (Moor et al. 1985), most directly by altering the hormone profile
(Szoltys et al. 1994). Research has shown in mice that there is a higher incidence for
spindle defects and aneuploidy following repeated superovulation (Van Blerkom and
Davis 2001). Superovulation can lead to alterations to germinal vesicle size, transcription
activity, cumulus to oocyte association, meiotic competence, and metabolism (Combelles
and Albertini 2003). Superovulation also leads to alterations to protein synthesis in the
oocyte (Moor et al. 1985) and decreased fertilization rates (Beaumont and Smith 1975).
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Even when the oocyte is capable of being fertilized, induced ovulation leads to an
increased likelihood for pregnancy and fetal abnormalities in rodents (Beaumont and
Smith 1975; Ertzeid and Storeng 1992; Fowler and Edwards 1957). In bovine and
hamster models, developmental competence of embryos produced from superovulated
oocytes is reduced (Blondin et al. 1996; McKiernan and Bavister 1998). Similar effects
have been observed in human assisted reproduction with delayed embryo development
and low birth weights following a superovulation regimen (Van Blerkom and Davis
2001). However, it is difficult to assess whether these abnormalities that are seen in
human assisted reproduction are primary or secondary in nature. Whether these affects
are entirely from a superovulation regimen or if they may be a consequence of the
subfertility issues the patient was being treated for in the first place is unknown.
Understanding the ultimate effects superovulation has in human assisted reproduction can
possibly be delineated using animal models, which are crucial for research applications to
determine what alterations may be occurring under specific circumstances. Even though
this method is widely used for many applications, superovulation has profound effects on
the quality of the oocyte.
Follicle size
The developmental competence of the oocyte is acquired throughout
folliculogenesis, when the follicle housing the oocyte is growing and developing. The
oocyte and follicle are closely linked with one another (Sirard 2012) so it is not surprising
that the developmental competence of the oocyte is affected by the size of the follicle
(Lonergan et al. 1994; Marchal et al. 2002; Pavlok et al. 1992). Oocyte growth coincides
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with the growth of the follicle, and in order for the oocyte to have enough time to achieve
competence the follicle must be at the preovulatory size. Oocytes recovered from small
follicles completed maturation at much lower rates, were less capable of being fertilized
in vitro, and had less success at reaching the blastocyst stage of embryo development
(Marchal et al. 2002). Ovulation of immature follicles in cows led to reduced fertility
(Atkins et al. 2010). Oocytes from small follicles have not yet completed cytoplasmic
maturation and most likely are deficient in the accumulation of necessary mRNAs and
proteins that are required for developmental successes. This deficiency would lead to a
decreased developmental competence.
Temperature
Oocytes are susceptible to extreme temperature stress (Roth 2008). During the
summer months, cows experience reduced reproductive performance due to heat (Roth
2008). Even in the fall, conception rates are still low. Oocytes from cows exposed to heat
stress had a reduction in their developmental competence (Roth 2008). Even the oocytes
recovered from later estrous cycles following heat exposure continued to have reduced
competence, which demonstrates that heat stress may be affecting the entire ovarian pool
and not just individual oocytes (Roth 2008). Extreme temperature stress leads to
alterations to the follicular microenvironment, and with the oocytes being exposed to this
environment for extended periods of time, it will undoubtedly have an effect on the
developmental competence of the oocyte (Roth 2008). Exposure of germinal vesicle stage
oocytes to heat stress reduced the proportion of oocytes that progressed to metaphase II
(Payton et al. 2004). Heat stress has also been shown to impair cytoplasmic and nuclear
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maturation. In particular, heat stress has been shown to impair the translocation of the
cortical granules, cytoskeletal rearrangement, and spindle formation (Ju et al. 2005;
Payton et al. 2004; Roth and Hansen 2005). Heat shock of oocytes in vitro led to reduced
maturation and fertilization with most of the oocytes arresting prior to reaching
metaphase II (Roth and Hansen 2005). These oocytes also had an increased incidence of
apoptosis. Steroid concentration amounts in the follicular fluid have also been shown to
be low following a hot season due to a lower production of these hormones by the theca
and granulosa cells (Wolfenson et al. 2000). Lower concentrations of steroid hormones
would most likely impact ovulation, as lower amounts of estrogen would lead to a
reduction in LH. Temperature, in particular heat, has a clear effect on reducing the
developmental competence of oocytes.
Culture conditions
In vitro-matured (IVM) oocytes lack the same developmental ability as oocytes
that are matured in vivo (IVV). Since almost 20% of women in the US are affected by
infertility, many of these women rely on assisted reproductive technologies (ARTs). In
fact, it has been estimated that 15% of women have received an infertility treatment
(Krisher 2004). Of the many ART cycles performed in a given year, 69% of in vitro
fertilization treatments will not result in pregnancy. ARTs typically involve ovarian
hyperstimulation with the collection of immature oocytes followed by in vitro maturation.
Oocytes collected at this stage of their development will typically have reduced
developmental competence most likely due to their inability to complete meiotic,
cytoplasmic or molecular maturation (Krisher 2004). In vitro maturation does not
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adequately support the correct development process within the oocyte, which is necessary
in order for the oocyte to be competent. In vitro culture conditions have also been
associated with a higher risk of aneuploidy and chromosomal errors, suggesting the
inability of these oocytes to complete meiotic maturation in a normal fashion (Bean et al.
2002) . In vitro-matured oocytes may complete meiotic maturation; however, they
typically lack the ability to fully complete cytoplasmic maturation (Krisher 2004).
Oocytes that cannot complete cytoplasmic maturation are of poor quality and lack
developmental competence (Krisher 2004). Blastocysts derived from in vitro-matured
oocytes result in lower rates of gestation (Sirard et al. 2006). Selection of good quality
oocytes in vivo involves a tremendous loss of oocytes that are unfit. In vitro maturation
lacks this rigorous selection, which could explain for the decrease in embryo quality
(Blanco M.R 2011). While it may be possible that the culture conditions the oocyte is
expected to mature in are not ideal compared to the in vivo environment, it is likely that
the simple action of taking immature oocytes from their follicles prior to them fully
completing their programming and growth process is responsible for the decrease in
quality. The induced maturation of immature and unfit oocytes is most likely perturbing
the normal process of the oocyte’s ability to acquire developmental competence, which
occurs during the growth phase, resulting in oocytes with reduced developmental
competence. In vitro maturation also requires the immature oocyte to become fully
matured in 1-2 days, a process that normally takes much longer in vivo.
Immature human oocytes may be capable of completing nuclear maturation in
vitro and can sometimes be fertilized and begin embryo development but they are often
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not capable of supporting further embryo development (Krisher 2004). These oocytes
most likely have not completed a normal cytoplasmic maturation, resulting in deficient
accumulation of mRNAs and proteins that are crucial for fertilization and sustaining early
embryo development (Krisher 2004). In vitro culture conditions most likely have
profound effects on the transcript abundances of IVM oocytes, which would explain why
only 30% of IVM oocytes from livestock species are able to reach the blastocyst stage
(Blanco M.R 2011). Thus, the lack of developmental competence of IVM oocytes
possibly reflects the abundance of specific transcripts in the oocyte (Lonergan et al.
2003b). With in vitro maturation, it is possible that there is insufficient degradation of
transcripts, which could be leading to altered transcript abundances. It is also possible
that there is a failure in these oocytes to become transcriptionally silent like they are
supposed to be at this point in development.
IVM oocytes have also been shown to have altered energy metabolism, whether it
be due to inefficient maturation medium or the innate quality of the oocyte itself (Krisher
2004). Even when only cultured for a short period of time, oocytes may lose their ability
to regulate metabolism correctly as has been seen with cultured embryos (Lane 2001). In
the porcine model system, good quality oocytes, such as those matured in vivo, have
increased glucose metabolism. Glucose metabolism is essential for the control of meiosis
so altered metabolism due to culture conditions could lead to impaired ability to progress
through meiosis. Krisher (2004) has shown that oocytes matured in vivo utilized glucose
via the glycolytic and pentose pyruvate pathway equally. However, oocytes matured in
vitro utilized glucose solely through the glycolytic pathway. Overall, the IVM oocytes
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were less metabolically active, which can ultimately affect many developmental
processes within the oocyte.
The generation of reactive oxygen species and oxidative stress is commonly
associated with in vitro culture (Combelles et al. 2009). Excessive oxidative stress
contributes to reduced development of oocytes and embryos (Guerin et al. 2001).
Reactive oxygen species have been shown to hinder oocyte maturation (Tamura et al.
2008). Oxidative damage in oocytes also results in impaired mitochondria leading to
further ROS formation, reduced ATP, and decreased glutathione, ultimately leading to a
decreased developmental competence (Krisher, 2004). Expression levels of antioxidant
related genes were found to be higher in IVM oocytes, suggesting that suboptimal in vitro
culture conditions can trigger a cytoprotective mechanism to protect oocytes from
oxidative damage (Lonergan et al. 2003a).
In vitro maturation of oocytes leads to a multitude of defects that impact the
development of the oocyte. With all the benefits that could come from using oocytes that
are matured in vitro, it is essential to more fully understand the nature of the in vitromatured oocyte in order to improve ART efficiency. Unless the quality of in vitromatured oocytes are improved, any efforts to use ARTs in the treatment of either human
infertility or animal production will continue to be less productive than possible.
Aging
A woman’s age is one of the most important factors affecting her ability to
conceive and give birth. By the time a woman hits mid 30’s, the ability to conceive and
give birth decreases significantly, with this rate declining further as age progresses
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(Johnson 2003). The oocyte is stored in meiotic arrest for possibly many decades causing
it to be a major contributor to the decline in fertility due to age (Johnson 2003). The
Center for Disease Control and Prevention demonstrates that when a patient’s own
oocytes are used for fertilization, birth rate declines with advancing age. However, when
oocytes are used from younger donors, birth rate will remain the same regardless of age.
This is a huge indicator that the oocyte is the primary cause for reproductive failure due
to aging. The molecular basis for the decline in oocyte competence due to aging is still
not fully understood. Profiling of global gene expression patterns in human and mouse
oocytes have revealed that aging alters the expression of many genes and that many
maternal mRNAs in aged oocytes are not properly degraded during maturation
(Santonocito et al. 2013). Thus, insufficient storage of mRNAs during maturation of aged
oocytes could be a likely cause for the reduction in the quality of the oocyte. Age
dependent oocyte deficiencies also include meiotic abnormalities and cytoplasmic
deficiencies (Jiao et al. 2012).
In humans, oocyte aging has been associated with a decline in mitochondrial
function, a reduction in transcripts from genes participating in spindle assembly, and an
increase in the frequency of apoptosis (Jiao et al. 2012). In mice, age related changes
included chromosome scattering, chromosome decondensation, alteration of gene
expression patterns, and high rates of DNA fragmentation (Jiao et al. 2012).
Transcriptome analysis of oocytes obtained from women over the age of 38 showed the
upregulation of pro-apoptotic genes such as CD40, TNFRSF10A, and TNFRSF21, and
the downregulation of anti-apoptotic genes such as BCL2 and CFLAR (Santonocito et al.
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2013). This analysis demonstrates that during maturation of oocytes of aged women,
accumulated mRNAs may be triggering the apoptotic pathway, leading to the decreased
developmental competence and quality of the oocyte.
The rate of aneuploid oocytes increases in aged females (Hassold and Hunt 2001;
Hassold and Hunt 2009; Hunt and Hassold 2010; Hunt and Hassold 2008; Nagaoka et al.
2012). Oocytes are maintained in meiotic arrest for many decades, leaving them
susceptible to environmental influences for many years, which could lead to detrimental
alterations such as aneuploidy. If an aneuploid oocyte is fertilized, the embryo may fail to
develop or implant. If the embryo does implant, it typically undergoes spontaneous
abortion. However, there are some instances when development goes to term, resulting in
congenital disorders (Shuda et al. 2009). Aneuploidy occurs due to meiotic errors in
chromosome condensation, spindle formation, chromosome alignment, or cytokinesis. In
particular, higher rates of aneuploidy are thought to occur due to premature separation of
the sister chromatids due to loss of cohesin (Nagaoka et al. 2012). Shortly before the first
meiotic arrest, homologous chromosomes pair up and remain this way due to the
chiasmata and the protein complex cohesin. Sister chromatids are held together at their
centromeres and pericentromeric regions by cohesin (Danylevska 2013). Cohesin
between the homologous pairs has to be abolished at the onset of anaphase I in order for
the chromatids to segregate (Danylevska 2013). However, cohesin at the centromeres
must remain intact until anaphase II. Over time, the cohesin connections weaken leading
to an increase in precocious segregation and non-disjunction (Danylevska 2013; Nagaoka
et al. 2012). REC8 is a prominent protein in the cohesin complex and was found to be
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significantly less abundant in aged oocytes, which would predispose these oocytes to
meiotic errors, including premature segregation (Chiang et al. 2010). Age related
depletion of SGO2, the protein responsible for preventing the degradation of the cohesin
complex, has also been observed (Lister et al. 2010). Alterations to Aurora kinase
function due to age was shown to lead to disruption of meiotic progression and
chromosome segregation errors, leading to nondisjunction (Shuda et al. 2009).
Understanding how the rates of aneuploidy can be improved is necessary in order to
reduce the rate of congenital disorders due to aged oocytes.
Oxidative stress in oocytes is another concern due to maternal aging. Oxidative
damage may accumulate in the oocyte after many years. Antioxidant expression has been
shown to be reduced due to advancing age (Combelles et al. 2009). A microarray analysis
demonstrated a reduced expression of those genes related to reducing oxidative stress in
oocytes from aged mice (Hamatani et al. 2004). Glutathione concentration has also been
shown to be decreased in aged oocytes (Tarin et al. 2004). Oxidative stress is associated
with mitochondrial defects, DNA damage, and apoptosis (Combelles et al. 2009).
Identification of how molecular components within the oocyte are altered due to
age will ultimately help to determine how fertility can be improved, regardless of age.
Nutrition
According to the Center for Disease Control and Prevention, approximately onethird of the adult population in the US is considered to be obese. Obesity has been shown
to impair reproductive performance (Norman and Clark 1998). From menstrual disorders
to infertility, miscarriage, poor pregnancy outcomes, and impaired fetal well-being,
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obesity can have significant consequences on the reproduction system. Many obese
women rely on ARTs to help assist them in getting pregnant. Obese women undergoing
ARTs have been shown to have a reduction in the number of oocytes retrieved, require a
higher dose of gonadotropins, have a lower pregnancy rate, and a reduced live birth rate
(Wu et al. 2011). The follicular fluid of obese women contains increased concentrations
of triglycerides and free fatty acids, which can impair oocyte maturation (Robker et al.
2009). Maternal nutrition can thus directly affect the quality of the oocyte. Over-nutrition
increases circulating glucose and insulin concentrations, which may have long-term
negative effects on the oocyte (Adamiak et al. 2005). Obese women have increased levels
of insulin and free fatty acids in the follicular fluid, which ultimately led to poor oocyte
quality (Jungheim et al. 2012). High glucose concentrations are detrimental to the oocyte
by delaying nuclear maturation, altering the oocyte’s interaction with the cumulus cells,
impairing oocyte metabolism, increasing oxidative stress, altering gene expression,
inducing embryo fragmentation, reducing blastocyst development, and inducing
apoptosis (Krisher 2004).
Obesity is known to cause lipotoxicity within the oocyte (Wu et al. 2010), which
occurs due to exposure to high levels of lipids in non-adipose tissue, causing the
accumulation of intracellular triglyceride droplets and free fatty acids (Wu et al. 2011).
This leads to significant damage to organelles such as the mitochondria and endoplasmic
reticulum due to the increased production of reactive oxygen species (Jungheim et al.
2012). Exposure to high concentrations of fatty acids results in perturbed oocyte
metabolism (Igosheva et al. 2010). Elevated free fatty acid levels also leads to impaired
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oocyte maturation and thus, decreased chances of successful pregnancy (Jungheim et al.
2012).
Obesity also increases palmitic acid concentrations (Wu et al. 2010). Increases of
palmitic acid in the environment surrounding the oocyte can impair cumulus expansion,
impair meiotic maturation, and increase the incidence of apoptosis in the oocyte (Leroy et
al. 2005). Palmitic acid is one of the most prevalent fatty acids in follicular fluid and is
altered under changing physiological conditions (Wu et al. 2011). Exposure of the
granulosa cells to palmitic acid led to the disruption of steroidogenesis and increased
rates of apoptosis (Jungheim et al. 2012). Granulosa cells are necessary for the survival of
the oocyte and any disruption to the communicative network between these cells and the
oocyte would lead to detrimental alterations to the oocyte.
Oocytes from obese mice have been shown to be smaller, have delayed meiotic
maturation, and increased rates of apoptosis (Jungheim et al. 2012). The offspring of
these mice displayed developmental defects and growth restriction (Luzzo et al. 2012).
Both obesity and diabetes lead to alterations to the mitochondria, exhibit spindle defects,
and chromosomal misalignment (Igosheva et al. 2010; Wang et al. 2009; Zhang et al.
2006).
By understanding how maternal nutrition impacts the molecular constituents
within the oocyte, this information can be used to identify potential applications to
increase the quality of the oocyte. Such applications might include therapeutic agents or
supplements, in order to increase fertility of those that are over-weight or obese.
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Environmental toxicants
Research has shown that chemicals that disrupt endocrine function are detrimental
to reproductive function. These endocrine disruptors alter reproductive behavior,
decrease fertility, increase the occurrence of pregnancy loss, and cause ovarian failure
(Pocar et al. 2003). The endocrine system is the main controller for many functions in the
reproductive system, including oocyte development. Exposure to these chemicals leads to
the disruption of endocrine balance through the decrease in production of the folliclederived sex steroid hormones. Without the adequate production of these hormones,
ovarian function is severely compromised, ultimately leading to the destruction of
oocytes and their development.
Xenoestrogens, synthetic or naturally occurring chemical compounds that mimic
estrogen activity, can directly affect the oocyte (Pocar et al. 2003). The ovary is a direct
target for xenoestrogens as they can easily interfere with the hypothalamic-pituitarygonadal axis and disrupt normal steroid hormone production. These toxic chemicals, as
well as other endocrine disruptors, decrease the viability of the oocyte as well as cause
the overall destruction of the oocyte. Concentrations of the xenoestrogen Bisphenol-A
(BPA) have been found in ovarian follicular fluid (Ehrlich et al. 2012). As oocytes are
bathed in the follicular fluid during their development, they too will be exposed to BPA.
In humans, high BPA levels were correlated with a reduced percentage of oocytes that
reached maturation (Ehrlich et al. 2012). There were also fewer normally fertilized
oocytes as well as decreased blastocyst formation. BPA adversely affects spindle
formation, centrosome dynamics, and chromosome alignment and segregation, leading to
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aneuploidy and chromosomal abnormalities (Hunt et al. 2003; Lenie et al. 2008; Susiarjo
et al. 2007). BPA also reduced Ca2+ oscillations, which directly affected meiotic
resumption, cortical granule exocytosis, and pronuclei formation (Lenie et al. 2008). BPA
can interrupt the earliest stages of oocyte development during fetal development, and any
disturbances at this time can significantly affect the entire cohort of oocytes produced
(Nagaoka et al. 2012). BPA also interferes with granulosa cell function and disrupts the
communicative network between the granulosa cells and oocytes, which ultimately
affects oocyte quality (Lenie et al. 2008).
Other environmental chemicals have been shown to decrease fertility by altering
oocyte function as well. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) can alter
reproductive capabilities through their incorporation into the follicular fluid and
interrupting ovulation of the oocyte (Pocar, 2003). Polychlorinated biphenyls (PCBs)
have also been shown to alter oocyte function. In rodent studies, administered PCBs
reduced the actual number of oocytes in the ovary, demonstrating that this toxicant
significantly affects reproduction by eliminating germ cells altogether (Pocar et al. 2003).
PCBs also can alter maturation of bovine oocytes in vitro as shown when the chemical
was placed in the maturation culture medium (Pocar et al. 2001). The majority of these
oocytes remained arrested in meiosis prophase I instead of advancing to metaphase II and
the oocytes that did mature properly showed a decrease in fertilization capabilities. PCBs
during maturation also led to an increase in polyspermy in bovine oocytes. Alm, et al.
(1998) demonstrated that exposure to the pesticide dichlorodiphenyltrichloroethane
(DDT) significantly altered maturation in bovine oocytes and led to high rates of
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chromatin degeneration. In rabbits, DDT led to decreased ovulation rates (Lindenau et al.
1994). Campagna, et al. (2001) used an organochlorine mixture to identify the effect(s)
that the exposure to multiple toxicants can have on porcine oocyte development. The
toxicants significantly altered oocyte maturation rates, reduced cumulus cell viability,
increased rates of degeneration in oocytes as well as reduced further developmental
competence. Exposure to organochlorine chemicals also induced changes to
polyadenylation patterns and led to altered translational regulation of transcripts (Pocar et
al. 2003). These toxic chemicals also affected other aspects of cytoplasmic maturation.
For instance, most oocytes exposed to these organochlorine chemicals exhibited delayed
migration and dispersal or cortical granules (Pocar et al. 2003). In vitro exposure of these
organochlorine chemicals to mouse oocytes also blocked cortical granule exocytosis
(Greenfeld et al. 1998). Endocrine disrupting chemicals can significantly affect the
reproduction system, in particular the oocyte.
Assessing oocyte quality
Currently, there is not an accurate means of assessing oocyte quality that is not
invasive and/or requires the destruction of the oocyte. There is an urgent need to identify
more objective, predictive, and non-invasive markers of oocyte competence.
Oocyte quality can be assessed using markers of oocyte differentiation, meiotic
competence acquisition, metabolism, developmental competence, fertilization
capabilities, and embryo/fetal development (Combelles and Albertini 2003). Other
markers of oocyte quality such as ATP content, glutathione and reactive oxygen species
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content, mRNAs and protein present, and mitochondrial activity are also used to assess
quality (Krisher 2004).
The most common technique for evaluating oocyte quality in vitro is meiotic
maturation. Assessing meiotic maturation is a quick, non-invasive method to observe
whether or not an oocyte has successfully gone through maturation and reached
metaphase II, indicated by the extrusion of the first polar body. At this point, the stage of
oocyte development can be confirmed as well as that it was capable of successfully
resuming meiosis and reaching maturation. However, this does not give any information
on the oocyte’s ability to successfully undergo cytoplasmic and molecular maturation.
Fertilization is obviously a method used to assess oocyte quality, as an
incompetent oocyte will be unable to be successfully fertilized. In order to have the
ability to be fertilized, the oocyte must not have only resumed meiosis and reached
metaphase II, but also have successfully undergone cytoplasmic maturation. Cortical
granules must be redistributed prior to fertilization so that they may successfully undergo
exocytosis and release their contents into the perivitelline space to prevent polyspermy
(Senger et al. 2012). While fertilization is a good indicator of the oocyte’s ability to
successfully complete meiotic and cytoplasmic maturation, it is not indicative of
molecular maturation and the oocyte’s previous performance in accumulating the
necessary mRNAs and proteins for embryo development.
Another common method used to assess oocyte quality is the development of the
embryo to the blastocyst stage. As mentioned previously, early embryo development is
reliant on the inherent quality of the oocyte. The oocyte must properly achieve the three
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levels of maturation in order to be competent. In particular, the oocyte must synthesize,
accumulate, and store essential transcripts not only for oocyte development, but embryo
development as well. The majority of embryos that do not reach the blastocyst stage of
development are blocked at the time of the embryonic genome activation (Sirard et al.
2006). This would indicate that the oocyte did not properly achieve competence during
development. Blastocyst quality is directly correlated with the quality of the oocyte from
which it derived (Sirard et al. 2006).
Many of these methods that are used are good starting points for assessing the
general quality of an oocyte but there are many underlying issues that cannot be
measured through these methods. There is not currently a complete means of thoroughly
measuring the quality of an oocyte. Examining different environmental aspects that could
be altering the oocyte (such as ART technologies themselves, nutrition, and age) could
provide information to help to identify markers that could be indicative of oocyte quality.
Identification of these markers will help to better understand the oocyte and how
developmental competence can be improved. Understanding the differences in mRNA
profiles and transcript abundance within individual oocytes might provide an
understanding of how to predict their competence and potential to produce viable
embryos.
Impact of the project
The quality of the oocyte is currently proving to be the cause for many fertility
issues as good oocyte quality is crucial for embryo development, maintaining pregnancy,
and ultimately the birth of the offspring. Identifying non-invasive markers of oocyte
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quality that could eventually be used to identify good quality oocytes during assisted
reproductive technologies would ultimately help improve many of these fertility issues.
This research has the potential to enhance our understanding of oocyte development and
ultimately improve embryo production.
Any alteration to the environment surrounding the oocyte has the possibility of
affecting the oocyte’s ability to achieve proper competence. The overall hypothesis that
was tested for this work is that manipulations to the environment surrounding the oocyte
alter the intracellular molecular and biochemical components that are determinants of
oocyte quality. To test this hypothesis, we 1) Characterized the molecular differences
between oocytes matured in vivo and those matured in vitro, 2) Identified how aging
alters the molecular composition within the oocyte, and 3) Described how maternal
nutrition can change the molecular constitution of the oocyte. By evaluating the
molecular components of oocytes for each described environmental factor, we expected
to identify what was being altered within the oocyte that may possibly explain their
decreased developmental ability. Identification of differentially expressed molecules will
help to identify what imparts oocyte developmental competence (Krisher 2004). Using
this knowledge will help to determine how the environment can be manipulated in each
of these circumstances or how the expression of specific transcripts can be altered in
order to improve oocyte quality.
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CHAPTER 2
GENE EXPRESSION ANALYSIS OF IN VIVO- AND IN VITROMATURED PORCINE METAPHASE II OOCYTES

Abstract
In vitro-matured (IVM) oocytes lack the same developmental competence as
oocytes that are matured in vivo (IVV), yet no compelling explanation for this
discrepancy has been provided at the molecular level. The aim of this study was to
identify molecular alterations between porcine oocytes that are matured in vitro
compared to those that are matured in vivo, which may ultimately lead to differences in
developmental competence. The transcriptomes of in vivo-matured and in vitro-matured
porcine oocytes were analyzed using the Illumina sequencing platform. This analysis
identified 493 transcripts that were differentially expressed (FDR-adjusted P<0.05)
between the IVV and IVM oocytes. Of these, 460 (93%) were more abundant in the IVM
oocytes, whereas 33 (7%) were more abundant in the IVV oocytes. In the second part of
this study, quantitative real-time PCR was used to evaluate relative gene expression
levels of 70 genes from a variety of functional gene categories in individual IVM and
IVV porcine oocytes. Relative transcript abundances for 18 out of the 70 genes tested
were found to be differentially expressed between the IVM and IVV oocytes. Of these
differentially expressed genes, 14 were higher in the IVM oocytes and only 4 were higher
in the IVV oocytes. Based on RNA sequencing and qPCR results, western blot analysis
of protein expression levels of the hypoxia-inducible chaperone protein HYOU1 in IVV
and IVM porcine oocytes was performed. Relative levels of HYOU1 protein were found
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to be significantly higher (P<0.05) in the IVM oocytes. We conclude that in vitro
maturation has profound effects on the molecular constituents of metaphase-II oocytes
with a particularly pronounced effect on RNA degradation.
Introduction
The Center for Disease Control and Prevention estimates that almost 20% of
women in the US are affected by infertility (Krisher 2004). Some causes of poor
infertility have previously been identified such as ovulation disorders, reproductive tract
abnormalities, and ovarian insufficiency, etc. However, the majority of causes have yet to
be fully delineated. Understanding the factors that may contribute to poor fertility will
ultimately facilitate improvement and optimization of reproductive efficiency in women.
Much of the research currently being performed to understand these causes of
subfertility uses large domestic species as model systems because of their similarities to
humans with respect to gametogenesis, fertilization, and early embryo development.
Successful research investigating the oocyte and early embryo relies on the availability of
high quality, competent oocytes. A good quality oocyte must be able to resume meiosis
after being meiotically quiescent for an extended period of time, cleave following
fertilization, develop to the blastocyst stage of embryo development, induce a pregnancy,
and develop to term (Sirard et al. 2006). While in vivo-matured oocytes are of the highest
quality, utilization of these oocytes is not practical in most settings using non-rodent
domestic species, leaving researchers to rely on oocytes matured in vitro for their
research material. However, in vitro-matured (IVM) oocytes have been shown to be
inferior to their in vivo-matured (IVV) counterparts in almost every aspect (Leibfried-
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Rutledge et al. 1987; Rizos et al. 2002): IVM oocytes lack the same developmental
competence as IVV oocytes (Leibfried-Rutledge et al. 1987), and IVM oocytes are
inferior in their ultrastructural morphology (Hyttel et al. 1986; Hyttel et al. 1988; Hyttel
et al. 1989), fertilization efficiency (Wang et al. 1998; Gioia et al. 2005), glucose
metabolism (Krisher et al. 2007), and chromatin reprogramming capabilities (Gioia et al.
2005) as well. Typically, only 30% of in vitro-matured oocytes from domestic livestock
species reach the blastocyst stage post-fertilization as opposed to almost 100% of in vivomatured oocytes (Peters et al. 2001; Blondin et al. 2002; Sirard et al. 2006). Blastocysts
derived from IVM oocytes will also typically result in lower pregnancy rates compared to
their in vivo counterparts, which is most likely due to faulty culture conditions that
prevent proper oocyte programming and acquisition of developmental competence
(Sirard et al. 2006). In order to enhance the efficiency of reproductive technologies and
research, it is essential to more fully understand the nature of the in vitro-matured oocyte
(Krisher 2004).
The growing and maturing oocyte has been shown to be very sensitive to changes
in its surrounding environment (Ashworth et al. 2009), and in vitro maturation systems
likely exert inappropriate influence on the molecular components and biochemical
signaling pathways within the oocyte during this period of extreme sensitivity, leading to
a decrease in oocyte quality. The oocyte relies on its surrounding environment for cues in
order to acquire proper molecular maturation. The oocyte’s ability to acquire
developmental competence can be strongly influenced by its environment, including pH,
oxidative and/or other metabolic stressors, and inadequate culture media that may be
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affecting gene expression (Katz-Jaffe et al. 2009). Trounson et al (2001) showed that the
reduced developmental potential of human in vitro-matured oocytes is attributable to
poor culture conditions that lead to incomplete oocyte growth and abnormal maturation.
During the growth phase, the oocyte accumulates RNAs and proteins that are required for
completion of the meiotic cell cycle, chromatin remodeling and cell cycle activation
associated with fertilization, the first mitotic cell cycles, establishing the embryonic
genome, and normal metabolic and homeostatic processes. Incomplete oocyte growth can
lead to a failure to complete any of these steps (Jones et al. 2008). During bovine in vitro
maturation, the germinal vesicle breaks down earlier, cumulus cells expand to a greater
extent, and meiotic maturation occurs more rapidly (Blanco M.R 2011). Since it is
primarily the intrinsic quality of the oocyte that determines whether a zygote has the
potential to progress through early development and, ultimately, on to the successful
establishment of pregnancy (Lonergan et al. 2003; Krisher 2004; Combelles and
Racowsky 2005; Roberts 2005; Sirard et al. 2006; Wang and Sun 2007) the intracellular
changes occasioned by in vitro culture conditions are likely directly responsible for the
observed decreased developmental capabilities of IVM oocytes, but the precise molecular
mechanism(s) responsible for these changes are still only poorly understood.
Messenger RNA transcript synthesis and storage occur during the growth phase of
the oocyte during oogenesis in vivo. Once oocyte growth is completed, maternally-stored
transcripts are degraded and/or genes are silenced (Krisher 2004). In vitro maturation
conditions can influence transcript acquisition and maintenance (Katz-Jaffe et al. 2009).
In vitro maturation most likely causes insufficient storage and/or degradation of
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transcripts, which could in turn affect the oocyte’s ability to achieve proper
developmental competence (Katz-Jaffe et al. 2009). The identification of perturbations
that may be occurring within the oocyte due to various environmental factors could
possibly determine how to improve oocyte developmental competence under these
environmental conditions.
For this set of experiments, we aimed to characterize the molecular differences
between porcine oocytes matured in vitro and in vivo. Specifically, we hypothesized that
in vitro maturation results in altered abundance of mRNA transcripts stored within the
oocytes in a manner that would eventually lead to a decrease in developmental
competence. In order to characterize the molecular differences between oocytes matured
in vivo and those that are matured in vitro, we first analyzed the global transcriptome
profile of the two populations of oocytes, IVM and IVV, using RNA-sequencing
technologies. We expected that the profiling by sequencing would help us to identify
gene families or functional groups that are differentially expressed due to the different
maturation protocols. Next, we evaluated the relative expression levels of 70 selected
genes using quantitative PCR analysis of individual IVM and IVV oocytes. And lastly, a
protein was selected, based on results from the RNA sequencing and qPCR data, to
evaluate whether changes between IVV and IVM oocytes at the transcript level also
occur at the protein level. These results should provide a better understanding of the
molecular differences that occur in oocytes due to in vitro maturation conditions in order
to eventually provide knowledge as to how these oocytes can be improved and the
efficiency of assisted reproductive technologies can be enhanced.
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Materials and methods
All chemicals and other bioreagents were purchased from Sigma-Aldrich (St.
Louis, MO), unless otherwise indicated. Animal use and handling was undertaken in
accordance with strict principles of animal welfare as approved of and overseen by the
veterinary staff and the Institutional Animal Care and Use Committee at Utah State
University (IACUC protocol #1471).
Experiment 1 – Global transcriptome profiling of IVV and IVM oocytes by RNA-Seq
Collection of oocytes
Surgery was performed on three pigs to obtain in vivo-matured oocytes, 44 hours
from first detection of heat to flush any oocytes that had been ovulated. A small, surgical
incision was made in the uterine horn just below the uterotubal junction (UTJ). A
sterilized glass pipette was then inserted into the uterine lumen until it but up against the
UTJ. A gavage needle and syringe filled with flushing medium was threaded through the
infundibulum to the opening of the oviduct. Flushing medium consisted of 114 mM
sodium chloride, 3.20 mM potassium chloride, 2 mM sodium bicarbonate, 0.34 mM
monosodium phosphate, 10 mM sodium lactate, 0.5 mM magnesium chloride
hexahydrate, 10 mM hepes, 50 µg/mL gentamicin, 2 mM calcium chloride dihydrate, 0.05
g polyvinyl alcohol, 12 mM sorbitol, and 0.2 mM sodium pyruvate. Approximately 20
mL of this medium were flushed through the oviduct, past the UTJ, through the glass
pipette, and into a 50 mL conical tube in order to collect any ovulated oocytes. Oocytes
were identified immediately using a stereomicroscope and were checked for maturation,
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indicated by the extrusion of the first polar body. Metaphase II oocytes were then washed
in phosphate buffered saline (PBS), pooled in groups of five for each pig, snap frozen in
liquid nitrogen, and stored at -80°C. An extra group of five oocytes was collected from
one of the three pigs and was frozen for future use as well, for a total of 4 groups of IVV
oocytes.
In order to collect the in vitro-matured oocyte samples, postmortem ovariectomy
was performed on the exact same three pigs used previously for in vivo oocyte flushes.
Oocytes were aspirated and matured in vitro for 44 hours essentially as described by Lai
and Prather (2003). In vitro maturation media consisted of 0.1% (w:v) polyvinyl alcohol,
30 mM sodium bicarbonate, 3.05 mM D-Glucose, 0.91 mM sodium pyruvate, 50 µg/mL
Gentamicin, 0.5 µg/mL LH (Sioux Biochemical; Sioux Center, IA, USA), 0.5 µg/mL
FSH (Sioux Biochemical), 0.57 mM cysteine, 10 ng/mL epidermal growth factor, and
10% (w:v) porcine follicular fluid in m199 base medium (Caisson Labs; Logan, UT).
After 44 hours, oocytes were stripped of cumulus cells using 1 mg/mL hyaluronidase
diluted in maturation media and vortexing. Oocytes were then checked for maturation,
indicated by the extrusion of the first polar body. Groups of five oocytes were then snap
frozen in liquid nitrogen and stored at -80°C for future use. An extra group of five
oocytes was collected from one of the pigs and was frozen for future use as well, for a
total of 4 groups of IVM oocytes.
RNA isolation
Total RNA was isolated from each group of oocytes using the DNA/RNA All
Prep Micro Kit from Qiagen (Valencia, CA, USA) according to the manufacturer’s
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recommended protocol with the exception that the final elution of the RNA off the
column was performed twice using 10 µL of elution buffer each time, for a final elution
volume of 20 µL. RNA samples from the eight pools of oocytes were then submitted to
the University of Utah Genomics Core for RNA-sequencing using the Genome Analyzer
II platform from Illumina (San Diego, CA).
cDNA synthesis and library preparation
cDNA synthesis and sequencing library preparation were performed by the
University of Utah Genomics Core. To briefly summarize the methods that were used,
poly-A mRNA was first separated from total RNA using oligo dT-attached magnetic
beads. Poly-A RNA was then eluted from the beads and fragmented and primed with
random hexamers in preparation for cDNA synthesis. First strand reverse transcription
was accomplished using Superscript II Reverse Transcriptase (Invitrogen cat#18064-014)
according to the manufacturer’s instructions, using the maximum volume allowed, 8 μL
of prepared poly-A mRNA per reaction. Following second strand synthesis, the cDNA
was converted to blunt-ended fragments. An A-base was added to the blunt ends to
prepare the fragments for adapter ligation and block concatamer formation during the
ligation step. Adapters containing a T-base overhang were then ligated to the A-tailed
DNA fragments. Ligated fragments were subjected to 12 cycles of PCR enrichment using
the SMARTer Ultra Low RNA Kit (Clontech; Mountain View, CA) for unbiased
preamplification of minute nucleic acid samples and the amplified library was purified by
Agencourt AMPure XP beads (Beckman Coulter Genomics cat#A63881). The
concentration of the amplified library was measured with a NanoDrop spectrophotometer
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and an aliquot of the library was resolved on an Agilent 2200 Tape Station using a High
Sensitivity D1K (cat# 5067-5363 and 5067-5364) assay to define the size distribution of
the sequencing library. Libraries were adjusted to a concentration of approximately
10nM and quantitative PCR was performed using the Kapa Biosystems Kapa Library
Quant Kit (cat# KK4824) to calculate the molarity of adapter ligated library
molecules. The concentration was further adjusted following qPCR to prepare the library
for Illumina sequence analysis.
Sequencing
Upon successful assembly of libraries, the samples were loaded on individual
lanes of GAII flow cells, and were sequenced using manufacturer recommended cycling
parameters. These sequencing efforts resulted in millions of sequencing ‘reads’,
approximately 50 base pairs in length. Read count normalization and alignment were
accomplished in a similar manner to what we have reported previously (Isom et al. 2010),
with individual reads being aligned to a custom swine transcriptome database using the
software program RSEM (Li and Dewey 2011). Read count normalization and alignment
was performed by the University of Missouri Bioinformatics Research Core Facility.
Statistical methods
The DESeq package (Anders and Huber 2010) in Bioconductor (Gentleman et al.
2004) was used to identify genes differentially expressed between oocytes from different
maturation methods. The test for differential expression was based on a model using the
negative binomial distribution, which included an estimate of the mean-variance

	
  

	
  
	
  

dependence. Each gene’s p-value for the IVV vs. IVM oocyte type difference was
adjusted to control the false discovery rate (Benjamini and Hochberg 1995), or FDR In
addition to statistical significance (with adjusted P-value less than 0.05), transcripts
needed to show at least a 2-fold mean expression difference between the IVV and IVM
oocyte types, and also a combined coefficient of variation less than 1 (CVIVM + CVIVV ≤
1) in order to be considered significantly differentially expressed. The mvGST package
(Stevens and Mecham 2014) in Bioconductor (Gentleman et al. 2004) and the
DAVID/EASE Functional Annotation tool (Huang et al. 2009), were used to identify
Gene Ontology biological processes that were differentially represented in the
upregulated gene lists from IVV and IVM samples. A multiple testing correction was
applied for both analyses using the Benjamini-Hochberg method to control the false
discovery rate (Benjamini and Hochberg 1995). For the GO analysis that was done using
the mvGST package, the gene lists used included the genes that were found to be
significantly more abundant in the IVM oocytes and those genes that were found to be
significantly more abundant in the IVV oocytes. These lists were used separately to
appropriately determine what biological processes were affected in IVM oocytes
compared to IVV oocytes. For the DAVID/EASE GO analysis, the genes that were found
to be significant in both IVM and IVV (with adjusted P-value less than 0.05), had at least
a 2-fold mean expression difference between the IVV and IVM oocyte types, and also
had a sum of both types’ coefficients of variation less than 1 were used to determine what
biological processes may be affected by these differentially expressed genes. The human
genome was used as the background gene list due to the swine genome list not being
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available. All terms listed in the functional annotation table given by the DAVID/EASE
software were used for our analysis.
A hierarchical clustering analysis was performed using the Multiexperimental
Viewer (MeV) data analysis software (Saeed et al. 2003). The Spearman Rank distance
complete linkage clustering algorithm was selected for this analysis. The log2
transformed normalized read-count values were used to identify similarities or
differences in expression patterns between all samples.
Experiment 2 - qPCR analysis of individual IVV and IVM oocytes
Collection of oocytes
To obtain in vivo-matured oocytes, surgery was performed on four different pigs,
approximately 44 hours from first detection of heat to flush any oocytes that had been
ovulated, as previously described. Oocytes were collected and checked for maturation,
which was indicated by the extrusion of the first polar body. Oocytes properly arrested at
the MII stage were washed and then frozen individually and stored at -80°C. For the in
vitro-matured oocyte samples, ovaries were obtained from a local slaughterhouse on six
different collection days. Oocytes were aspirated from ovaries and put into the same in
vitro maturation medium defined previously. After 44 hours, oocytes were stripped of
cumulus cells using 1 mg/mL of hyaluronidase diluted in maturation media and
vortexing. Oocytes were checked for maturation, indicated by the extrusion of the first
polar body and then stored at -80°C for future use.
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RNA isolation and reverse transcription
Total RNA was isolated from individual oocyte samples using the Quick-RNA™
Micro Kit (Zymo Research; Irvine, CA). The manufacturer’s protocol was followed
precisely with the exception that the final elution of the RNA off the column was
performed twice for a final elution volume of 20 µL. Eight microliters of RNA from each
oocyte was used for reverse transcription using the GoScript Reverse Transcription
system from Promega (Madison, WI). A mix of 2 µL (0.5 µg each) of the oligo-dT and
random primers supplied in the kit, 4 µL of the 5x Reaction Buffer, 4.8 mM of MgCl2, 2
mM of Nucleotide Mix, 20 U of RNasin, and 1 µL of reverse transcriptase were used for
each reaction. Following reverse transcription, cDNA quality was confirmed with a PCR
reaction using Qiagen’s Hot Start PCR kit. cDNA samples were then stored at -20°C until
further use.
Fluidigm qPCR analysis
The qPCR system used in these experiments is a novel platform from the
Fluidigm Corporation (South San Francisco, CA). This qPCR system follows standard
PCR chemistry with the incorporation of an elaborate network of nanoliter-scale
microfluidics based reaction wells for analyzing the expression of up to 96 genes for each
of 96 samples on Fluidigm’s 48.48 Dynamic Array Integrated Fluidic Circuits (IFC). Of
these genes, 21 were selected based on differential expression in the RNA sequencing
experiment. The remaining genes selected fell into the following functional categories:
housekeeping (EIF4A1, ACTB, GAPDH, HSP90AA1, RPN1, TAF11), RNA degradation
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(CNOT3, DCP1A, DCP2, DCPS, DDX6, LSM1, PABPC1, PABPC1L, PABPC4,
PABPN1, PABPN1L, PAN3, PARN, XRN2), maternal effect (H1FOO, YBX2, ZP2, ZP3,
BMP15, GDF9, MOS, NOBOX, ZAR1), epigenetic modifiers (SIRT1, HDAC3, EZH2,
EHMT2, DNMT3A, DNMT1, DMAP1, ASH2L), pluripotency factors (SOX2, POU5F1,
LIN28, KLF4), apoptotic regulators (ATM, BCL2L1, XIAP), and imprinting (IGF2R,
PEG10, UBE3A). The corresponding gene names for each symbol can be found in Table
2-1. Custom primers were designed through the Fluidigm Corporation’s DeltaGene assay
design service. Each primer was designed based on NCBI’s reference sequence for swine.
Supplemental Table 2-1 provides the gene and PCR primer information.
Fluidigm’s recommended protocol (ADP 14) was followed for performing
quantitative PCR gene expression analysis using the Biomark system. Prior to
quantitative PCR thermal cycling, a specific target amplification (STA) was performed to
enrich each sample. A 200 nM STA primer mix was prepared by pooling 1 µL of each
primer pair (20 µM each). The STA reaction mixtures consisted of 1.25 µL of the STA
primer mix, 2.5 µL of TaqMan PreAmp Master Mix (Applied Biosystems; Foster City,
CA), and 1.25 µL of cDNA. The reactions were activated at 95°C for 10 minutes and
then amplified for 14 cycles (95°C for 15 seconds then 60°C for 4 minutes). Following
STA thermal cycling, each reaction was treated with Exonuclease I (ExoI; New England
Biolabs; Ipswich, MA) to remove any unincorporated primers. The ExoI reaction pre-mix
consisted of 1.4 µL water, 0.2 µL ExoI Reaction Buffer and 0.4 µL ExoI enzyme for each
STA reaction. Two microliters of the ExoI reaction pre-mix were added to each STA
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reaction and combined reactions were then incubated at 37°C for 30 minutes in order to
allow the digestion of unincorporated primers to run to completion. Reactions were then
inactivated at 80°C for 15 minutes. Each reaction was diluted 5-fold as suggested for a
total volume of 25 µL, and then stored at -20°C until they were analyzed with the
Fluidigm IFC gene expression chip.
Individual sample and primer solutions were then prepared for qPCR cycling. The
sample pre-mix solutions consisted of 2.5 µL of the 2x TaqMan Gene Expression Master
Mix (Applied Biosystems), 0.25 µL of 20x DNA Binding Dye Sample Loading Reagent
(Fluidigm), 0.25 µL 20x EvaGreen DNA Binding Dye (Biotium) and 2 µL of the diluted
ExoI-treated STA sample. The primer mix was made for every primer set using 2.5 µL of
the 2x Assay Loading Reagent (Fluidigm), 0.25 µL water, and 2.25 µL of each 20 µM
Forward and Reverse primer mix. The IFC was first inserted into the IFC controller to be
primed and prepared for sample loading using the Prime Script (113x). After priming the
chip, 5 µL of each assay (primer pair) and 5 µL of each cDNA sample were pipetted into
their respective inlets on the chip. The chip was then returned to the IFC Controller for
chip loading using the Load Mix (113x) script in order to load the samples and assays
into the reaction chambers on the chip. Once chip loading had finished, the chip was
placed in the BioMark thermal cycler for quantitative PCR. Cycling parameters consisted
of 5 minutes of initial enzyme activation, followed by 35 denaturation/extension cycles
(95°C for 15 seconds followed by 60°C for 60 seconds) and a 3-minute final extension
cycle. A melt curve analysis was performed following PCR amplification to assess the
quality of each amplicon.

	
  

	
  
	
  

68	
  
The Fluidigm Real-Time PCR Analysis Software was used to analyze the data.

This software uses the raw cycle threshold value determined through thermal cycling in
order to quantitate the ∆Ct value by normalizing through one selected housekeeping gene
that worked most consistently for all samples (HSP90AA1). This software also assessed
the melting curve to determine the quality of each reaction. A selected calibrator sample
(a pooled 100 oocyte sample) was used to determine the ∆∆Ct value for each reaction,
which was done by subtracting the ∆Ct of each experimental sample by the ∆Ct of the
calibrator sample for each gene. Lastly, the fold change was determined for each sample
by using the equation 2-∆∆Ct.
A standard curve was used to calculate primer efficiencies using the formula
equation E=10-1/slope (Applied Biosystems, 2004). Any primers that had amplification
efficiencies of less than 80% or were unable to provide good amplification in at least half
the samples were excluded from the analysis. A total of 70 genes were included further in
our analysis where each gene was evaluated in 29 individual IVV oocytes and 33
individual IVM oocytes. Statistical evaluations involved a per-gene ANOVA with
particular attention to differential expression (normalized log2 fold change values)
between maturation groups. A Bonferroni multiple testing adjustment was applied to
control the family-wise error rate and significance was set at P<0.05. For each gene found
to be significantly differentially expressed between IVV and IVM maturation groups, a
model was fit to test the main effect of donor pig on relative gene expression levels. A
post-hoc pairwise comparison of log2 fold change values between individual donor pigs
was done to identify the source of any maternal effects that may be contributing to
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variability within maturation groups. Only those genes that were found to be expressed
at different levels between maturation groups and showed no significant effect of donor
pig on relative transcript levels were reported here as being significantly influenced by
maturation.
A hierarchical clustering analysis was performed using the Multiexperimental
Viewer (MeV) data analysis software (Saeed et al. 2003). The Spearman Rank distance
complete linkage clustering algorithm was selected for this analysis. The log2 fold change
values were used to identify similarities or differences in expression patterns between all
samples.
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Experiment 3- Western blot analysis of individual IVV and IVM oocytes
Collection of oocytes
We performed a western blot analysis of ORP150 (HYOU1) protein levels in
order to test whether differential transcript abundance between IVM and IVV oocytes
would manifest as differential protein expression as well. In vivo- and in vitro-matured
oocytes (from abattoir-derived ovaries) were collected and prepared as described above.
Two western blot replicates were performed. For the first western blot replicate, 15 IVV
oocytes collected from two different pigs, and 15 IVM oocytes from two different IVM
days were used; and for the second replicate, 60 IVV oocytes from five different donor
pigs, and 60 IVM oocytes from two different batches of abattoir-derived ovaries were
used. A pooled sample containing 100 IVM oocytes collected from multiple ovaries was
used as the control sample.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western
blotting analysis
Oocytes were first treated with 15uL Laemmili Sample Buffer (Bio-Rad;
Hercules, CA), 4µL β-mercaptoethanol, and 1µL of 5x protease inhibitor. (Thermo
Fisher/Life Technologies; Grand Island, NY, USA). Proteins were separated on a 7.5%
Tris-Glycine gel (BioRad; Hercules, CA, USA) using SDS-PAGE. Gel proteins were
transferred using a standard wet transfer protocol to a Immobilin-P PVDF membrane
(EMD Millipore; Billerica, MA, USA) overnight at 130 mA at 4°C. The membrane was
then blocked using 5% skim milk in 1xTris-buffered saline/0.05% Tween 20 (TBST) for
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7 hours at 4°C. TBST was composed of 100 mL10xTBS (80 g NaCl, 2 g KCl, 30 g TrisFree Base in 1L double distilled water) and 500 µL Tween 20 in 1 L double distilled
water. Incubation of primary antibody was performed overnight at 4°C with rabbit
polyclonal anti-ORP150 (Catalog No. ab125281; Abcam; Cambridge, MA, USA), at a
1:500 dilution in 1% skim milk in TBST. This was followed by incubation with goat antrabbit secondary antibody conjugated to horseradish peroxidase (Catalog No. sc-2004;
Santa Cruz Bio; Dallas, TX, USA,) for 1 hour at a concentration of 1:2000 in 1% skim
milk in TBST. Bands were detected using Pierce ECL2 Western Blotting Kit (Catalog
No. 80197; Thermo Fisher/Pierce, Waltham, MA, USA) at an exposure time of 1 minute.
The western blots were evaluated with a standard densitometry approach, using Adobe
Photoshop for image analysis of the scanned blots as described by the Dalton
Cardiovascular Research Center at the University of Missouri (Miller 2011). An average
relative intensity for IVM and IVV samples was calculated and a ratio was taken to
determine relative difference in protein expression. A student’s t-test was performed to
determine statistical significance, which was set at P<0.05.
Results
Experiment 1 – Global transcriptome profiling of IVV and IVM oocytes by RNA-Seq
Global gene expression profiles of pooled in vivo-matured (IVV) and in vitromatured (IVM) oocytes from 3 pigs were analyzed by RNA-Seq using the Illumina
sequencing platform. Illumina sequencing effectively produced large numbers of high
quality reads from the sample types submitted. After reads were trimmed and filtered and
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contaminants were removed, 1 x 107 reads per sample remained that uniquely aligned to
the custom swine transcriptome database.
Sequencing reads were aligned using RSEM, a package that assigns the reads to
the custom database. Table 2-2 provides summary data for the alignment statistics for the
IVV and IVM samples. Supplemental Table 2-3 provides a more thorough explanation of
the filtering, trimming, and alignment statistics for all samples. Alignment statistics were
extremely low for one sample (IVV #3). The quality of this sample proved to be lesser
and it had far fewer reads aligned compared to the other samples. When the statistical
analysis was performed, this sample again appeared to be inconsistent with poor quality
evident so it was not used further in the analysis.
Between the IVV and IVM oocytes, 493 transcripts were found to be
differentially expressed (FDR-adjusted P<0.05) with at least a 2-fold difference in
abundance and a combined coefficient of variation ≤ 1. Of these transcripts, 460 (93%)
were more abundant in the in vitro oocytes, whereas only 33 (7%) were more abundant in
the in vivo oocytes. A summary of the number of significant genes determined after each
step of the statistical analysis is shown in Supplemental Table 2-3. A list of the top ten
most significant genes in the IVM and IVV oocytes is shown in Table 2-2. Figure 2-1
shows the results of the bidirectional hierarchical clustering analysis performed, where
the samples are segregated or clustered together based on similarities in expression
profiles. This figure demonstrates that the respective samples are correlated with one
another, with the IVV samples clustering with one another and the IVM samples cluster
with one another.
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Two Gene Ontology analyses were performed to determine what biological

processes are affected due to altered transcript abundances between the IVM and IVV
oocytes using the mvGST package in Bioconductor (Stevens and Mecham 2014) and the
DAVID/EASE Annotation tool (Huang et al. 2009). The mvGST analysis revealed that
there were 666 biological processes found to be significantly more active in the IVM
oocytes and 983 biological processes found to be significantly more active in the IVV
oocytes. Genes were allowed to be included in multiple biological processes for this
analysis, which could explain for the large abundance of processes that are significant.
Also, all of genes that had an adjusted p-value of less than 0.05 were included in the
analysis. Table 2-4 shows the top ten most significant biological processes affected in
both the IVV and IVM oocytes determined by the mvGST package. The complete list of
the biological processes found to be significantly enriched in both the IVM and IVV
oocytes can be found in the Appendix (Tables A-1 and A-2). For the GO analysis using
DAVID/EASE, 298 biological processes were found to be enriched in the IVM oocytes
but only 19 of these were significant (adjusted p-value <0.05). There were no processes
determined to be enriched in the IVV oocytes.
Experiment 2 - qPCR Analysis of individual IVV and IVM oocytes
For these particular experiments, we aimed to quantify and compare mRNA levels
in individual IVM and IVV porcine oocytes using quantitative real-time PCR to evaluate
relative gene expression levels of 70 selected genes. Based on previous data as well as the
RNA sequencing data described herein, we hypothesized that those transcripts that code
for pluripotency factors, epigenome modification enzymes, and RNA degradation
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machinery would be more abundant in the in vivo-matured oocytes and that transcripts
for oocyte specific genes and apoptosis-related genes would be more abundant in the in
vitro-matured oocytes. Table 2-6 shows the various functional categories associated with
the 70 genes. Relative transcript abundances for 18 out of the 70 genes tested were found
to be differentially expressed between the IVM and IVV oocytes (CLDN10, CNOT3,
CSTF1, DDX6, DUSP1, EHMT2, FYN, HYOU1, IRAK2, PABPC4, PARN, PDHA1,
POLDIP2, PTPN9, RAP1A, TCTN3, XIAP, XRN2). Of these differentially expressed
genes, 14 were higher in the IVM oocytes, including CLDN10, CNOT3, DDX6, DUSP1,
FYN, HYOU1, IRAK2, PABPC4, PARN, PDHA1, POLDIP2, PTPN9, TCTN3, and XRN2.
Alternatively, only 4 genes were more abundant in IVV oocytes, including CSTF1,
EHMT2, RAP1A, and XIAP. . The results of an unsupervised bidirectional hierarchical
clustering analysis of the qPCR data (log2 fold-change values) are presented in Figure 22. In this figure, the samples and genes are segregated and clustered together based on
similarities in expression pattern. This cluster graph demonstrates that while there is
some variability among the samples, the individual IVM oocytes generally cluster with
one another, and a majority of the IVV oocytes cluster with one another as well.
The 18 differentially expressed genes were then evaluated in relation to their
corresponding functional gene categories. For the apoptosis functional gene category,
three apoptosis related genes were tested; one of these genes (XIAP) was found to be
significantly differentially expressed (38% lower; P = 0.02) in the IVM oocytes (Figure
2-3). For the epigenetic modifier genes that were tested, one was found to be significantly
less abundant in the IVM oocytes (Figure 2-4): EHMT2 was 26% lower in the IVM
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oocytes (P=0.01). Five out of 14 of the RNA degradation related genes were found to be
significantly more abundant in the IVM oocytes (Figure 2-5): CNOT3 was found to be
80% higher in IVM oocytes (P<0.0001); DDX6 was found to be 83% higher in IVM
oocytes (P=0.003); PABPC4 was found to be 27% higher in the IVM oocytes (P=0.03);
PARN was found to be 53% higher in the IVM oocytes (P=0.007); and XRN2 was found
to be 35% higher in the IVM oocytes (P=0.02). None of the oocyte-specific (Figure 2-6),
pluripotency, or imprinted genes tested were found to be differentially expressed between
the IVV and IVM oocytes.
Twenty-one genes were selected from the RNA sequencing data for validation
using qPCR. Figure 2-7 shows the log2 fold change and log2 read count ratios of these
genes based on the qPCR and RNA-sequencing data. Of these 21 genes, 12 followed
similar trends as compared to the RNA sequencing data (CSTF1, DUSP1, FYN, HYOU1,
IRAK2, LDHB, LEF1, MARK2, PDHA1, ROCK1, RTCD1 and TIAM2) and half of these
were significant. The remaining nine of the genes (ABHD5, CLDN10, HADH, POLDIP2,
PRDX2, PTPN9, RAP1A, RB1, TCTN3) were more abundant in the opposite oocyte type
from the RNA-sequencing data, however only 5 of these were found to be significant.
Experiment 3- Western blot analysis of individual IVV and IVM oocytes
In this experiment, protein expression of ORP150 (HYOU1) was analyzed in
porcine oocytes that were either matured in vivo or in vitro. HYOU1 was chosen based on
our RNA-sequencing and qPCR results where we found the transcript to be differentially
expressed. Protein expression of HYOU1 was found to be expressed about 2.2 times
higher in the IVM oocytes compared to IVV oocytes (Figure 2-8).

	
  

	
  
	
  

76	
  

Discussion
The experiments described herein aim to further describe how oocytes matured in
vitro have reduced developmental competence compared to oocytes that are matured in
vivo in their natural environment. The origin of the oocyte and the environment in which
it is matured are the main factors determining embryo developmental potential (Gu et al.
2010). A number of studies have shown that oocytes matured in vitro are less competent
than those that are matured in vivo (Greve et al. 1987; Leibfried-Rutledge et al. 1987;
Van Soom et al. 1992; Bordignon et al. 1997; van de Leemput et al. 1999; Rizos et al.
2002). The decreased developmental potential of IVM oocytes is possibly a reflection of
the abundance of specific transcripts in the oocyte (De Sousa et al. 1998; Lonergan et al.
2003), which led us to hypothesize that the population of mRNAs in the IVM oocytes is
distinctly different from that of oocytes that are matured in vivo. Jones et al (2008) used
microarray technology to evaluate gene expression differences between IVM and IVV
human oocytes where they observed that of the genes that were differentially expressed,
98% were more abundant in the IVM oocytes. The results of this study are similar to the
results of the RNA-sequencing experiment described herein. This phenomenon of a vast
increase in transcript abundance in IVM oocytes was also observed by Zheng et al.
(2005). The results of this experiment contribute to the previous findings by Jones et al
(2008) and Zheng et al (2005) by providing a more thorough investigation of gene
expression differences between IVM and IVV oocytes using a more novel technique than
microarray. The ultimate cause for this difference is not yet clearly defined. However,
two possible explanations include a failure in the oocyte to undergo the normal pattern of
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transcript silencing or a dysregulation of transcript degradation (Zheng et al. 2005; Jones
et al. 2008).
Many of the biological processes that were found to be more active in the IVV
oocytes by the GO analysis were related to crucial molecular mechanisms including DNA
replication, aspects of mitosis and meiosis, and many signaling pathways such as MAPK
signaling. These processes are all necessary for normal cellular mechanisms to function
properly. Alterations to these vital biological processes in the IVM oocytes could indicate
they are of lesser quality than the IVV oocytes and would most definitely contribute to
their decreased developmental competence. Biological processes related to chromosome
segregation were also determined to be more active in IVV oocytes in our GO analysis.
In vitro culture conditions have been associated with a higher risk of aneuploidy and
chromosomal errors (Bean et al. 2002). If this biological pathway is perturbed or less
active in IVM oocytes, this could lead to a multitude of meiotic errors and ultimately, a
decreased developmental competence in these oocytes. Some of the other biological
processes suggested to be impacted by in vitro maturation protocols were related to
mRNA processing and post-transcriptional regulation. Jones et al. (2008) also reported
biological processes related to transcription, cell cycle, and DNA/RNA metabolism to be
affected in the IVM oocytes. Their results led them to hypothesize that the
overabundance of transcripts in the IVM oocytes is caused by dysregulation of gene
transcription or post-transcriptional modification of genes. We postulated that there might
be a perturbation to the mechanism responsible for the proper degradation of transcripts
in IVM oocytes, thus providing a potential explanation for why so many transcripts were
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found to be more abundant in the IVM oocytes compared to the IVV oocytes. Further
validation of this hypothesis will be necessary to determine the nature and extent of this
putative deficiency of IVM oocytes.
For the next set of experiments, we aimed to evaluate relative expression levels of
selected genes to further identify any alterations to transcript abundance between IVM
and IVV oocytes. Genes were selected based on previous data demonstrating that these
processes may be affected due to in vitro culture conditions. In vitro culture conditions
may lead to high rates of apoptosis in oocytes due to the increase in oxidative stress
(Combelles and Racowsky 2005). XIAP is an apoptotic inhibitor that prevents cell death
from occurring. We propose that the lower abundance of XIAP transcripts in the IVM
oocytes could potentially causes oocytes to have a lesser developmental quality.
Epigenetic marks are established throughout oogenesis in order to prepare the
oocyte for fertilization and to establish a totipotent embryo (Kageyama et al. 2007). As
expected, of the epigenetic modifiers that were differentially expressed, the higher
abundance was always in the IVV oocytes. EHMT2 is a histone methyltransferase that
functions to condense chromatin structure in order to turn off gene expression. In
particular, EHMT2 is responsible for the methylation status of Histone 3 Lysine 9, which
has been shown to be higher in condensed chromatin (Kageyama et al. 2007; Gu et al.
2010). The transition from decondensed to condensed chromatin is critical for the
acquisition of oocyte developmental competence as it is necessary for transcription to
cease during growth and maturation (Zuccotti et al. 2005). H3K9 methylation and
expression levels of EHMT2 have been shown to increase during growth and maturation
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of mouse oocytes (Kageyama et al. 2007). This histone methyltransferase may work in a
normal fashion to condense the chromatin in order to silence the appropriate transcripts in
the IVV oocytes, but the transcript for this methyltransferase is slightly perturbed in IVM
oocytes and genes are not getting silenced properly. The epigenome appears to be most
mutable in the late stages of oocyte development, in particular during the time of
maturation. Thus, it is possible that in vitro maturation may alter the establishment and/or
maintenance of epigenetic marks (El Hajj and Haaf 2013). There is also the possibility
that aspirating immature oocytes for in vitro maturation prevents these oocytes from
undergoing the normal, full duration of oocyte growth that would occur in vivo and forces
these oocytes to complete growth and maturation in a shorter amount of time. This
hurried growth process could prevent the ability of these oocytes to acquire appropriate
levels of the epigenetic marks that are essential for developmental competence. Other
histone modifications and the transcripts that code for the enzymes responsible for these
modifications have been shown to be altered in oocytes due to in vitro maturation as
compared to oocytes that were matured in vivo (Franciosi et al. 2012). Further research to
evaluate histone methylation patterns, in particular H3K9 methylation, would be
necessary and useful in order to understand whether the altered EHMT2 transcript levels
are leading to altered histone methylation levels in IVM oocytes.
RNA degradation is a pathway that is highly active through oocyte maturation in
order to selectively degrade transcripts in preparation for fertilization and early embryo
development. Zheng et al. (2005) suggested that is a failure to undergo the normal pattern
of transcript silencing or degradation in IVM oocytes leads to the reduced developmental

	
  

	
  
	
  

competence of these oocytes. Jones et al (2008) hypothesized that failure in the normal
post-transcriptional regulatory processes causes the transcripts to be more abundant in the
in vitro-matured oocytes. We hypothesized that increased transcript abundance could be
caused by a perturbation in the RNA degradation machinery in the IVM oocytes, which
prevented the proper degradation of transcripts. However, the results of our qPCR
analysis contradicted the original hypothesis. Transcript abundance for 13 out of 14 of
these genes that code for the RNA degradation and/or stability machinery was
numerically higher, and relative levels of five of the 14 were statistically higher in the
IVM oocytes. All of the 14 genes tested followed the same trend in our RNA-Seq
experiment where all transcript levels were numerically higher in the IVM oocytes and
four were statistically higher. The unexpected observation that essentially all of the genes
coding for components of the RNA degradation machinery were more highly expressed
in IVM oocytes is difficult to reconcile with the general overabundance of mRNA
transcripts that was observed in the IVM oocytes. It could be that other mechanisms are
responsible for RNA protection or overexpression, and that these transcripts for the RNA
degradation machinery are simply beholden to the same trend seen for so many other
transcripts (i.e. overabundance in IVM oocytes). There is also a possibility that the oocyte
can somehow sense deviating and overabundant transcript levels and can provide
protection against inappropriate RNA accumulation by upregulating the RNA
degradation machinery within the cell. Transcripts coding for one of the poly(A) binding
proteins (PABPC4) were observed to be more abundant in the IVM oocytes. These
proteins are typically responsible for protecting the mRNA from degradation by binding
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the poly(A) tail and shielding it from being deadenylated, which is often the first step in
the process of mRNA degradation. If the transcripts are protected from deadenylation by
an overabundance of PABPs, they may be protected from undergoing the degradation
process, which could provide a plausible explanation for why overall transcript
abundance is higher in the IVM oocytes.
One of the aims for the qPCR experiment was to validate and compare the
expression levels of 21 selected genes from the RNA-sequencing experiment. A different
experimental design was employed for the qPCR experiment so it is not unexpected that
there is some variation between the results of both of these experiments. For example, for
the RNA-sequencing experiment, the oocytes were pooled into groups of five whereas, in
the qPCR experiment, single oocytes were evaluated. Pooling the oocytes could provide
more variability than evaluating the oocyte at a single oocyte level so we would expect to
find some variations between the two experiments. There is also a possibility for
variation due to oocyte source. In the RNA sequencing experiment, both IVV and IVM
oocytes were derived from the same three pigs. In the qPCR experiment, IVM oocytes
were collected from a variety of donor animals. Overall, the qPCR results did follow a
similar trend as the RNA sequencing data in the sense that many of the differentially
expressed transcripts were more abundant in the IVM oocytes.
The last experiment entailed looking at a specific protein of interest to evaluate if
this protein was altered in the IVM oocytes compared to the IVV oocytes. Only one
protein of interest was selected due to a limitation to sample size of IVV oocytes. We
chose HYOU1 based on our RNA-sequencing and qPCR results where we found the
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transcript to be differentially expressed. This experiment was repeated only twice because
of the difficulty and cost associated with obtaining IVV oocytes, but more than one
animal (oocyte donor source) was represented in each of the replicate IVV samples, with
a total of seven animals represented across the experiment. Both of our western blot
replicates showed the relative expression level of this protein to be two or more times
higher in the IVM oocytes compared to the IVV oocytes. These results correlate with
both the RNA sequencing data and qPCR data where HYOU1 was found to be over 2
times higher in the IVM oocytes. From this specific example it has been shown that the
increase in transcript abundance level in the IVM oocytes could also lead to increases to
the protein expression level, which could ultimately impact the activity and physiology
within the oocyte.
HYOU1 is part of the heat shock protein family that has a cytoprotective role in
oxygen-induced perturbations within the cell. Higher abundance of HYOU1 in the IVM
oocytes could potentially indicate high levels of stress within these oocytes. The GO
analysis using the DAVID/EASE functional annotation tool demonstrated that the stress
response biological processes was enriched in the IVM oocytes, which could indicate
there are higher levels of oxidative stress in these oocytes. Oxidative stress has been
shown to have detrimental effects on oocytes (Combelles et al. 2009) and it is likely that
in vitro culture conditions during oocyte maturation are causing high rates of oxidative
stress. During in vitro maturation, oocytes are matured in an environment with oxygen
levels above physiological levels so high rates of oxidative stress would not be surprising.
High oxygen concentrations in vitro have been shown to be associated with increased
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reactive oxygen species and ultimately, increased oxidative stress (Agarwal et al. 2003;
Agarwal et al. 2006). Possible oxidative stress experienced by IVM oocytes could
contribute to their apparent poor developmental competence (Combelles et al. 2009).
In summary, we have found that there are many transcripts that are differentially
expressed between IVM and IVV oocytes, and majority of these transcripts are more
abundant in the IVM oocytes. It is possible that the overabundance of transcripts is
caused by any number of mechanisms, including dysregulation of posttranscriptional
control. We have shown that there are transcripts for apoptosis inhibitors and epigenetic
modifiers that are significantly more abundant in IVV oocytes. There is evidence to
suggest that RNA degradation and chromatin remodeling pathways may be significantly
perturbed in IVM oocytes based on altered abundance of a few selected transcripts
involved in these pathways. We have also shown that the expression of the protein
HYOU1 is altered due to in vitro maturation and is expressed at higher levels in IVM
oocytes. We expect that this data will lead to a better understanding of how we can
improve the quality of oocytes that are matured in vitro as well as provide further
information to help to identify markers that could be indicative of oocyte quality.
Ultimately, this knowledge will help to determine how the in vitro environment can be
manipulated or how the expression of specific transcripts can be altered in order to
improve oocyte quality.
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Tables and Figures
Table 2-1. Definition of gene names used in qPCR analysis

	
  

Gene
Symbol

Gene Name

ABHD5

Abhydrolase domain containing 5

ACTB

B-Actin

ASH2L

ASH2 (absent, small, or homeotic)-like

ATM

ATMserine/threonine kinase

BCL2L1

BCL2-like 1

BMP15

Bone morphogenetic protein 15

CLDN10

Claudin 10

CNOT3

CR4-NOT transcription complex, subunit 3

CSTF1

Cleavage stimulation factor subunit 1

DCP1A

Decapping mRNA 1A

DCP2

Decapping mRNA 2

DCPS

Decapping enzyme, scavenger

DDX6

DEAD (Asp-Glu-Ala-Asp) box helicase 6

DMAP1

DNA methyltransferase 1 associated protein 1

DNMT1

DNA (cytosine-5-)-methyltransferase 1

DNMT3A

DNA (cytosine-5-)-methyltransferase 3 alpha

DUSP1

DNA methyltransferase 1 associated protein 1

EHMT2

Euchromatic histone-lysine N-methyltransferase 2

EIF4A1

Eukaryotic translation initiation factor 4A1

EZH2

Enhancer of zeste 2 polycomb repressive complex 2 subunit

FYN

FYN proto-oncogene, Src family tyrosine kinase

GAPDH

Glyceraldehyde-3-phosphate dehydrogenase

GDF9

Growth differentiation factor 9

H1FOO

H1 histone family, member O, oocyte-specific

HADH

Hydroxyacyl-CoA dehydrogenase

HDAC3

Histone deacetylase 3

HPRT1

Hypoxanthine phosphoribosyltransferase 1

HSP90AA1

Heat shock protein 90kDa alpha (cytosolic), class A member 1

HYOU1

Hypoxia up-regulated 1

IGF2R

Insulin-like growth factor 2 receptor

IRAK2

Interleukin 1 receptor associated kinase 2

KLF4

Kruppel-like factor 4

LDHB

Lactate dehydrogenase B

LEF1

Lymphoid enhancer binding factor 1

LIN28

LIN-28 homolog A

LSM1

LSM1 U6 small nuclear RNA associated
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MARK2

Microtubule affinity regulating kinase 2

MOS

Moloney sarcoma oncogene

NOBOX

NOBOX oogenesis homeobox

PABPC1

Poly(A) binding protein, cytoplasmic 1

PABPC1L

Poly(A) binding protein, cytoplasmic 1-like

PABPC4

Poly(A) binding protein, cytoplasmic 4

PABPN1

Poly(A) binding protein, nuclear 1

PABPN1L

Poly(A) binding protein, nuclear 1-like

PAN3

PAN3 poly(A) specific ribonuclease subunit

PARN

Poly(A)-specific ribonuclease

PDHA1

Pyruvate dehydrogenase (lipoamide) alpha 1

PEG10

Paternally expressed 10

POLDIP2

DNA polymerase delta interacting protein 2

POU5F1

POU class 5 homeobox 1

PRDX2

Peroxiredoxin 2

PTPN9

Protein tyrosine phosphatase, non-receptor type 2

RAP1A

RAP1A, member of RAS oncogene family

RB1

RB transcriptional corepressor 1

ROCK1

Rho associated coiled-coil containing protein kinase 1

RPN1

Ribophorin I

RTCD1

RNA 3'-terminal phosphate cyclase

SIRT1

Sirtuin 1

SOX2

SRY (sex determining region Y)-box 2

TAF11

TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor

TCTN3

Tectonic family member 3

TIAM2

T-cell lymphoma invasion and metastasis 2

UBE3A

Ubiquitin protein ligase E3A

XIAP

X-linked inhibitor of apoptosis

XRN2

5'-3' exoribonuclease 2

YBX2

Y box binding protein 2

ZAR1

Zygote arrest 1

ZP2

Zona pellucida glycoprotein 2

ZP3

Zona pellucida glycoprotein 3
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Table 2-2. Short read alignment summary
for RNA sequencing data*
Sample

Reads Aligned

%

IVV-1
9947922
42.7
IVV-2
10007898
46.7
IVV-3
933084
7.1
IVV-4
16158468
64.5
IVM-1
6605766
38.7
IVM-2
8972251
41.1
IVM-3
9127217
34.7
IVM-4
16574544
61.6
Maximum:
16574544
64.5
Minimum:
933084
7.1
Average:
9790893.75
42.1
*Presented in the "Reads Aligned" column are the total numbers of reads that were
uniquely aligned with one database member. The data in the "%" column show what
percentage of the total number of reads (after purging endogenous contaminants) aligned
to the custom database for each sample.
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Table 2-3. List of the Top 10 most significant genes for RNA-sequencing data
found to be more abundant in the IVM or IVV oocytes
IVM
Gene Name

PCDHGC5
SLC12A9
KIAA0913
PALM3
PELP1
ZFYVE27
KCNIP4
U2AF2
HYOU1
NDUFA6

IVV Avg. Relative
Expression Level

34.33
16.33
13.00
41.33
37.33
39.00
82.67
162.00
588.67
334.67

IVV SD

5.51
3.51
5.29
4.04
10.02
14.73
20.31
92.24
324.93
87.12

IVM Avg. Relative
Expression Level

987.75
296.25
207.75
635.25
546.25
535.00
1088.50
2071.75
7235.00
4019.25

IVM SD

P-Value

612.13
223.70
98.58
273.13
179.25
163.76
635.91
760.93
2323.38
2031.95

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

IVM SD

P-Value

IVV
Gene Name

TCTN3
PEX11B
FBXO3
ITGB8
RTCD1
HIST1H1E
GTF3C6
SH3BGR
PTPN9
MEIS2

	
  

IVV Avg. Relative
Expression Level

IVV SD

IVM Avg. Relative
Expression Level

422.33

57.93

86.50

34.08

<0.0001

660.33
111.00
104.33
1179.00
63.33
163.00
301.33
275.67
300.00

69.29
61.26
70.04
285.41
20.26
30.81
33.84
142.76
90.34

222.50
43.25
33.75
442.00
18.00
53.25
88.25
62.75
115.75

85.68
16.07
6.90
99.41
12.03
36.18
54.43
23.26
74.43

<0.0001
<0.0001
0.0033
0.0092
0.01
0.0151
0.0229
0.0467
0.048
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Table 2-4. Gene ontology analysis of RNA sequencing data*
A. IVM
GO ID

GO TERM

P-VALUE

GO:0000019
GO:0000059
GO:0000070
GO:0000281
GO:0000738
GO:0001503
GO:0001523
GO:0001654
GO:0001656
GO:0001657

regulation of mitotic recombination
protein import into nucleus; docking
mitotic sister chromatid segregation
cytokinesis after mitosis
DNA catabolic process; exonucleolytic
ossification
retinoid metabolic process
eye development
metanephros development
ureteric bud development

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

GO ID

GO TERM

P-VALUE

GO:0000002
GO:0000045
GO:0000050
GO:0000053
GO:0000076
GO:0000085
GO:0000089
GO:0000090
GO:0000132
GO:0000165

mitochondrial genome maintenance
autophagic vacuole assembly
urea cycle
argininosuccinate metabolic process
DNA replication checkpoint
G2 phase of mitotic cell cycle
mitotic metaphase
mitotic anaphase
establishment of mitotic spindle orientation
MAPK cascade

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

B. IVV

*Top ten most significant biological processes that may be more active in IVM (A.) and
IVV (B.) oocytes based on the GO analysis using the mvGST package in Bioconductor.
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Table 2-5. Gene set enrichment analysis in IVM results using DAVID/EASE
functional annotation tool
Category
SP_PIR_KEYWORDS
SP_PIR_KEYWORDS
INTERPRO
INTERPRO
SMART
SP_PIR_KEYWORDS
SP_PIR_KEYWORDS
SP_PIR_KEYWORDS
UP_SEQ_FEATURE
UP_SEQ_FEATURE
SP_PIR_KEYWORDS
KEGG_PATHWAY
UP_SEQ_FEATURE
SP_PIR_KEYWORDS
GOTERM_MF_FAT
SP_PIR_KEYWORDS
GOTERM_MF_FAT
UP_SEQ_FEATURE
UP_SEQ_FEATURE

	
  

Term
phosphoprotein
acetylation
Nucleotide-binding, alpha-beta plait
RNA recognition motif, RNP-1
RRM
rna-binding
cytoplasm
alternative splicing
domain:RRM 2
domain:RRM 1
nucleus
Spliceosome
splice variant
stress response
nucleotide binding
ubl conjugation
RNA binding
compositionally biased region:Glu-rich
compositionally biased region:Gln-rich

Adjusted PValue
1.10E-15
8.10E-06
9.00E-06
1.50E-05
2.40E-05
3.50E-04
1.30E-03
1.40E-03
1.80E-03
1.80E-03
1.80E-03
2.20E-03
1.70E-02
2.10E-02
2.40E-02
2.50E-02
2.70E-02
3.50E-02
3.70E-02
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Table 2-6. Genes tested for quantitative PCR and their functional gene
categories
Functional Gene
Categories

	
  

Number of Genes

Genes Tested

RNA Degradation

14

Oocyte Specific

9

Epigenetic Modifiers

8

Pluripotency Factors

4

CNOT3, DCP1A, DCP2, DCPS,
DDX6, LSM1,
PABPC1, PABPC1L, PABPC4,
PABPN1,
PABPN1L, PAN3, PARN, XRN2
H1FOO, YBX2, ZP2, BMP15,
GDF9, MOS,
NOBOX, ZAR1, ZP3
SIRT1, HDAC3, EZH2, EHMT2,
DNMT3A,
DNMT1, DMAP1, ASH2L
SOX2, POU5F1, LIN28, KLF4

Apoptotic Regulators

3

ATM, BCLX, XIAP

Imprinting

3

Housekeeping

7

RNA Sequencing
Validation

21

IGF2R, PEG10, UBE3A
EIF4A1, GAPDH, ACTB,
HSP90AA, TAF11,
HPRT1
ABHD5, CLDN10, CSTF1, DUSP1,
FYN,
HADH, HYOU1, LDHB, LEF1,
TCTN3,
PTPN9, IRAK2, MARK2, PDHA1,
POLDIP2,
PRDX2, RAP1A, RB1, ROCK1,
RTCD1, TIAM2
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0

9

12

Fig. 2-1. Unsupervised bidirectional hierarchical clustering graph of the RNAsequencing data using the complete Spearman Correlation. The log2 read count
values for each of the 493 transcripts that were differentially expressed (P<0.05) and had
at least a 2-fold difference between IVV and IVM oocytes were used to generate this
figure showing the unsupervised hierarchical clustering of the experimental samples.
Based on the relative expression values of these 493 differentially expressed genes, all
replicates of the IVV samples cluster with one another and the individual replicates of
IVM samples cluster together. It is also evident in this figure that majority of the
differentially expressed genes are more abundant in the IVM samples and only a small
number are more abundant in the IVV sample.

	
  

	
  
	
  

92	
  

Fig. 2-2. Unsupervised bidirectional hierarchical cluster graph of the log2 fold
change gene expression values in individual oocytes tested for 70 genes with
quantitative PCR using the complete Spearman Correlation. Samples and genes are
segregated and clustered together based on similarity in expression pattern.
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Fig. 2-3. Log2 fold-change values of every gene for the apoptosis functional gene
category tested by qPCR. In each of these panels, the blue bars correspond to the Log2
fold-change values of the IVV oocytes and the Log2 fold-change values of the IVM
oocytes are represented in the yellow bars. One out of the three apoptotic transcripts
tested was significantly differentially expressed (XIAP; 38% lower in the IVM oocytes
(P=0.02). IVV = in vivo-matured oocytes; IVM = in vitro-matured oocytes; * = P < 0.05.
Data are the mean ± S.E.M.
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Fig. 2-4. Log2 fold-change values of every gene for the epigenetic modifiers
functional gene category tested by qPCR. In each of these panels, the blue bars
correspond to the Log2 fold-change values of the IVV oocytes and the Log2 fold-change
values of the IVM oocytes are represented in the yellow bars. One out of the eight
epigenetic modifiers tested was significantly different between treatment groups
(EHMT2; 26% lower in the IVM oocytes (P=0.01)). IVV = in vivo-matured oocytes; IVM
= in vitro-matured oocytes; * = P < 0.05. Data are the mean ± S.E.M.
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Fig. 2-5. Log2 fold-change values of every gene for the RNA degradation functional
gene category tested by qPCR. In each of these panels, the blue bars correspond to the
Log2 fold-change values of the IVV oocytes and the Log2 fold-change values of the IVM
oocytes are represented in the yellow bars. Five out of the fourteen RNA degradation
genes tested were significantly higher in the IVM oocytes (CNOT3; 80% higher in IVM
oocytes (P<0.0001), DDX6; 83% higher in IVM oocytes (P=0.003), PABPC4; 27%
higher in the IVM oocytes (P=0.03), PARN; 53% higher in the IVM oocytes (P=0.007),
XRN2; 35% higher in the IVM oocytes (P=0.02)). IVV = in vivo-matured oocytes; IVM =
in vitro-matured oocytes; * = P < 0.05. Data are the mean ± S.E.M.
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Fig. 2-6. Log2 fold-change values of every gene for the oocyte specific functional
gene category tested by qPCR. In each of these panels, the blue bars correspond to the
Log2 fold-change values of the IVV oocytes and the Log2 fold-change values of the IVM
oocytes are represented in the yellow bars. Zero out of the nine oocyte specific genes
were differentially expressed. IVV = in vivo-matured oocytes; IVM = in vitro-matured
oocytes; * = P < 0.05. Data are the mean ± S.E.M.
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Fig. 2-7. Transcript profiling data using RNA-seq and qPCR. The yellow bars
represent the log2 fold change ratios of the qPCR data and the blue bars represent the log2
ratio of the read counts from the RNA-sequencing data. Those genes that are more
abundant in the IVM oocytes are shown as greater than 0 and those that are more
abundant in the IVV oocytes are less than 0. 12 of the genes gave results as predicted and
followed similar trends as compared to the RNA sequencing data.
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Fig. 2-8. Protein expression of ORP-150 (HYOU1) in IVM and IVV oocytes. Protein
expression was analyzed by western blot in porcine oocytes that were either matured in
vivo (n = 75 oocytes) or in vitro (n = 75 oocytes). A. Image of a representative western
blot membrane. B. Average relative HYOU1 band intensities of IVM oocytes (yellow
bar) compared to the IVV oocytes (blue bar), normalized to 1. HYOU1 was found to be
expressed 2.2 times higher in the IVM oocytes compared to IVV oocyte.
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Supplementary Table 2-1. Gene Names, corresponding accession numbers, and
forward and reverse primer sequences utilized for quantitative PCR

	
  

Gene

Design RefSeq

5'-Forward Primer-3'

5'-Reverse Primer-3'

ABHD5
Symbol
ACTB
ASH2L
ATM
BCLX
BMP15
CLDN10
CNOT3
CSTF1
DCP1A
DCP2
DCPS
DDX6
DMAP1
DNMT1
DNMT3A
DUSP1
EHMT2
EIF4A1
EIF4A1
EZH2
FYN
GAPDH
GDF9
H1FOO
HADH
HDAC3
HPRT1
HSP90
HYOU1
IGF2R
IRAK2
KLF4
LDHB
LEF1
LIN28
LSM1
MARK2
MOS
NOBOX
PABPC1
PABPC1
PABPC4
L
PABPN1
PABPN1
PAN3
L
PARN
PDHA1
PEG10
POLDIP2

NM_001012407.
XM_003357928.
1
NM_001243568.
1
NM_001123080.
1
NM_214285.1
1
NM_001005155.
NM_001243444.
1
XM_003127414.
1
NM_001110430.
2NM_001244358.
1
XM_003123832.
1
NM_213790.1
2XM_003129914.
NM_001243640.
2
NM_001032355.
1
NM_001097437.
1
NM_001256075.
1
NM_001101823.
1
NM_001100196.
1NM_001100196.
1
NM_001244309.
1
NM_001080206.
1NM_001206359.
2
NM_001001909.
1
NM_001205063.
1
NM_214331.1
1
NM_001243827.
NM_001032376.
1
NM_213973.1
2XM_003129922.
NM_001244473.
1
XM_003132364.
1NM_001031782.
1
NM_001113287.
1
NM_001129967.
1
NM_001123133.
1
XM_003359487.
1
XM_003480685.
2
NM_001113219.
1NM_001195116.
1
XM_001927747.
1
XM_001927407.
2XM_003127813.
1
NM_001243548.
2
XM_003126806.
1
XM_003130910.
2
XM_003124583.
1
XM_003360244.
3
NM_001109944.
2XM_003358174
1

TCCTAGCTGCTGCTTACTCAC
ATGTGTCCGAGCTCCTATTCC
TTTCCGGCCATCTCACTGTA
TTAAGAGCTTGGGCTCTGGAA
AGCGTAGACAAGGAGATGCA
GGCCATTGGTTAATGGAGCAA
TTGCAAGGATTTCCCCTCCA
GACAAGAGGCAGCTGATAGACA
GACGAACGCTGGTCAGATAC
TTGCCCAGCCTAAGGTGTTA
ACCTCAGTGTGGGATAAGAGAC
CTCTGACGGCTTTGTCCTCA
ACGGGAGTTGCTAATGGGAA
GACGGAGCCATGTTCTTCCA
AAAGGCGCTCATAGGCTTCA
ATGACCTCTCCATCGTCAACC
TCTTGCAGCACTCCACTCTAC
ACTTCAGCCTCTACTACGATTCC
AGGATCATGTCTGCGAGTCA
GAGAAGCCCTCTGCCATCC
CGAAGGATCCAGCCTGTTCA
ACACTGGGACCTTGCGTAC
AGTGGACATTGTCGCCATCA
AACACTGTCCGGCTCTTCAC
TCCTGGGAGTCGGAATTCAA
CCGTACCTCATAGAAGCAGTCA
ATCGATTGGGCTGCTTCAAC
AAAGAGATGGGAGGCCATCA
ACCCTCACGATAGTGGACAC
TCTTCACTGAGGTGGAGATGAC
TGTGGTGGTGGCAAGAGAATA
GGAAGCTGACTCCTTCTCTGAA
GGGAAGGGAGAAGACACTG
CAGGATTCACCCAGTGTCAAC
ACCATGACAAGGCCAGAGAA
TTCGGCTTCCTGTCCATGAC
CTGCTTCGAGATGGAAGGAC
AGTGGCTCATGGCAGGATGAA
GGCTTCGGCTCGGTATACAA
CCACTATCCGGACAGCGAAA
CATGGATGATGAGCGCCTTA
AGGTTCGAGCAGATGAAGCA
TACTTTGTGCCAGCAGTTCC
GTTCCCGCTCTCGATTCTACA
CCTACATAGAGTTTGCCACCGAGAG
ACAGTGCCAAGCCATATGCA
CGCCGCAGAATCACTACTAC
GCAGCCAGCACTGACTACTA
AGTCCTCGCGTGGTGAGTA
TCTATCTGGCACCTTGGAGAC

TCAGGAAAACCCCAAGGTT
TCAGACCGGCAAGACAGAA
CA
TCCTTCGGCGGATACTTGAA
A
TGGTACAGCGAGATCACAC
TTCAGGTAAGTGGCCATCCA
A
GCTACCCGGTTTGGTCTCA
GCTGACAGCGGCAATCATA
CTTGGTCTCTCGCTCCACAA
A
TAGTCCTCCGTGTGGTTGAA
CTGCTGAGGTTGTTGCAGTA
CTTCACCTTGAGGCAGCAAA
A
GGCAGATGGCGATCAGGTA
AAAGCAATGGGAATGCTCT
TA
ACCTGCACCGTCTTGTTGAA
CC
ACGCTGAACAGTGGTGCAT
CAGGAGGCGGTAGAACTCA
A
AGAAGCATGGTAGGCACTC
AA
GTTCAGCCAGAGCTTCAACC
C
CCTTCGGGCTCCATCC
ATTGGGCTTGAGCGATCACA
ACGGGATGACTTGTGTTGGA
CTTCCGTCCGGGCTTCATAA
A
CGTGGGTGGAATCATACTG
TCAACAGCAGTAACACGAT
GAA
CCCATCTTCGTTTTGGCTGT
CCA
AGCACCCAGCTTCATAGCA
A
GAGGGATGTTGAAGCTCTTG
GTAATCCAGCAGGTCAGCA
AC
AGACTTGGCGATCGTACCA
AA
GCCATGGTTGCATTCTTCCA
A
CAGCACTGGAGCACTCTCTA
CATCAGTTTCCTTTTGGCCT
A
TCTTTGCTTCATGTGGGAGA
CA
ACACATGGAAGGCTCAGGA
GTAAGAGGGCCCCTTGTTGT
A
GCCCTCCATGTGCAGCTTA
A
TCCACAGTCTGATGTAGCAC
TGACAGTACTGCACAGCAG
TA
GTTCTTGGTGCATCTGCTCA
ACA
CCGGCGATTCTGGAACCA
C
GATTTTCCACTCTCGTCAGT
TGGAGTCATCCAGGTTCTTC
CA
TTAGGCCTCATCTGTGCTAA
AC
ATACCATGATGTCGCTCTAG
C
TTGATGACCCGGCCTCGAAA
CC
GAGAGATGTTGAGGGCACC
A
TTCTGCTTGACAGGGACTCA
AAA
GGACACACAGGATATCCAT
CCCAGGTGTAGCTTCACTCC
TCCA
GGCTGCTCCTTGGATAACAC

	
  
	
  

105	
  
POU5F1
PRDX2
PTPN9
RAP1A
RB1
ROCK1
RPN1
RTCD1
SIRT1
SOX2
TAF11
TCTN3
TIAM2
UBE3A
XIAP
XRN2
YBX2
ZAR1
ZP2
ZP3

	
  

NM_001113060
NM_001244474.
XM_003128481.
1
XM_001928649.
1XM_001926853.
3
XM_003356367.
4
NM_214333.1
1NM_001243470.
NM_001145750.
1
NM_001123197.
1
NM_001184894.
1XM_001927628.
1
XM_003121130.
2
NM_001243181.
3NM_001097436.
1
XM_003134307.
1
XM_003131938.
2NM_001129956.
2
NM_213848.1
1
NM_213893.1

AGAAGAGGATCACCCTGGGATA
GTCTCCGTTGACTCTCAGTTCA
GCTCATGGTTTGGGAGCAAAA
TGCTGCTTTAGACCTGCAGTA
AACTCTTCAGGCTGATCCTAC
GCTTTTGTTGGCAATCAACTACC
AGACAGTGGGATCTCCTCCA
CAGAGAAGATCAAAGGCGGAAC
TGTCAGAGTTACCACCCACAC
CCTGCAGTACAACTCCATGAC
AGAGAAGAAGCAGAAAGTGGATGA
TTCCTATACCAGTGCCAGTCC
A
CTGCACCGTCTGAGTATATGCA
ACTTTTCGTGACTTGGGAGAC
GAGTGCTCAGAAAGACAATGCA
AGCCTAACCATGACCCAAACA
AACAGTGGGGACCCCTCAA
CCCTTATCGCGTGGAGGATA
GGATGGCTGACGAAAATGTGAA
CACCGTAATGGTGGAGTGTCA

ATGGTCGTTTGGCTGAACAC
CCAAGCCTCCCTCCTTCC
AGTACTGCCCACACTTTCTC
GGCACTTTCCAATTAGGCAA
C
TCACCTCTTCATCAGGGTTA
CA
CGTTAGGATTTGCGGCAGAT
C
GGTGGAAACATTGCCAATCT
AA
GGCATTGACACCTGCATCAA
CA
ACTGAAGAAGCTGGTGGTG
TGCGAGTAGGACATGCTGT
AA
GGTTCAGCTGCTCCTCAGAA
A
CGTCCACAAAGGTCACAAC
TGAGCTGCACGTCGTAAAC
A
CTTCCACACTTCCTTCATAC
A
CCTCAGCTGTTCTTCAGCAC
TCC
TGTAGCAAGGCCGAGCATA
TA
TGGCTCTGGGTGTCCTTCA
A
TCCACGTGGCGAAGTTTTAC
GCTCTTTCACCGTCACCAAC
CCTGATGAGCTTCCCGGTAC
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Supplementary Table 2-2. Detailed alignment statistics for all 31 lanes of data.

Sample

Number
of reads

Number
after
trimming

Number
after
filtering

Number
after
TruSeq
Adaptor
Trimmed

IVV-1

23286342

23103278

22990139

22715693

97.5

Number
after Poly
(A or T) or
Clontech
Adapter
Removed
21366303

IVV-2

21451715

21338783

21248432

21233963

98.9

IVV-3

13163024

12876057

12703102

11649038

IVV-4

25047517

24926398

24821259

IVM-1

17083304

16923644

IVM-2

21812917

IVM-3
IVM-4

%
Remain

Number after
Contaminants
Removed

%
Remain

91.8

14653267

62.9

9947922

20864602

97.3

20402703

95.1

10007898

88.4

5456423

41.5

4976787

37.8

933084

24778194

98.9

24493889

97.8

23567151

94.1

16158468

16797397

16234738

95

15276715

89.4

10087581

59

6605766

21688521

21593738

21354244

97.8

20465585

93.8

12515046

57.4

8972251

26285561

26089351

25968146

25892645

98.5

24237424

92.2

13015564

49.5

9127217

26904260

26754242

26636549

26572984

98.7

25734332

95.7

23293338

86.6

16574544

Column
Sample
Number of reads
Number after trimming
Number after filtering
Number after TruSeq Adaptor Trimmed
% Remain
Number after Poly(A or T) or Clontech Adaptor removed
% Remain
Number after Contaminants Removed
% Remain
Number of read aligned

	
  

%
Remain

Number of
reads aligned
(RSEM)

Description
Total number of reads in the lane
Bases whose identity was called with p>0.05 were removed
Number of reads in the lane that passed filter
Number of reads remaining after TruSeq adaptor was removed
% of reads remain after trimming, filtering, and adaptor
removed
Number of reads remaining after removing Adaptor
% of reads remaining after adaptor removal
Number of reads remaining after contaminants (rRNA, mitochondrial
DNA, or PhiX DNA) were removed
% of reads remaining after contaminant removal
Number of reads aligned to database
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Supplementary Table 2-3. Summary of Significant Genes for RNA-Sequencing
Data*
Number of Significant
Transcripts Higher in
IVM Oocytes

Number of Significant
Transcripts Higher in
IVV Oocytes

Estimate Variance-Mean
Dependence (P<0.05) and
Control for False Discovery
Rate (<0.05)

1,274

1,554

Coefficient of Variance <1

465

546

Fold Change >2

460

33

*After testing for differential expression using the negative binomial distribution and
controlling for the false discovery rate, there were 1,274 significant transcripts higher in
the IVM oocytes and 1,554 significant transcripts in the IVV oocytes. After applying the
coefficient of variance (CV) cutoff of less than 1, there were 465 significant transcripts
higher in the IVM oocytes and 546 significant transcripts higher in the IVV oocytes. Of
these remaining transcripts, only those transcripts that also had at least a 2-fold difference
between the IVV and IVM samples were finally considered to be significantly
differentially expressed. There were 460 significant transcripts higher in the IVM oocytes
and 33 significant transcripts higher in the IVV oocytes.
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CHAPTER 3
EXPRESSION PROFILES OF SELECT GENES IN CUMULUS-OOCYTE
COMPLEXES FROM YOUNG AND AGED MARES

Article first published under the following citation: Cox L, Vanderwall DK, Parkinson
KC, Sweat L, Isom SC. 2015. Expression Profiles of Select Genes in Cumulus-Oocyte
Complexes from Young and Aged Mares. Reproduction, Fertility, and Development.
27(6): 914-924. http://www.publish.csiro.au/index.cfm?paper=RD14446
Abstract
There is compelling evidence that oocytes from mares >18 years of age have a
high incidence of inherent defects that result in early embryonic loss. In women, an agerelated decrease in oocyte quality is associated with an increased incidence of aneuploidy
and it has recently been determined the gene expression profile of human oocytes is
altered with advancing age. We hypothesized that similar age-related aberrations in gene
expression occur in equine oocytes. Therefore, the objective of this study was to
compare gene expression profiles of individual oocytes and cumulus cells from young
and aged mares, specifically evaluating genes that have been identified as being
differentially expressed with advancing maternal age and/or aneuploidy in human
oocytes. Expression of 48 genes was compared between 14 cumulus-oocyte complexes
from mares 3 to 12 years of age and ten cumulus-oocyte complexes from mares ≥ 18
years of age. Three genes (IF3, HSF5 and YBX2) were differentially expressed in the
oocytes, with all of these being more abundant in young mare oocytes. Three genes
(ARL6IP, BAX and HYOU1) were differentially expressed in the cumulus cells, with all
of them more abundant in the aged mares. The results of this study confirm there are age-
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related differences in gene expression in equine cumulus-oocyte complexes, which may
be associated with the lower quality and decreased developmental competence of oocytes
from aged mares.
Introduction
Based upon serial examination with transrectal ultrasonography, the incidence of
embryonic loss in mares between days 12 and 60 of gestation (ovulation = day 0) has
ranged from 2.6 to 24.0%, with a weighted-mean across studies of 8.6% (Vanderwall
2008). The highest embryonic loss rates (20 to 30% or higher) have been detected in
mares greater than 18 years of age (Woods et al. 1987; Carnevale and Ginther 1992;
Hemberg et al. 2004; Allen et al. 2007). Although the lack of a practical method of
pregnancy diagnosis prior to day 10 makes detection of embryonic loss between
fertilization and day 10 difficult, three studies that recovered embryos on day 2 found that
fertilization rates were 91% in young mares and 85% in aged mares inseminated with
fresh, fertile semen; therefore, fertilization rates appear to be high in both young and aged
mares (Ball et al. 1986; Woods et al. 1991; Brinsko et al. 1994). However, embryo
recovery rates on days 6 to 9 were approximately 30% lower in aged versus young mares
(30 to 40% vs. 60 to 70%, respectively), which implies a high rate of embryonic loss
during the first week of gestation in aged mares (Woods et al. 1986; Vogelsang et al.
1989). Similarly, Morel et al. (2005) demonstrated that the detected day-14 pregnancy
rate per ovulation was lower in aged mares compared to young mares (i.e., fewer detected
embryonic vesicles compared to the number of ovulated follicles in aged mares), which
like the embryo recovery data, is consistent with a higher incidence of embryonic loss
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(per oocyte/embryo) in aged mares. These clinical data agree with experimental evidence
that the estimated embryonic loss rate between fertilization and day 14 was <10% for
young mares compared with 60 to 70% for aged mares (Ball et al. 1986; Ball et al. 1989).
There is compelling evidence the oocytes of mares >18 years of age have a high
incidence of inherent defects that result in early embryonic loss (Carnevale & Ginther,
1995). In women, age-related decreases in oocyte quality and developmental potential
are associated with several factors, including abnormal chromosome microtubule
interactions at the meiotic spindle that lead to chromosome segregation errors and a
markedly increased incidence of aneuploidy (Battaglia et al. 1996). Similar defects have
also been described for equine oocytes (Rambags et al. 2005; Carenvale et al. 2012).
More recently, it has been determined the gene expression profile of human oocytes is
altered with advancing maternal age (Grondahl et al. 2010), and importantly, that gene
expression differs between aneuploid and euploid oocytes (Fragouli et al. 2010).
Cumulus cells are known to play a direct role in influencing oocyte quality by
providing essential nutrients to support oocyte development via gap junctions (Wang et
al. 2010). The bidirectional communication between the oocytes and cumulus cells is
crucial for oocyte competence. For example, the cumulus cells control glucose and
pyruvate metabolism essential for energy production within the oocyte (Russell et al.
2007). Therefore, any aberration within the cumulus cells can disrupt normal signaling to
and within the oocyte, leading to developmental incompetence. Advancing maternal age
has been shown to have a direct impact on gene expression profiles of cumulus cells
(Russell et al. 2007). It has also been shown that several genes that control the
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communication between the cumulus cells and oocyte were altered due to aging
(Eichenlaub-Ritter et al. 2011). Any alteration in gene expression patterns in the cumulus
cells may in turn influence oocyte physiology and potentially impact oocyte quality.
We hypothesized that age-related aberrations in gene expression occur in the
oocytes and cumulus cells of mares that contribute to higher early embryonic loss rates in
aged mares. Therefore, the objective of this study was to perform a systematic analysis
and comparison of the gene expression profiles of individual cumulus-oocyte complexes
from young and aged mares, specifically evaluating a group of select genes that have
been identified as being differentially expressed with advancing maternal age (Grondahl
et al. 2010) and/or aneuploidy (Fragouli et al. 2010) in human oocytes.
Materials and methods
Animals
Quarter Horse-type mares aged 3-12 years (n=10) and ≥ 18 years (n=8) were used
in this study. All animal procedures were approved and conducted following the
guidelines of the Utah State University Animal Care and Use Committee. The
reproductive tract of mares was examined three times weekly with transrectal palpation
and ultrasonography, and then daily when an ovarian follicle >30 mm was observed.
When mares developed an ovarian follicle ≥ 35 mm in diameter in conjunction with
prominent endometrial edema, 2,500 IU of human chorionic gonadotropin (hCG) was
administered intravenously. Approximately 28 to 32 hours after hCG treatment, mares
underwent transvaginal ultrasound-guided follicle aspiration (TVA) to collect the
cumulus oocyte complexes from the preovulatory follicle. Transvaginal ultrasound	
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guided follicle aspiration was performed as previously described (Vanderwall et al. 2006)
with the following modifications: mares received n-butylscopal-ammonium bromide
(Buscopan™, 0.1 to 0.4 mg kg-1, IV) to induce relaxation of the rectum and the follicle
was irrigated with ViGro Complete Flush Solution (Bioniche Animal Health USA, Inc.,
Pullman, WA) containing 10 units mL-1 heparin. At the completion of the TVA
procedure the entire volume of effluent recovered from the follicle was immediately
transported to the laboratory for oocyte identification and processing.
Oocyte processing
After an oocyte was identified, it was transferred immediately into 1.0 mL of
0.1% (w:v) hyaluronidase in HEPES-Buffered Tyrode’s Lactate solution (Lai et al. 2003)
for cumulus cell removal. The cumulus-oocyte complex was gently pipetted within the
enzyme solution until the oocyte was devoid of bound cumulus cells. The oocyte was
checked for maturation, indicated by the protrusion of the first polar body and only
oocytes in metaphase II were processed and analyzed. Each oocyte and its attendant
cumulus cells were separately washed, snap frozen in liquid nitrogen, and stored at -80°C
until further use.
RNA isolation and reverse transcription
Total RNA was isolated from individual oocyte and cumulus cell samples using
the Quick-RNA™ Micro Kit (Zymo Research). The manufacturer’s protocol was
followed precisely with the exception that the final elution of the RNA off the column
was performed twice using 10 µL of elution buffer each time, for a final elution volume
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of 20 uL. Eight microliters of RNA from each oocyte and cumulus cell sample was used
for reverse transcription using the GoScript Reverse Transcription system from Promega
(Madison, WI). A mix of 2 µL (0.5 µg each) of the oligo-dT and random primers
supplied in the kit; 4 µL of the 5x Reaction Buffer; final concentrations of 4.8 mM of
MgCl2 and 2 mM of Nucleotide Mix; 20 U of RNasin; and 1 µL of reverse transcriptase
were used for each reaction. Following reverse transcription, the quality of the cDNA
was confirmed with a PCR reaction using Qiagen’s Hot Start PCR kit. Complementary
DNA samples were then stored at -20°C until further use.
In parallel to the preparation of the experimental oocyte and cumulus cell
samples, a reference cDNA sample was prepared using a pooled mixture of RNA samples
from various horse tissues and cell types (muscle tissue, fibroblast cells, liver tissue,
ovarian tissue, cumulus cells, and oocytes). This pooled reference sample was prepared
using the same protocols and procedures as described above. This reference sample was
used as a positive PCR control and for creating a standard curve for use in calculating
primer efficiencies (see below for further details).
qPCR analysis
The qPCR system used in these experiments is an innovative and unique platform
from the Fluidigm Corporation (South San Francisco, CA). This qPCR system involves
the use of a DNA binding dye Evagreen (Biotium; Hayward, CA) with otherwise
standard PCR chemistry in a novel and elaborate network of nanoliter-scale microfluidics
based reaction wells for analyzing the expression of up to 48 genes for each of 48
samples on Fluidigm’s 48.48 Dynamic Array Integrated Fluidic Circuits (IFC). The 48
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genes that were analyzed are associated with the following functional categories:
housekeeping (β-Actin (ACTB), eukaryotic translation initiation factor 4A1 (EIF4A1),
heat shock protein 90kDa alpha (cytosolic), class A member 1 (HSP90AA1), and zona
pellucida glycoprotein 2 (ZP2)), apoptosis (ATM serine/threonine kinase (ATM), BCL2associated agonist of cell death (BAD), BCL2-associated X protein (BAX), BCL2-like
1(BCL2L1), BH3 interacting domain death agonist (BID), caspase 3(CASP3), caspase 8
(CASP8), caspase 9 (CASP9), tumor protein p53 (p53), and X-linked inhibitor of
apoptosis (XIAP)), aneuploidy (asp (abnormal spindle) homolog, microcephaly
associated (ASPM), autophagy related 7 (ATG7), ubiquitin domain containing 2 (DCUbP), dynein, light chain, roadblock-type 2 (DNCL2B), E74-like factor 1 (ets domain
transcription factor) (ELF1), ligand of numb-protein X 2 (LNX2), Meis homeobox 2
(MEIS2), polycomb group ring finger 3 (PCGF3), pyruvate dehydrogenase (lipoamide)
beta (PDHB), RCC1 domain containing 1 (RCCD1), transforming growth factor beta
regulator 4 (TBRG4)), maternal aging (ADP-ribosylation factor-like 6 interacting protein
(ARL6IP6), cyclin-dependent kinase inhibitor 1A (CDKN1), DEAD (Asp-Glu-Ala-Asp)
box polypeptide 20 (DDX20), echinoderm microtubule associated protein like 1 (EML1),
fumarylacetoacetate hydrolase domain containing 1 (FAHD1), heat shock transcription
factor 5 (HSF5), LSM5 homolog, U6 small nuclear RNA associated (LSM5), nuclear
autoantigenic sperm protein (NASP), selenoprotein I (SELI), spastic paraplegia 20
(SPG20), and zinc finger RNA binding protein (ZFR)), and oocyte viability (aurora
kinase A (AURORA-A), cytochrome c oxidase subunit I (COX1), dicer 1, ribonuclease
type III (DICER1), DNA methyltransferase 1 (DNMT1), glyceraldehyde-3-phosphate
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dehydrogenase (GAPDH), hypoxia upregulated 1 (HYOU1), mitochondrial translational
initiation factor 3 (IF3), ornithine decarboxylase 1 (ODC1), ribosomal protein S25
(RPS25), signal transducer and activator of transcription 3 (STAT3), transcription factor
A, mitochondrial (TFAM), and Y box binding protein 2 (YBX2)). Custom primers were
designed through the Fluidigm Corporation’s DeltaGene assay design service. Each
primer was designed based on NCBI’s reference sequence for equine. Gene and PCR
primer information for these genes are presented in Supplemental Table 1.
Fluidigm’s recommended protocol (ADP 14) was followed for performing
quantitative PCR gene expression analysis using the Biomark system. This protocol is
briefly summarized below. Prior to quantitative PCR thermal cycling, specific target
amplification (STA) was performed to enrich each sample as follows. A 200 nM STA
primer mix was prepared by pooling 1 µL of each primer pair (20 µM each). The STA
reaction mixtures were comprised of 1.25 µL of the STA primer mix, 2.5 µL of TaqMan
PreAmp Master Mix (Applied Biosystems; Foster City, CA), and 1.25 µL of cDNA. The
reactions were activated at 95°C for 10 minutes and then amplified for 14 cycles (95°C
for 15 seconds then 60°C for 4 minutes). Following STA thermal cycling, each reaction
was treated with Exonuclease I (ExoI; New England Biolabs; Ipswich, MA) to remove
any unincorporated primers. The ExoI reaction pre-mix was assembled by combining 1.4
µL water, 0.2 µL ExoI Reaction Buffer and 0.4 µL ExoI enzyme for each STA reaction
to be treated. Two microliters of the ExoI reaction pre-mix were added to each STA
reaction and then the complete reaction mixtures were incubated at 37°C for 30 minutes
in order to allow the digest to run to completion. Reactions were then inactivated at 80°C
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for 15 minutes. Each reaction was diluted 5-fold for a total volume of 25 µL, after which
they were stored at -20°C until they were analyzed with the Fluidigm IFC gene
expression chip.
Individual sample and primer solutions were made in preparation for qPCR
cycling as follows. The sample pre-mix solutions consisted of 2.5 µL of the 2x TaqMan
Gene Expression Master Mix (Applied Biosystems), 0.25 µL of 20x DNA Binding Dye
Sample Loading Reagent (Fluidigm), 0.25 µL 20x EvaGreen DNA Binding Dye
(Biotium) and 2 µL of the diluted ExoI-treated STA sample. The assay (primer) mix was
made for every primer set using 2.5 µL of the 2x Assay Loading Reagent (Fluidigm);
0.25 µL water; and 2.25 µL of each 20 µM Forward and Reverse primer mix. After
priming the chip, 5 µL of each assay and 5 µL of each sample were pipetted into their
respective inlets on the chip. The chip was then returned to the IFC Controller for chip
loading using the Load Mix (113x) script in order to load the samples and assays into the
chip. Once chip loading had finished, the chip was placed in the BioMark thermal cycler
for quantitative PCR. Cycling parameters consisted of 5 minutes of initial enzyme
activation, followed by 35 denaturation/extension cycles (95°C for 15 seconds followed
by 60°C for 60 seconds) and a 3 minute final extension cycle. A melt curve analysis was
performed following PCR amplification to assess the quality of each amplicon.
Data analyses
Data were analyzed using the Fluidigm Real-Time PCR Analysis Software. This
software uses the raw cycle threshold value determined through thermal cycling to
quantitate the ∆Ct value by normalizing through one selected housekeeping gene that
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worked most consistently for all samples (HSP90AA1). This software also assessed the
melting curve to determine the quality of each reaction. A selected calibrator was used to
determine the ∆∆Ct value for each sample, which was done by subtracting the ∆Ct of each
experimental sample by the ∆Ct of the calibrator sample (a reference sample of various
pooled equine tissue/cell types) for each gene. Lastly, the fold change for each sample
was determined by using the equation 2-∆∆Ct.
Primer efficiencies were calculated from the standard curve using the formula
equation E=10-1/slope (Applied Biosystems, 2004). Statistical evaluations involved a pergene ANOVA with particular attention to differential expression (normalized log fold
change values) between age groups. A Bonferroni multiple testing adjustment was
applied to control the false discovery rate. Significance was set at P<0.05. For each gene
found to be significantly differentially expressed between age groups, a model was fit to
test the main effect of donor mare on relative gene expression levels, and a post-hoc
pairwise comparison of log fold change values between individual donor mares was done
to identify the source of any maternal effects that may be contributing to variability
within age groups. Only those genes that were found to be expressed at different levels
between age groups and showed no significant effect of donor mare on relative transcript
levels were reported here as being significantly influenced by age.
A hierarchical clustering analysis was performed using the Multiexperimental
Viewer (MeV) data analysis software (Saeed et al. 2003). The Spearman Rank distance
average linkage clustering algorithm was selected for this analysis. The log2 fold change
values of the genes that were found to be differentially expressed in the oocytes and
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cumulus cells were used to identify similarities or differences in expression patterns
between all samples.
Results
Fourteen cumulus-oocyte complexes were recovered from eight young mares and
ten cumulus-oocyte complexes were recovered from five aged mares. After sample and
data processing, one of the young cumulus cell samples and two of the MII oocyte
samples from aged mares were excluded from analysis based on inadequate detectable
expression in more than half of the genes tested. Similarly, because of low primer
efficiencies or an inability to provide good amplification in at least half of the samples,
eleven and three primer sets were excluded from further analysis in the oocyte and
cumulus cell samples, respectively.
In the analysis of the oocytes, relative transcript abundances of three genes were
different between the oocytes of young and aged mares: IF3, HSF5, and YBX2. NASP
was also initially found to be differentially expressed, however, an in depth statistical
analysis revealed there was a significant effect of donor animal within age group that was
a main driver of statistical significance within the model. In the cumulus cell analysis, the
relative transcript abundances of three genes were significantly different between the
cumulus cells of young and aged mares, with all of the genes more abundant in the
cumulus cells of aged mares. These genes were: ARL6IP6, BAX, and HYOU1. NASP was
initially determined to be differentially expressed in the cumulus cells, but after further
investigation, it was determined that there was a significant maternal effect once again.
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For the apoptosis functional gene category, none of the seven genes tested in the

oocytes were significantly differentially expressed (Figure 3-1A). In the cumulus cells,
relative expression levels of one of ten apoptosis related genes was significantly different
between sample types (BAX was 2.7 fold higher in the cumulus cells from aged mares
[P=0.03]; see Figure 3-2A). For the aneuploidy-related genes, none of seven genes tested
in the oocytes and none of ten genes tested in the cumulus cells were differentially
expressed (Figures 3-1B and 3-2B). For the maternal aging-related genes, one of eight
genes was differentially expressed in the oocytes from young and aged mares (HSF5 was
1.8 fold higher in the oocytes from aged mares [P=0.03]; see Figure 3-1C). In the
cumulus cells, transcript levels of one of ten genes tested were more abundant in the
cumulus cells from aged mares (ARL6IP6 was 2.4 fold higher [P=0.02]; see Figure 32C). For the oocyte viability functional gene category, two of ten genes tested in the
oocytes were differentially expressed (IF3 was 1.9 fold higher [P=0.02] and YBX2 was
2.3 fold higher [P=0.02] in the oocytes from young mares; see Figure 3-1D). For the
cumulus cells, one of 12 genes was different (HYOU1 was 1.9 fold higher [P=0.04] in
cumulus cells from aged mares; see Figure 3-2D).
Figure 3-3 shows an unsupervised bidirectional hierarchical clustering graph of
the three oocyte genes that were significantly different between the two age groups. The
samples and genes are segregated and clustered together based on similarities in
expression pattern. This figure demonstrates that while there is some variability among
the samples, the oocytes from young mares cluster together and the oocytes from aged
mares cluster separately. Figure 3-4 shows the unsupervised bidirectional hierarchical
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clustering of the three cumulus cell genes that were significantly different between the
two age groups using the Spearman Rank Correlation. This figure demonstrates that the
majority of the cumulus cells from the young mares cluster together, demonstrating a
similarity in gene expression patterns
Discussion
This study utilized an innovative and unique qPCR platform that allows for the
single cell analysis of the expression of up to 48 genes for each of 48 samples. There are
numerous studies that have used this method to perform single cell gene expression for a
variety of different applications with similar success through the incorporation of a
specific target amplification (STA) step (Ennen et al. 2014; Jasnos et al. 2014; Burton et
al. 2013; Vincent et al. 2013; Li et al. 2013; Vincent et al. 2011). There is no evidence
that this preamplification step introduces any bias (Devonshire et al. 2011). During the
STA preamplification, the primers are pooled together in very low concentrations, so that
the reaction is primer limited. Only 14 cycles are done during the STA, so the reaction
never reaches the exponential phase before the primers are exhausted. This step only
serves to increase input copy number of the target, especially when the starting sample is
of low abundance. This novel qPCR method has thus allowed for the gene expression
analysis of many genes in single oocytes.
It is well known that the quality of the oocyte decreases with associated maternal
age. In humans, oocyte aging has been associated with a decline in mitochondrial
function, a reduction in transcripts from genes coding for proteins that participate in
spindle assembly, and an increase in the frequency of apoptosis (Jiao et al. 2012). In
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mice, age-related changes included chromosome scattering, chromosome decondensation,
alteration of gene expression patterns, and high rates of DNA fragmentation (Jiao et al.
2012). It is also well known that aneuploidy is very common in oocytes from aged
females. However, the precise reason(s) why chromosome segregation abnormalities
occur more frequently in oocytes from aged females is poorly understood (Shomper et al.
2014).
There have been relatively few studies that have looked at transcript differences
between single oocytes from young and aged females. Jiao et al. (2012) found that select
oocyte specific genes as well as genes involved in reproduction had an overall lower
expression in oocytes from aged mice compared to those from young mice. It has also
been demonstrated that the gene expression profiles of human oocytes is altered with
advancing maternal age (Grondahl et al. 2010) and that gene expression differs between
aneuploid and non-aneuploid oocytes (Fragouli et al. 2010). There has been only one
other previous study comparing gene expression profiles of oocytes and cumulus cells
from young and aged mares (Campos-Chillon et al. 2008). In that report, seven oocytes
were compared between young and aged mares to identify differences in the relative
expression levels of genes involved in the resumption of oocyte maturation. Five genes
(AREG, PDE4, GPR3, GDF9 and BMP15) were differentially expressed between oocytes
from young and aged mares.
The results of the present study add to the findings of Campos-Chillon et al.
(2008) by demonstrating that there are age-related differences in gene expression at the
individual oocyte/cumulus cell level, which may plausibly be associated with the lower
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quality and decreased developmental competence of oocytes from aged mares. While
there were different genes analyzed between that study and the present study, both
provide further knowledge as to the profound effects maternal aging may have on oocyte
and/or cumulus cell gene expression, and the potential impact these changes might have
on oocyte function. For instance, cumulus cells are in direct contact with the oocyte via
gap junctions and provide various nutrients, growth factors, metabolic components, and
signaling molecules that are necessary for proper oocyte development (Wang et al. 2010).
Any deleterious effects on the cumulus cells, such as apoptosis, could lead to a disruption
in essential interactions between the cumulus cells and its attendant oocyte adversely
affecting oocyte quality. BAX is a pro-apoptotic gene that was found to be expressed at
over two-fold higher levels in cumulus cells from aged mares. A higher relative
abundance of BAX transcripts in cumulus cells from aged mares could be indicative of a
propensity for higher rates of apoptosis, which could adversely affect oocyte quality
and/or developmental competence. Entry of the cumulus cells into apoptosis could also
potentially accelerate the aging process within the oocyte (Wu et al. 2011). Apoptosis in
the cumulus cells has been correlated with a delay in oocyte maturation and thus,
decreased oocyte quality through possible toxic metabolites that may be generated in the
cumulus cells that then travel to the oocyte via gap junctions (Nakahara et al. 1997;
Kaneko et al. 2000; Pocar et al. 2005). It is possible these metabolites lead to increased
rates of fragmentation in the oocytes, causing a decrease in oocyte competence and
subsequent embryo development (Wu et al. 2011).
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A group of genes that had previously been shown to be differentially expressed in

aneuploid human oocytes (Fragouli et al. 2010) was selected for analysis in this study,
but none of these genes were differentially expressed in oocytes or cumulus cells between
young and aged mares. In women, the age-related decrease in oocyte quality has been
associated with many chromosomal and meiotic spindle abnormalities within the oocyte,
which has ultimately led to the increased observation of aneuploidy (Battaglia et al.
1996). In fact, most oocytes from women over 40 have been shown to likely be aneuploid
(Hassold et al. 1984). Since similar defects have also been described for equine oocytes
(Rambags et al. 2005; Carenvale et al. 2012), we had expected to find expression of
many of these genes linked to aneuploidy to be markedly different in our study. It is
possible that a more thorough examination of the genes involved in normal chromosomal
alignment and meiotic spindle formation could lead to observations that are consistent
with the literature regarding aneuploidy in aged oocytes. Further research efforts are
needed to characterize the incidence of aneuploidy and meiotic spindle defects in equine
oocytes, perhaps using an immunochemistry approach as described in Vanderwall, et al.
(2010).
Another group of genes that had been shown to be differentially expressed with
advancing maternal age in human oocytes (Grondahl et al. 2010) was selected for
analysis in this study, and the results indicate that one of these genes was significantly
differentially expressed in the oocytes and one gene was differentially expressed in
cumulus cells between young and aged mares. HSF5 was significantly higher in the
oocytes from young mares. The heat shock factors are recognized as the master regulator
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of the heat shock response, a crucial mechanism to help limit the damage caused by stress
and aid in cellular recovery (Arya et al. 2007). More importantly, the heat shock response
is also a protective mechanism that allows the cell to properly respond to oxidative stress
(Westerheide et al. 2012). A lower abundance of transcripts from this gene in the oocytes
from aged mares could potentially lead to an inadequate response to increasing oxidative
stress, which has been observed in oocytes from aged females (Lord and Aitken, 2013).
ARL6IP6 was significantly higher in the cumulus cells from aged mares. ARL6IP6 is an
ADP-ribosylation factor interacting protein that plays a role in DNA repair and apoptosis.
ADP-ribosylation is involved in the cellular response to free oxygen radicals and
combating oxidative stress (Franceschi et al. 1990). A 2.4 fold increase of this gene in the
cumulus cells could be indicative of increased rates of oxidative stress and an increased
need for DNA repair mechanisms.
One gene was initially found to be significantly differentially expressed in both
the oocytes and the cumulus cells, but further statistical analysis demonstrated that some
of the variability was due to mare. NASP expression was over 10 times higher in cumulus
cells from aged mares and 4 times higher in the oocytes from aged mares, which is
consistent with the study done by Grondahl et al. (2010) where an almost 4 fold increase
in oocytes from aged human oocytes was also observed. This gene is thought to be
important for assembly and repair of newly replicated DNA and may help cope with
increased DNA damage. A higher abundance of NASP could be indicative of DNA
damage in both the oocytes and cumulus cells from aged mares and this gene is serving
as part of a mechanism that is more active in an effort to handle high rates of damage to
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DNA. It is well known that oxidative stress and reactive oxygen species increase with
advancing maternal age (Takahashi et al. 2003; Tatone et al. 2011; Lord and Aitken,
2013), and the oocyte’s ability to defend against oxidative stress through glutathione
decreases with age (Boerjan and de Boer, 1990; Yoshida et al. 1993). Oxidative stress
has been shown to have detrimental effects on oocytes from aged females (Keefe et al.
1995; Cummins et al. 2000; Thouas et al. 2005). Oxidative stress also leads to a
multitude of downstream effects, with DNA damage and fragmentation being a primary
effect. It is possible that cumulus-oocyte complexes from aged mares are exposed to
higher rates of oxidative stress, which may cause significant DNA damage, leading to
higher expression of both ARL6IP6 and NASP in order to counteract and attempt to repair
DNA damage. We did test one oxidative stress-related gene (COX1) but relative
expression levels of this gene were not found to be different between age groups in either
oocytes or cumulus cells. A more in depth analysis of genes involved in oxidative stress
will be needed to further understand the role these genes may be playing in relation to
maternal aging. It has been shown in mice that some of the most notable age-related
differences in global gene expression profiles are related to oxidative damage and stress
(Hamatani et al. 2004).
Another group of genes was selected based on the results of a study that aimed to
determine candidate genes for equine oocyte viability (Mohammadi-Sangcheshmeh et al.
2011). Of the genes presumably related to oocyte viability, two of ten were differentially
expressed in the oocyte samples (both IF3 and YBX2 were higher in oocytes from young
mares). IF3 is a gene that encodes for a translation initiation factor involved in
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mitochondrial protein synthesis. In a study looking at equine oocyte viability, IF3 was
found to be more abundant in oocytes with increased viability compared to those with
decreased viability (Mohammadi-Sangcheshmeh et al. 2011). A decreased abundance of
this gene in the aged mares could be indicative of a decrease in their viability and
developmental competence. YBX2 (MSY2) is an RNA binding protein that stabilizes
mRNA transcripts and protects them from degradation early in oocyte development.
Alterations to this gene can lead to perturbations in RNA stability (Medvedev et al.
2011). Shortly before maturation occurs, YBX2 is phosphorylated and is thus inactivated,
allowing the oocyte to degrade the majority of the transcripts in preparation for
fertilization (Medvedev et al. 2008). This process is crucial for the normal transition from
oocyte to embryo development. Zheng et al. (2005) have shown that reduced
developmental competence of oocytes matured in vitro is related to the failure of these
oocytes to undergo the normal pattern of transcript silencing or degradation. It is possible
that a lower abundance of this protein in the oocytes of aged mares causes an improper
degradation of transcripts that are necessary for proper oocyte developmental
competence. Degradation of too many transcripts in the oocyte could lead to inadequate
amounts of essential transcripts and proteins that are needed to support embryo
development prior to the activation of the embryonic genome. More research into the
lower abundance of YBX2 in the aged mares is necessary to understand the effect this
may have on oocytes from aged mares.
In the cumulus cells, HYOU1 transcripts were found to be significantly more
abundant in the cumulus cells from aged mares. HYOU1 is part of the heat shock protein
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family that has a cytoprotective role in hypoxia-induced perturbations within the cell.
Higher abundance of HYOU1 in the cumulus cells of aged mares could potentially
indicate high levels of stress within these cells, which would ultimately influence the
oocyte and possibly be another mechanism for their decreased developmental
competence. Fragouli et al. (2010) also observed several genes involved in pathways
related to hypoxia to be upregulated in their analysis of human aneuploid oocytes. AlEdani, et al. (2014) observed an increased expression of angiogenic genes in aged
cumulus cells and they hypothesized that these genes were being upregulated in an
attempt to neutralize the deleterious effects of a hypoxic environment. Our findings, in
combination with those of Fragouli et al. (2010) and Al-Edani, et al. (2014), indicate
there could be insufficient oxygen in these cells and thus, increased oxidative stress.
While it seems counter intuitive to have a hypoxic environment with high levels of
oxidative stress, it has been shown that superoxide generation can be elevated in response
to both high and low levels of oxygen (Clanton et al. 2007). Both of these situations
could be mechanisms for the decreased oocyte quality due to aging, as hypoxic follicular
environments have also been shown to cause meiotic spindle abnormalities in oocytes
(Van Blerkom et al. 1997).
In summary, the results of the present study confirm there are age-related
differences in gene expression in equine cumulus-oocyte complexes, which may
plausibly be associated with the lower quality and decreased developmental competence
of oocytes from aged mares. One possible mechanism for this decreased competence in
aged oocytes could be caused by increased rates of oxidative stress and subsequent DNA
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damage, which may be associated with the increased expression of ARL6IP6 and NASP
and decreased expression of HSF5. Increases in oxidative stress will also have a direct
impact on the mitochondria, which could lead to mitochondrial dysfunction (EichenlaubRitter et al. 2011). Evaluating the effects maternal aging has on mitochondria in equine
oocytes could provide a better understanding of how the quality of oocyte is
compromised. Even though we did not observe any alterations to the expression profiles
of genes related to aneuploidy, it is possible oxidative stress could be playing a role in the
observed compromised chromosomal segregation in aged oocytes (Schon et al. 2000;
Tarin et al. 1998). There is also a possibility for higher incidences of apoptosis in the
cumulus cells from aged mares, as one of the pro-apoptotic genes was found to be
significantly higher in these cumulus cells. Further analysis as to whether aged cumulus
cells do have an increased propensity for apoptosis is necessary. It is possible that
changes in, and abnormal activity of, the pathways described could result in an
environment that leads to an increased incidence of meiotic spindle and chromosomal
alignment defects, ultimately decreasing the quality of the oocyte.
The mare is an excellent and most logical model for studying age related
alterations to the oocyte due to their many reproductive similarities to humans as well as
their long lifespan (Carnevale et al. 1992; Carnevale et al. 1993; Carnevale et al. 1995;
Carenvale 2008; Ginther et al. 1993; Ginther 2012). Additional work is needed to more
fully characterize age-related changes in gene expression in equine cumulus-oocyte
complexes and determine whether/how such changes adversely affect embryonic
development in aged mares.
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Tables and Figures

Fig. 3-1. Summary of relative gene expression levels in oocytes from young versus
aged mares. Graphs depicting the average log10 fold change values of every gene for
each of the functional gene categories tested by qPCR in the oocyte samples. In each of
these graphs, the blue bars correspond to the average log10 fold change of samples from
old mares and the red bars represent the average log10 fold change of samples from young
mares. A. Zero of seven apoptosis related genes tested were significantly differentially
expressed in the oocytes. B. Zero of seven aneuploidy related genes tested were
differentially expressed in the oocytes. C. Expression levels of one of eight maternal
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aging related genes (HSF5) were significantly different in the oocytes. D. Transcript
levels from two of ten oocyte viability related genes (IF3 and YBX2) tested were
significantly different in oocytes. * = P < 0.05. Data are the mean + S.E.M.
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Fig. 3-2. Summary of relative gene expression levels in cumulus cells from young
versus aged mares. Graphs depicting the average log10 fold change values of every gene
for each of the functional gene categories tested by qPCR in the cumulus cell samples. In
each of these graphs, the blue bars correspond to the average log10 fold change of samples
from old mares and the red bars represent the average log10 fold change of samples from
young mares. A. One of ten seven apoptosis related genes tested were significantly
differentially expressed in the cumulus cells. B. Zero of ten aneuploidy related genes
tested were differentially expressed in the cumulus cells C. Expression levels of one of
ten maternal aging related genes tested were significantly different in the cumulus cells.
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D. Transcript levels from one of eleven oocyte viability related genes (HYOU1) tested
were significantly different in the cumulus cells. * = P < 0.05. Data are the mean +
S.E.M.
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Fig. 3-3. Unsupervised bidirectional hierarchical cluster graph of log2 fold change
gene expression values in oocytes of young and aged mares. Samples and genes are
segregated and clustered together based on similarity in expression pattern. Each sample
type is fairly segregated and clustered together due to their similar expression pattern.
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Fig. 3-4. Unsupervised bidirectional hierarchical cluster graph of log2 fold change
gene expression values in cumulus cells from young and old mares. Samples and
genes are segregated and clustered together based on similarity in expression pattern. The
cumulus cells from the young mares tended to segregate together, while the cumulus cells
from the aged mares somewhat cluster with one another as well.
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Supplementary Table 3-1. Gene names, corresponding accession numbers, and
forward and reverse primer sequences utilized for quantitative PCR

Gene
Symbol
ACTB
ARL6IP6

Functional
Category
HKG
MATERNAL
AGING

ASPM
ATG7

ANEUPLOIDY
ANEUPLOIDY

XM_001492586.3
XM_001493002.3

ATM

XM_001501161.4

AURORA-A
BAD
BAX
BCL2L1

APOPTOSIS
OOCYTE
VIABILITY
APOPTOSIS
APOPTOSIS
APOPTOSIS

BID

APOPTOSIS

XM_001489368.2

CASP3

APOPTOSIS

NM_001163961.1

GTCCCCAGGCCACTGAATAA
AGGATGAGCGACGAGTTCCA
CTCTTGTCCTCCCTGGGGAA
AGCGTAGACAAGGAGATGCA
CACCCAAGGCTGGTGAATAA
C
GCAGAAGTCTAGCTGGAAAA
CC

CASP8
CASP9

APOPTOSIS
APOPTOSIS
MATERNAL
AGING
OOCYTE
VIABILITY

XM_001496753.2
XM_001489054.3

CGTGCCCAAACTTCAGAACA
GTGTCCAGTTTGCCCACAC

XM_001499918.2

ACCTCTCAGGGCCGAAAAC

NM_001163976.1

ATTTGTCAACGCCACCTTCA

ANEUPLOIDY
MATERNAL
AGING
OOCYTE
VIABILITY
ANEUPLOIDY
OOCYTE
VIABILITY

XM_001499628.3

CAGCACCTTGCTTGCAGTAC

GCTGGGGATAAGGTTGGAAC
CGCTTTTCCATTTGGGTTTCTC
C

XM_001498695.3

AGCAGTTTCATTGCAGAGTCC

ACCACCAGATTCACCTTCTCA

XM_001496169.4
XM_003364605.1

ACCTGACCAACCTCAACCA
AGGATCCGATCAAAGAAGCA

CAGATGGCGAGGTGTCAAAA
TCACACGGATTCTGAATGACA

XM_001916437.2

AGAACCAGTGGGCATGGAA

HKG
ANEUPLOIDY
MATERNAL
AGING
MATERNAL
AGING
OOCYTE
VIABILITY
MATERNAL
AGING

XM_003362448.1
XM_001492891.2

CGAAACCGCTGTACTTAGCC
TTCCAAAAGCTCAACAGCAA
CA
CAACTGCGTGCAGGATGAAA

XM_001488002.3

CACTGTTCACACGGATGGAA

XM_001497855.3

ATGAAGACAGCGTCAGATCG

TGGGAGCCTATCGCTAAGAA
CGAAAGGGTCCTCAGAAAGA
G

NM_001163856.1

ATGGCCCCTCTGGGAAGAT

XM_001917801.2

HKG
OOCYTE
VIABILITY
OOCYTE
VIABILITY
ANEUPLOIDY
MATERNAL

NM_001163955.1
XM_001503114.4

ATTTGTGCAGGAAGGGCTAC
GAAGATCCCCAGACACATGC
TA
GAAGATGCAAAGCCCGTTTC
A

XM_001915024.3
XM_001491794.2
XM_001500817.3

AGCGGAAAGGCTAGACCTAC
GCAGTGTGCCAAGATGTCA
GGAAATTGTTGGCACGCTTCT

CDKN1
COX1
DC-UbP
DDX20
DICER1
DNCL2B
DNMT1
EIF4A1
ELF1
EML1
FAHD1
G3PDH
HSF5
HSP90AA1
HYOU1
IF3
LNX2
LSM5

Design RefSeq
NM_001081838.1
XM_001489885.2

XM_001489270.4
XM_001916754.2
XM_001504223.2
XM_001499745.3

5'-Forward Primer-3'
GGCTCCCAGCACGATGAA
TGAAGAAAGAAGCTGATGTA
GACAC
GGGAATGCAGAAGAGCAGAA
AGCTTTCAAGGCTGCGGATA
CCTTGAGACAGCAATCTCCTC
A

	
  
	
  

5'-Reverse Primer-3'
GGTGGACAATGAGGCCAGAA
GAAAAGCTGCAGCAGGAGAA
ATGACTCGAAGAGGCTGAAA
C
CGCCCGATTTTATGGATTCCC
AGAATGTGGCAGAGTCCCAA
A
CTCTTTTGATGCCAGTTCCTTT
TCA
AGTTCCGATCCCACCAGGAC
TGACCACCAGCCCCACATATA
GCTCTAGGTGGTCATTCAGGT
TGCTCCAGCGCAGAAGTAA
ACCACTGTCCAGTTCTGTACC
GCTCAGTAAAGGTCATGCTCA
AA
GATCCCGCCAGGAGACAAA
GGCTTCCTCTTGGAGAAGATC
C

TGGTCACCTCAAGCACATCA
GAACTTGGGTTGGAGCCTGTA

CCTTGGCAGCACCAGTAGAA
GGTGGATTGGTCTGGCATTTT
A
CGGTGGGGTCATCTTCATCA
ACCTCCTAACTCCAGAGGTTC
A
TGTGTCCAAATCATGTTGTCC
AA
CTCTCCGATGAGAAGCTCCA
AACTCAGTGACATCTTCCAGT

	
  
	
  

MEIS2
NASP
ODC1
P53
PCGF3
PDHB
RCCD1
RPS25
SELI
SPG20
STAT3
TBRG4
TFAM
XIAP
YBX2
ZFR
ZP2
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AGING
ANEUPLOIDY
MATERNAL
AGING
OOCYTE
VIABILITY
APOPTOSIS
ANEUPLOIDY

XM_003363526.1
XM_001495872.3

A
CGCAAGACACAGGACTTACA

XM_001502323.4
NM_001202405.1
XM_001488170.4

ATAGTGGGAACGCAGCTGAA
TGACAGCAGAACCATCGTGA
A
AGAAGCCACTGGATGGAGAA
AAGTTGGTTCCAGGCCTCCA

ANEUPLOIDY
ANEUPLOIDY
OOCYTE
VIABILITY
MATERNAL
AGING
MATERNAL
AGING
OOCYTE
VIABILITY
ANEUPLOIDY
OOCYTE
VIABILITY

XM_001489051.3
XM_001917377.1

TCCTGAGGAGACGCTTTCA
TGGCGGAGGATGGAAAGAC

XM_001503063.2
NM_001168391.1

GACTGAAGATTCGCGGTTCC
GTTTGGATTGTAGTGGGCATC
C

XM_001495257.2

TGGAGGAGCAGTGAAAGTCA

TGTGGAGCTAGTTCCTTTCCA

XM_003362556.2
XM_001497439.2

CACCTTCACTTGGGTGGAGAA
CTCCGCCCTGAATTTCACAC

TGTTCAGCTGCTGCTTGGTA
ATGTGGAGCAGCTTCTGGAA

XM_001503382.2

TACCCAAGGCGGACGAAAA

APOPTOSIS
OOCYTE
VIABILITY
MATERNAL
AGING
HKG

XM_001500906.3

TGCGCGAGCTGTGGAA
CCCAGTGAAGATCCTTGGGA
A

XM_005597979.1

GGGCACTGTCAAATGGTTCA

AGACGTCCTCTTTGGTGTCA

XR_131552.1
XM_001494769.2

TGACTGACCAGCAACGTGAA
AGCCAGGTCAACTTGCCTTA

TGTGTATCTGGCGGAATGCA
AGGGTACTCCTTGTCCCCATA

	
  

	
  
	
  

ACC
TGGTCAATCATGGGCTGTAC
CTCCTCCACTAGGAGTGAAAC
C
CGAGACTCTGCACCAGTTGTA
TCAGCTCTCGGAACATCTCA
TCCAGGCACTTCCATGCCTAA
CTTTCCAGCTCCTCATCCATA
C
TGTGCTCTTCACGTCAGGAC
CTTGAGCTCTGTGCTTTGAAA
C
TTCTACGGGCTTGCTTTCCA

ACTCCTGCCCCTTCTCTTCTA
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CHAPTER 4
IMPACT OF TOTAL WESTERN DIET ON GAMETE QUALITY IN SWINE

Abstract
Maternal nutrition has a direct impact on the health and well-being of the mother,
but it can also have profound consequences for embryonic/fetal fitness. In humans, it has
been suggested that maternal preconception diet plays an important role in dictating
reproductive success, possibly by affecting oocyte quality. The hypothesis for this study
was that consumption of a swine total western diet (sTWD), which is macro- and
micronutrient unbalanced, will lead to changes in the expression of genes involved in
various pathways such as one carbon metabolism, epigenetic modifiers, apoptosis, and
other metabolic pathways. Ten female pigs were assigned to be fed either the sTWD
(n=5) or a control (CON) pig diet (n=5). Pigs were fed for 12 weeks and allowed ad
libitum access to diets. Pigs fed the sTWD gained significantly more weight than CON
pigs, 83.6 kg vs. 54.2 kg (P= 0.029). sTWD pigs also had elevated levels of serum
glucose at 6 weeks (95.8 mg/dL vs. 77.8 mg/dL; P=0.0045) and the end of the 12 weeks
(123.2 mg/dL vs. 91.4 mg/dL; P=0.0021), which may indicate that the sTWD pigs were
pre-diabetic by the end of the feeding trial. Expression levels of 56 genes in 10 individual
oocytes from CON pigs versus 12 individual oocytes from the sTWD pigs from a variety
of functional pathways were tested using quantitative PCR. Twelve genes (AHCY, AKT2,
ATM, ENO1, FABP3, G6PD, LDLR, MTHFS, MTR, PPAR-D, RXRG, TLR5) were found
to be differentially expressed in the oocytes from the different treatment groups. In
addition to the gene expression analysis, cytochemistry experiments were carried out to
	
  
	
  

	
  
	
  

145	
  

compare the amount of glutathione and reactive oxygen species in oocytes from sTWD
and CON pigs. Glutathione was found to be significantly higher in oocytes from pigs fed
the sTWD (P<0.03). We conclude that the sTWD is a suitable diet for inducing an obese
phenotype in pigs. The sTWD also has profound effects on specific transcripts and
glutathione levels in the oocytes. We expect that this data will lead to a better
understanding of the impact diet has on oocyte quality.
Introduction
The Center for Disease Control and Prevention estimates that almost 20% of
women in the US are affected by infertility. Poor fertility has been clearly delineated in
some aspects: congenital defects, male factor in/subfertility, disease and/or lifestyle
choices, etc. However, many causes of poor fertility are left unexplained. Maternal
nutrition can significantly affect reproductive outcomes (Brewer and Balen 2010), but in
many cases, it is not clear whether nutrition-associated reproductive failures are primary
or secondary in nature. For instance, whether dietary factors are directly responsible for
causing reproductive inefficiencies or whether reproductive inefficiency is a
manifestation of a complex, chronic, multi-symptomatic disease (pre-metabolic or
metabolic syndrome) that is tightly associated with poor dietary habits in humans is
unknown. In order to optimize reproductive efficiencies in women who are overweight, it
is essential to more fully understand what factors are contributing to these fertility issues.
Maternal nutrition will obviously have a direct impact on the health and wellbeing of the mother. The diet a woman consumes before conception also plays an
important role in dictating reproductive success as well, by influencing gamete (ovum)
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quality and/or the uterine environment before or during development (Adamiak et al.
2005; Ashworth et al. 2009; Igosheva et al. 2010; Vucetic et al. 2010; Wang et al. 2010;
Wu et al. 2010; Luzzo et al. 2012; Twigt et al. 2012). Oocytes during later stages of
follicular development through ovulation and final maturation, and embryos during early
development are very sensitive to changes in maternal environment (Ashworth et al.
2009). Poor diets, especially those high in processed foods and sugars, typically lead to
high levels of glucose and insulin. High blood concentrations of insulin have detrimental
effects on the oocyte and impair embryo development (Adamiak et al. 2005). High
glucose levels have been shown to have numerous effects on the oocyte such as delayed
nuclear maturation, altered oocyte/cumulus cell interaction, impaired oocyte metabolism,
increased oxidative stress, reduced blastocyst development, and apoptosis (Krisher 2004).
Numerous aspects of the oocyte have been shown to be affected by poor nutrition. Wu et
al (2010) observed that oocytes retrieved from rats fed a high fat diet had an increase in
lipid content. Mice models of type 1 diabetes have been shown to produce smaller
oocytes that display signs of impaired maturation and increased granulosa cell apoptosis.
Similar impacts were also seen in mice fed a high fat diet (Luzzo et al. 2012). Luzzo et
al. (2012) explain that a possible mechanism for the decrease in oocyte quality could be
altered mitochondria activity. Igosheva et al. (2010) showed that obesity can cause
uneven mitochondria distribution, altered morphology, as well as alterations to
mitochondrial DNA within the oocyte. Wang et al. (2010) demonstrated that oocytes
from diabetic mice also display meiotic defects. The follicular environment surrounding
the oocyte is also altered due to poor nutrition (Hernandez-Medrano et al. 2012), which
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may potentially lead to alterations to gene expression profiles within the oocyte itself
and/or in the essential companion cells to the oocyte, the cumulus granulosa cells.
Micronutrient deficiencies have been shown to be associated with high
reproductive risks, such as fetal structural defects and long term diseases (McArdle and
Ashworth 1999). For example, low iron prior to conception was related to defects in
regulators of growth and development (Gambling et al. 2002). Deficient levels of
Vitamin B6 prior to conception was associated with altered metabolism of amino acids,
lipids, nucleic acids, and glycogen and also affected implantation and early placental
development (Ronnenberg et al. 2007). Many micronutrients are not only essential for
post-implantation fetal development, but also for oocyte and early pre-implantation
embryo development (Cetin et al. 2010) as well. Folate is very important for oocyte
quality and maturation (Ebisch et al. 2007). Zinc plays a role in the estrous cycle and
ovulation and is shown to prevent many adverse reproductive outcomes like neural tube
defects (Velie et al. 1999). Several of the most basic molecular processes, like DNA
synthesis, rely on zinc and the B vitamins, so it is not surprising they would have a
crucial role in oocyte development. Lastly, decreases in vitamins A, C, and D have all
been associated with diminished fertilization capabilities (Ebisch et al. 2007).
While there have been numerous studies looking at how single dietary
components affect various reproductive endpoints, there has been no description of
whether a total western diet, which is not only high in fat and simple sugars, but also
unbalanced in the micronutrients, will affect reproductive success. The goals for this
study were to administer a diet that accurately mimics western dietary consumption
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patterns and to test the direct effect of this unbalanced diet on the molecular constitution
of developing porcine oocytes. The total western diet is a calorie-rich, micronutrientdeficient diet characterized by high intakes of red and processed meats, sweets, fried
foods and refined grains that was originally formulated in rodents (Hintze et al. 2012). As
most micronutrients are acquired through the diet, consumption of energy-dense,
nutrient-poor foods may result in micronutrient intakes below Recommended Daily
Allowances (RDAs). Although these low nutrient intakes do not trigger symptoms of
acute deficiency, other adverse health effects from prolonged low dietary nutrient
exposure are possible, including increased risk or acceleration of degenerative diseases
such as cancer, cardiovascular disease and diabetes, as well as depression, chronic
inflammatory disease, and even infertility. The diet that was formulated is more
representative of typical U.S. intakes, which is necessary to appropriately evaluate the
real impact of diet on fertility/oocyte quality and to develop specific and effective
prevention strategies.
The hypothesis for this study was that a total western diet for swine – formulated
on principles outlined by Hintze et al (2012) for mouse studies – would result in a
phenotype in domestic pigs reminiscent of obesity and insulin resistance in humans, and
that the diet would induce specific and reproducible changes in gene expression levels
and an increase in intracellular reactive oxygen species in oocytes and their surrounding
cumulus cells. These analyses provide a better understanding of how western dietary
consumption patterns, where the diet is vastly unbalanced in both macro- and
micronutrients, impacts oocyte quality.
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Materials and methods
Animal use and handling was undertaken in accordance with strict principles of
animal welfare as approved of and overseen by the veterinary staff and the Institutional
Animal Care and Use Committee at Utah State University (IACUC #1471).
Diet formulation
In 2012, Hintze et al formulated a so-called “total Western diet” for rodents using
energy and nutrient profiles that emulate a typical Western diet using available U.S.
survey data from the National Health and Nutrition Examination Survey (NHANES). The
TWD was formulated using a nutrient density approach described by Hintze et al. (2012).
The amount of each macro- and micronutrient was adjusted to match 50th percentile
intakes for Americans as reported in NHANES survey data. The NHANES survey
contains information on total energy intake, macronutrient ratios (protein, fat and
carbohydrates), macronutrient sources (complex carbohydrates versus simple sugars and
fatty acid composition), as well as information on most essential micronutrients. The
nutrient consumption data that matched the 50th percentile intakes was used to normalize
the daily intake to calories consumed in order to establish a nutrient density measure
(mass of nutrient/kcal/day). For the present study, a similar approach was used to
generate the TWD for swine (sTWD). After determining an average intake for each
nutrient from the NHANES data, the next step in formulating the swine diet required
translation of the human nutrient intake information to a diet suited for pigs using the
nutrient density approach.
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The nutrient density for each non-caloric dietary component was calculated as the

quotient of the daily intake of each nutrient divided by the average caloric intake per day
from NHANES. The nutrient density for each component was then translated to the
sTWD as follows: 2070 kcal/day is the average daily caloric intake reported at the
NHANES 50th percentile so the mass of each nutrient at the NHANES 50th percentile
was divided by 2070 kcal to determine nutrient density (mass of nutrient/kcal/day). The
nutrient density calculation was then used to translate nutrient amounts to the swine diet.
Pigs from 5 to 110 kg consume on average ~5241 kcal/day (National Research Council
2012) and each nutrient was added to the swine diet to match the nutrient density
(mass/kcal/day) of the NHANES 50th percentile. Of the macronutrient components,
protein content is the most similar between the control diet and the newly devised sTWD,
as soybean meal and corn are the primary protein sources in both diets. However, to
match total caloric contribution of protein to the NHANES data set, the sTWD contains
15.4% of total energy from protein compared to 17.7% in the control diet. Overall, the
sTWD is more energy dense than the control diet because of its much higher fat content.
It is also lower in carbohydrates and protein. The sTWD is higher in sodium and many of
the B vitamins, likely because these nutrients are commonly fortified in human foods.
Compared to the control diet, the sTWD is much lower in several minerals including
calcium, phosphorus, magnesium, copper, iron and zinc. Table 4-1 shows the
composition of the control diet and table 4-2 shows the composition of the swine TWD.
A comparison of a typical swine diet with the formulated sTWD can be seen in Table 43.
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Nutrition trial and sample collection
The nutrition trial consisted of 10 pigs that were randomly assigned to either the
western diet or a control diet. The pigs were fed ad libitum for 12 weeks and food
consumption was measured daily. Weight gain was measured every week to evaluate if
the diet was inducing obesity. At the end of the trial, pigs were euthanized and ovaries
were excised from each pig. Oocytes and their cumulus cells were aspirated from
medium sized follicles (4-6mm) of the ovaries of each of the pigs from the treatment
groups to ensure they were all at similar stages of oocyte development. One of the CON
pigs did not have active ovaries and thus oocytes and cumulus cells were not collected
from this pig. After an oocyte was identified, it was transferred immediately into 1
mg/mL hyaluronidase diluted in HEPES-Buffered Tyrode’s Lactate solution (Lai and
Prather 2003) for cumulus cell removal. The cumulus-oocyte complex was gently
pipetted within the enzyme solution until the oocyte was devoid of bound cumulus cells.
Each oocyte was separately washed, snap frozen in liquid nitrogen, and stored at -80°C
until further use. Cumulus cells from all oocytes collected from each pig were pooled
together, washed, snap frozen in liquid nitrogen, and stored at -80°C until further use.
Blood glucose measurement
Blood was collected at the beginning, middle and end of the trial after overnight
fasting and centrifuged at 10,000 x g for 10 minutes to separate plasma and red blood
cells. Plasma glucose was measured with a glucose meter (Accu-Chek Integra, Roche
Diagnostics; Indianapolis, IN). To determine differences in blood glucose levels among
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diet treatments at each of the three time points, a two-way ANOVA statistical analysis
was performed using SAS (SAS Institute Inc; Cary, NC). A Bonferroni multiple testing
adjustment was applied to control the family-wise error rate and significance was set at
P<0.05.
Follicular fluid mineral analysis
Follicular fluid was aspirated from multiple follicles on every ovary from each pig
separately and then pooled together so that one fluid sample was available for each pig in
order to perform a mineral analysis for 29 minerals/trace elements. Samples were
digested (1:1) in trace mineral grade nitric acid (Fisher Scientific, Pittsburgh,
Pennsylvania 15275, USA) in sealed 10 ml Oak Ridge screw-cap Teflon digestion tubes
(Nalge Nunc International, Rochester, New York 14625, USA) on a heat block for 2 hour
at 90 C. The digest was then diluted 1:10 with 18.2 mohm water in a 15 ml polypropylene
trace metal free tube (ELKAY, Mansfield, Massachusetts 01801, USA). This provided
5% nitric acid matrices for analysis, which was matrix matched for all standard curve and
quality control samples. Mineral content analysis was performed using an ELAN 6000
inductively coupled plasma mass spectrometer (ICP-MS) (Perkin Elmer, Shelton,
Connecticut 06484, USA). Flush solution used between samples was 5% nitric
acid. Standard curves and quality control (QC) samples were analyzed every 5 samples.
National Institute of Standards and Technology (NIST) standards were also analyzed to
verify accuracy of the analytical results. QC analyses were considered acceptable if +/10% of the known mineral concentration but were typically less than +/- 5%. The Utah
Veterinary Diagnostics Laboratory in Logan, UT completed this work.
	
  
	
  

	
  
	
  

153	
  

Gene expression analysis
RNA isolation and reverse transcription
Total RNA was isolated from individual oocyte and pooled cumulus cell samples
using the Quick-RNA™ Micro Kit (Zymo Research; Irvine, CA). The manufacturer’s
protocol was followed precisely with the exception that the final elution of the RNA off
the column was performed twice. Eight microliters of RNA from each oocyte and
cumulus cell sample was used for reverse transcription using the GoScript Reverse
Transcription system from Promega (Madison, WI). A mix of 2 µL (0.5 µg each) of the
oligo-dT and random primers supplied in the kit; 4 µL of the 5x Reaction Buffer; final
concentrations of 4.8 mM of MgCl2 and 2 mM of Nucleotide Mix; 20 U of RNasin; and 1
µL of reverse transcriptase were used for each reaction. Following reverse transcription,
the quality of the cDNA was confirmed with a PCR reaction using Qiagen’s Hot Start
PCR kit. cDNA samples were then stored at -20°C until further use. A pooled reference
sample of various tissue samples was used as a positive PCR control and for creating a
standard curve for use in calculating primer efficiencies (see below for further details).
qPCR analysis
For the qPCR analysis, a unique and innovative qPCR platform from the Fluidigm
Corporation (South San Francisco, CA) was implemented. This qPCR system
incorporates typical PCR chemistry with a novel and elaborate network of nanoliter-scale
microfluidics based reaction wells for analyzing the expression of up to 96 genes for each
of 96 samples on Fluidigm’s 96.96 Dynamic Array Integrated Fluidic Circuits (IFC).
Custom primers were designed through the Fluidigm Corporation’s DeltaGene assay
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design service. Each primer was designed based on NCBI’s reference sequence for swine.
Gene and PCR primer information for these genes are presented in Supplemental Table
4-1.
Fluidigm’s recommended protocol (ADP 14) was followed for performing
quantitative PCR gene expression analysis using the Biomark system. To briefly
describe, specific target amplification (STA) was performed to enrich each cDNA sample
prior to quantitative PCR thermal cycling. A 200 nM STA primer mix was prepared by
pooling 1 µL of each primer pair (20 µM each). The STA reaction mixtures consisted of
1.25 µL of the STA primer mix, 2.5 µL of TaqMan PreAmp Master Mix (Applied
Biosystems; Foster City, CA), and 1.25 µL of cDNA. The reactions were activated at
95°C for 10 minutes and then amplified for 14 cycles that consisted of 95°C for 15
seconds then 60°C for 4 minutes. To remove any unincorporated primers, each reaction
was treated with Exonuclease I (ExoI; New England Biolabs; Ipswich, MA) once STA
thermal cycling was finished. The ExoI reaction pre-mix was made by combining 1.4 µL
water, 0.2 µL ExoI Reaction Buffer and 0.4 µL ExoI enzyme for each of STA reactions.
Two microliters of the ExoI reaction pre-mix were added to each STA reaction and then
the reaction mixtures were incubated at 37°C for 30 minutes for digestion to take place.
Reactions were then inactivated at 80°C for 15 minutes. Each reaction was diluted 5-fold
for a total volume of 25 µL per protocol recommendations and then stored at -20°C until
they were analyzed with the Fluidigm IFC gene expression chip.
Each sample and primer solution was made individually in preparation for qPCR
cycling. The sample pre-mix solutions consisted of 2.5 µL of the 2x TaqMan Gene
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Expression Master Mix (Applied Biosystems), 0.25 µL of 20x Sample Loading Reagent
(Fluidigm), 0.25 µL 20x EvaGreen DNA Binding Dye (Biotium) and 2 µL of the diluted
ExoI-treated STA sample. The assay (primer) mix was made for every primer set using
2.5 µL of the 2x Assay Loading Reagent (Fluidigm), 0.25 µL water, and 2.25 µL of each
20 µM Forward and Reverse primer mix. After priming the chip, 5 µL of each assay and
5 µL of each sample were pipetted into their respective inlets on the chip. The chip was
then returned to the IFC Controller in order to load the samples and assays into the chip.
Once chip loading had finished, the chip was placed in the BioMark thermal cycler for
quantitative PCR. Cycling parameters consisted of 5 minutes of initial enzyme activation,
followed by 35 denaturation/extension cycles (95°C for 15 seconds followed by 60°C for
60 seconds) and a 3-minute final extension cycle. A melt curve analysis was performed
following PCR amplification to assess the quality of each amplicon. Data were analyzed
using the Fluidigm Real-Time PCR Analysis Software, which uses the raw cycle
threshold value determined through thermal cycling to quantitate the ∆Ct value by
normalizing through one selected housekeeping gene that worked most consistently for
all samples (HSP90AA1). This software also assessed the melting curve to determine the
quality of each reaction. A selected calibrator (a pooled 100 oocyte sample for the
oocytes and a reference sample of various pooled porcine tissue/cell types for cumulus
cells) was used to determine the ∆∆Ct value for each sample, which was done by
subtracting the ∆Ct of each experimental sample by the ∆Ct of the calibrator sample for
each gene. Lastly, we determined the fold change for each sample by using the equation
Fold Change = 2-∆∆Ct.
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Primer efficiencies were calculated from the standard curve using the formula

equation E=10-1/slope (Applied Biosystems, 2004). Any primer sets that had low
efficiencies (<70%) or an inability to provide good amplification in at least half of the
samples were excluded from further analysis. Statistical evaluations involved a per-gene
random nested design where pig was considered a random factor nested within the diet
treatment group, with particular attention to differential expression (normalized log2 fold
change values) between diets. A Bonferroni multiple testing adjustment was applied to
control the false discovery rate and significance was set at P<0.05.
A hierarchical clustering analysis was performed using the Multiexperimental
Viewer (MeV) data analysis software (Saeed et al. 2003). The Spearman Rank distance
complete linkage clustering algorithm was selected for this analysis. The log2 fold change
values of the genes that were found to be differentially expressed in the oocytes were
used to identify similarities or differences in expression patterns between all samples.
Cytochemistry analysis
A cytochemistry analysis was performed in order to measure levels of glutathione
and reactive oxygen species in three oocytes collected from each of CON (n=4) and
sTWD (n=5) pigs. Glutathione levels were measured using monochlorobimane (MCB), a
nonfluorescent chemical that becomes fluorescent when it conjugates with glutathione.
MCB is commonly used to measure intracellular glutathione levels in cells, as the greater
amount of fluorescence is indicative of higher glutathione levels. Oocytes were incubated
with 50 µM MCB for 40 minutes then imaged on a Zeiss fluorescent microscope. ROS
were measured using dihydroethidium (HeT), which gives off a blue fluorescence until it
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reacts with oxygen species, which causes dihydroethidium to be oxidized to ethidium,
giving off a red fluorescence. Oocytes were incubated with 20 µM HeT for 40 minutes
and then imaged on a Zeiss fluorescent microscope. A greater red fluorescence is
indicative of greater levels of ROS within the cell. Average pixel intensities of each
oocyte were determined using Adobe Photoshop.
Results
Food and energy intakes, body weights, and metabolic efficiency
Food intakes are reported on a per week basis (Fig. 4-1A) or on a per pig, per
week basis (Supplemental Fig. 4-1A) for individual pigs on the CON or sTWD diet for
the entire 12 week feeding period. Total amount of food consumed for the entire 12-week
feeding period for each diet is reported in Figure 4-2A and total amount consumed by
each pig individually for the entire feeding period is reported in Supplemental Figure 42A. Over the course of the feeding period, pigs fed the control diet consumed more food
numerically than those pigs on the sTWD for almost every week. The total amount
consumed by these control pigs for the duration of the feeding period was also higher
than the pigs fed the sTWD. However, the total amount of food consumed between the
two diets was not significant (P=0.3312).
Energy intakes were calculated using the specific energy density for each
experimental diet and the recorded food intake values and are presented on a per week
basis (Fig. 4-1B) or on a per pig, per week basis (Supplemental Fig. 4-1B) for individual
pigs on the CON or sTWD diet for the entire 12 week feeding period. Total energy
intakes for the entire 12 week feeding period for each diet are reported in Figure 4-2B
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and total energy intakes by each pig individually for the entire feeding period are reported
in Supplemental Figure 4-2B. The specific energy density for the sTWD was higher than
the control diet (4,400 kcals vs. 3,000 kcals). Throughout the duration of the feeding
period, pigs fed the sTWD as a whole had higher total energy intakes and higher energy
intakes for every week despite consuming less food. However, the total energy intakes
between the two diets were not significant (P=0.1296).
Body weight gain data are reported on a per week basis (Fig. 4-1C) or on a per
pig, per week basis (Supplemental Fig. 4-1C) for individual pigs on the CON or sTWD
diet for the entire 12 week feeding period. Total body weight gained for the entire 12
week feeding period for each diet is reported in Figure 4-2C and total body weight gained
by each pig individually for the entire feeding period is reported in Supplemental Figure
4-2C. Pigs that were fed the sTWD consistently gained more weight than the pigs on the
CON diet. The amount of total weight gain for all the pigs was significantly higher by
54% (P<0.029). The total weight gain for the pigs on the CON diet was 54.2 kg whereas
the total weight gain for the pigs on the sTWD was 83.6 kg. Actual body weights are
reported on a per week basis (Fig. 4-1E) or on a per pig, per week basis (Supplemental
Fig. 4-1E) for individual pigs on the CON or sTWD diet for the entire 12-week feeding
period.
The amount of body weight gain relative to the starting weight for each pig was
calculated as a percentage. The percent body weight gain data are reported on a per week
basis (Fig. 4-1D) or on a per pig, per week basis (Supplemental Fig. 4-1D) for individual
pigs on the CON or sTWD diet for the entire 12-week feeding period. Total percent body
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weight gained for the 12-week feeding period for each diet is reported in Figure 4-2D and
total percent body weight gained by each pig individually for the entire feeding period is
reported in Supplemental Figure 4-2D. The pigs fed the sTWD had a significantly higher
percent body weight gain (P=0.0255), where there was a 48.93% total body weight
increase as compared to a 34.86% total body weight increase in the pigs fed the control
diet.
Metabolic efficiency was calculated (weekly energy intake divided by weekly
body weight gain) for each of the pigs on the two diets. Metabolic efficiencies are
reported on a per week basis (Fig. 4-1F) or on a per pig, per week basis (Supplemental
Fig. 4-1F) for individual pigs on the CON or sTWD diet for the entire 12-week feeding
period. Total metabolic efficiency for the entire 12-week feeding period for each diet is
reported in Figure 4-2E and total metabolic efficiency by each pig individually for the
entire feeding period is reported in Supplemental Figure 4-2E. Pigs fed the sTWD tended
to have lower total metabolic efficiency, suggesting they may be less efficient at
converting nutrients to energy. Total metabolic efficiency between the two diet groups
was not significant but trended towards significance (P=0.06). Results of the statistical
analyses for each of these parameters evaluated for the pigs on the different diets are
presented in Table 4-4.
Blood glucose results
Blood glucose levels were measured in all CON and sTWD pigs at the beginning,
middle, and end of the 12 week trial (Figure 4-3). At the baseline measurement, the mean
glucose level for the CON pigs was 88.4 mg/dL and the mean level for the sTWD pigs
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was 99.4 mg/dL. These glucose levels were not statistically different between the CON
and sTWD pigs. At the midpoint measurement, the mean glucose level for the CON pigs
was 77.8 mg/dL and the mean glucose level for the sTWD pigs was 95.8 mg/dL. This
difference of 18mg/dL in glucose levels between the CON and sTWD pigs was
statistically different (P=0.0045). At the end of the trial, the mean glucose level for the
CON pigs was 91.4 mg/dL and the mean glucose level for the sTWD pigs was 123.2
mg/dL. This difference of 31.8 mg/dL in glucose levels between the CON and sTWD
pigs was statistically different (P=0.0021).
Follicular fluid mineral analysis results
A mineral analysis was conducted to identify if there were any alterations to 29
trace minerals in the follicular fluid from pigs on the sTWD (Table 4-5). Only two
minerals were found to be statistically different: Boron was found to be 2.25 times lower
in the follicular fluid of sTWD pigs (P=0.009) and Cobalt was found to be 1.75 times
lower in the follicular fluid of sTWD pigs (P=0.011). Both of these minerals were within
physiological levels for both CON and sTWD follicular fluid samples so it is unclear
what biological effect these differences might have.
qPCR results
We aimed to quantify and compare mRNA levels in individual oocytes and
pooled cumulus cell samples using quantitative real-time PCR. The purpose of this qPCR
analysis was to evaluate the relative gene expression levels of 96 selected genes in
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oocytes and cumulus cells. Table 4-6 shows the various functional categories the genes
tested fell under.
Relative transcript abundances for 12 out of the 56 genes tested were found to be
differentially expressed between the CON and sTWD oocytes. All of these transcripts
were found to be more abundant in the CON oocytes compared to the sTWD oocytes. For
the one carbon metabolism pathway, three of the five genes tested were found to be
significantly differentially expressed (Figure 4-4A): Adenosylhomocysteinase (AHCY)
was 2.4 fold higher in the CON oocytes (P=0.03); 5,10-methenyltetrahydrofolate
synthetase (MTHFS) was 4.8 times higher in the CON oocytes (P=0.01); and 5methyltetrahydrofolate-homocysteine methyltransferase (MTR) was 3.9 times higher in
the CON oocytes (P=0.03). For the apoptosis related category, there was one gene that
was found to be differentially expressed (Figure 4-5A): ATM serine/threonine kinase
(ATM) was found to be 5.3 fold higher in the CON oocytes (P=0.033). Two out of five of
the carbohydrate metabolism related genes were found to be differentially expressed
(Figure 4-6A): V-akt murine thymoma viral oncogene homolog 2 (AKT2) was 2.4 fold
higher in the CON oocytes (P=0.04) and Glucose-6 phosphate dehydrogenase (G6PD)
was 5.2 fold higher in the CON oocytes (P=0.03). For the cholesterol synthesis pathway,
two genes were found to be differentially expressed (Figure 4-7A): Low density
lipoprotein receptor (LDLR) was found to be 3 fold higher (P=0.03) and Retinoid X
receptor gamma (RXRG) was 3.4 fold higher in the CON oocytes (P=0.04). One out of
three fatty acid oxidation related genes was found to be differentially expressed (Figure
4-8A): Fatty acid binding protein 3 (FABP3) was 3 fold higher in the CON oocytes
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(P=0.04). For the glutaredoxin category, none of the seven genes were found to be
differentially expressed (Figure 4-9A). One gene related to glycolysis was found to be
differentially expressed (Figure 4-10A): Enolase 1 (ENO1) was 3.7 fold higher in the
CON oocytes (P=0.007). None of the inflammation related genes were found to be
differentially expressed (Figure 4-11A). Two of the five metabolic syndrome related
genes tested were found to be differentially expressed (Figure 4-12A): Peroxisome
proliferator-activated receptor delta (PPAR-δ) was 2.4 fold higher (P=0.01) and Toll-like
receptor 5 (TLR5) was 20.6 fold higher in the CON oocytes (P=0.01). Lastly, for the
peroxiredoxin. epigenetic modifiers, and protein metabolism related categories, none of
the genes tested were found to be differentially expressed (Figure 4-13A; Figure 4-14A;
Figure 4-15A). Figure 4-16 shows an unsupervised bidirectional hierarchical cluster
graph of the individual oocytes tested for 56 genes with quantitative PCR using the
complete Spearman Correlation.
In the cumulus cells, Tumor necrosis factor, alpha-induced protein 3 (TNFAIP3)
is an inflammation related gene that was found to be over 3 times higher in the sTWD
cumulus cells (P=0.005) (Figure 4-11B).
Cytochemistry results
A cytochemistry analysis was done to quantify and compare intracellular
glutathione and reactive oxygen species levels between CON and sTWD oocytes. Both
glutathione and reactive oxygen species were found to be higher in oocytes from pigs fed
the sTWD but only glutathione was significantly higher (P<0.03) where there was a 1.5
fold increase in the sTWD oocytes. Figure 4-17A shows the glutathione levels measured
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in each of the three oocytes collected from CON (n=4) and sTWD (n=5) pigs. Reactive
oxygen species levels measured in each of the three oocytes collected from CON (n=4)
and sTWD (n=5) pigs are shown in Figure 4-17B.
Discussion
The total western diet is a calorie-rich, micronutrient-unbalanced research animal
diet that was formulated to be representative of the diet consumed by the majority of
Americans, which is necessary to appropriately evaluate the real impact that diet has on
oocyte quality and metabolic parameters. This diet had a significant impact on the
amount of weight gained and is thus a suitable diet for inducing an obese phenotype in
swine. The sTWD also led to increased levels of serum glucose. Elevated glucose levels
can lead to a multitude of negative effects both metabolically and within the oocyte
(Krisher 2004). Since recent evidence has pointed at poor oocyte quality as being a
primary cause for poor reproductive efficiency in women who are overweight (Robker
2008; Purcell and Moley 2011), the objective of these experiments was to provide better
knowledge as to how diet influences the quality of the oocyte and ultimately leads to
decreases in their developmental competence. The overall hypothesis was that a total
western diet would have profound effects on a variety of metabolic parameters and would
induce specific and reproducible changes in gene expression levels in oocytes and their
accompanying cumulus cells.
In order to identify what alterations are occurring to the gene expression profiles
of oocytes from pigs fed a sTWD, we first aimed to quantify the relative expression
levels of 56 genes that were selected from a variety of metabolic related categories. The
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results of the qPCR analysis determined that 12 out of the 56 genes tested were found to
be differentially expressed. The roles that some of these genes have in oocytes in
particular is poorly delineated, as many of them have yet to be described. One-carbon
metabolism is a combination of metabolic pathways that include folate, methionine, and
choline metabolism. Many of the enzymes involved in this pathway have been shown to
be expressed in the ovary, oocytes, and preimplantation-stage embryos (Xu and Sinclair
2015). The one carbon metabolism pathway is responsible for generating Sadenosylmethionine, the universal methyl donor required for methylation of DNA
and histones (Bailey et al. 2012). Dietary sources of methyl groups like folate,
methionine, and choline are critical for maintaining epigenetic marks (Niculescu and
Zeisel 2002). Since the sTWD is high in B vitamins, which are many of the cofactors
utilized in the one carbon metabolism pathway, it would not be unexpected to find many
of the genes involved in this pathway to be affected. We found three of the genes related
to one carbon metabolism to be differentially expressed in the sTWD oocytes. AHCY was
found to be lower in the sTWD oocytes. Deficiencies of this gene play a role in
hypermethioninemia and possibly higher levels of DNA methylation. MTR is part of the
methionine metabolism pathway and is responsible for catalyzing the conversion of
homocysteine to methionine. The lower expression of MTR in the sTWD oocytes could
lead to the inadequate conversion of homocysteine to methionine, resulting in elevated
levels of homocysteine. Elevated homocysteine levels have been linked to numerous
diseases (Williams and Schalinske 2010) and maintaining normal homocysteine levels is
essential for optimizing health. MTHFS, a gene involved in folate utilization, was also
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found to be much lower in the sTWD oocytes. A decreased abundance of this enzyme
could be indicative of impaired folate metabolism, which could also lead to altered rates
of DNA methylation. The sTWD diet is 457% higher in folate than the control diet, and
higher levels of folate have been shown to lead to increased DNA methylation (Choi et
al. 2005). Deficiencies in one carbon metabolism related factors prior to conception are
known to lead to epigenetic alterations in genes that regulate key developmental
processes in the embryo (Xu and Sinclair 2015). Alterations to this pathway may also
lead to disturbances in gametogenesis, fertilization, implantation, and placentation
(Steegers-Theunissen and Steegers 2003). It is possible that these alterations can lead to
long-term negative effects on the subsequent health and metabolism of offspring. It
would be useful to further evaluate more aspects to the one carbon metabolism pathway,
including analyzing the methylation status of oocytes from pigs fed the sTWD, in order
to identify if DNA methylation patterns are truly different due to alterations to this
pathway.
For the apoptosis gene category, ATM was found to be higher in the CON
oocytes. This gene is one of the master regulators of cell cycle signaling pathways that
are required for responding to DNA damage. A lower abundance of this transcript in the
sTWD oocytes could lead to an inadequate response to the normal cellular mechanisms
responsible for repairing DNA damage. For the carbohydrate metabolism category, there
were two genes that were found to be differentially expressed and at lower levels in
sTWD oocytes. AKT2 is an essential gene in the maintenance of normal glucose
homeostasis (Cho et al. 2001). AKT2 plays a role in the regulation of adipocyte glucose
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metabolism by possibly mediating the action of insulin (Taniguchi et al. 2006). A
decreased expression leads to increased glucose levels through impaired insulinstimulated glucose uptake (George et al. 2004; McClung et al. 2004). Deletion of AKT2
has been shown to result in impaired glucose tolerance and insulin resistance (Cho et al.
2001; Garofalo et al. 2003). Expression of AKT2 can be decreased by oxidative stress and
reactive oxygen species (Furukawa et al. 2004; McClung et al. 2004), which could
indicate increased levels of oxidative stress within the oocyte. It is possible that a lower
expression of AKT2 in sTWD oocytes could be indicative of increased levels of glucose
within these oocytes, which may ultimately cause a decrease in quality. G6PD is part of
the pentose phosphate pathway (PPP), one of the key metabolic pathways in the oocyte.
Elevated levels of G6PD and elevated activity of PPP are normal events that occur within
the oocyte during growth and development and are correlated with increased
developmental competence (Krisher et al. 2007). Lower levels of G6PD could be
indicative of decreased utilization of the PPP in the sTWD oocytes and ultimately, a
decrease in quality due to decreased metabolic activity. G6PD is also responsible for
generating NADPH, a crucial cellular cofactor. If lower transcript abundance of G6PD
causes lower production of NADPH, this could lead to a multitude of negative effects in
these oocytes.
For the cholesterol synthesis pathway, two genes were found to be differentially
expressed. LDLR is the gene that codes for the LDL receptor and was found to be
expressed lower in sTWD oocytes. LDLR is involved with lipid homeostasis and
clearance. Alterations to LDLR levels have been associated with defective clearance of
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LDL, leading to the accumulation of cholesterol and ultimately, hyperlipidemia and
obesity (Wouters et al. 2005). LDLR−/−mice have been shown to exhibit diet-induced
weight gain and glucose intolerance. They have also been shown to have fewer ovarian
follicles overall, more atretic follicles, lower estrogen levels and they spent significantly
less time in estrus (Guo et al. 2014). This is a huge indicator that defects in LDLR or
alterations to the abundance of this transcript, could also lead to decreases in reproductive
capabilities and fertility. RXRG is another cholesterol synthesis related gene that was
found to be lower in sTWD oocytes. RXRG is part of the gene family coding for the
retinoid x receptor, which plays important roles in lipid homeostasis. Alterations to the
retinoid X receptor have also been shown to lead to hyperlipidemia (Sentinelli et al.
2013). RXRG heterodimerizes with the farnesol X receptor, the liver X receptors, and the
peroxisome proliferator-activated receptors to influence glucose, triglyceride, cholesterol,
and bile acid homeostasis. Dysregulation to these processes have been shown to result in
metabolic syndrome related effects such as obesity, diabetes, and hyperlipidemia (Szanto
et al. 2004). Since both LDLR and RXRG play a role in maintaining lipid homeostasis,
decreases in their abundance in the sTWD oocytes could indicate altered lipid
metabolism in these oocytes. Alterations to lipid metabolism in the oocyte have been
shown to alter meiotic maturation and decrease developmental competence of the oocyte
(Sanchez-Lazo, 2014).
For the fatty acid oxidation category, there was one gene that was found to be
differentially expressed and lower in the sTWD oocytes. FABP3 is involved in the
uptake, metabolism, and transport of fatty acids. Dysregulation of the fatty acid binding
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proteins have been shown to be associated with numerous metabolic diseases including
obesity (Thumser et al. 2014). In the oocyte, FABP3 is thought to play a role in meiotic
maturation and a decrease in this transcript could lead to altered oocyte maturation
competence (Sanchez-Lazo, 2014). One gene related to glycolysis was found to be
differentially expressed. ENO1 is the transcript that codes for a glycolytic enzyme that is
important for the conversion to pyruvate. The oocyte requires a tremendous amount of
pyruvate for energy metabolism (Krisher, 2004). Energy metabolism in the oocyte is
crucial in order for the oocyte to properly progress through maturation (Sanchez-Lazo et
al. 2014). An impaired pyruvate conversion can severely affect glucose metabolism and
thus, oocyte quality. Two of the metabolic syndrome related genes were found to be
differentially expressed. PPAR-δ is thought to be responsible for improving lipid profiles
and reducing adiposity (Wang et al. 2003). Wang et al. (2003) found that the activation of
PPAR-δ in mice fed a high fat diet protected those mice from hyperlipidemia and obesity.
When PPAR-δ was induced in obese mice, it led to a dramatic depletion of lipid
accumulation and fat mass, improving obesity. Mice that were deficient in PPAR-δ and
fed a high fat diet were prone to obesity due to increased lipid accumulation. It is possible
that a decrease in this gene in the sTWD oocytes could lead to an increase in lipid
accumulation within the oocyte, which may also result in a decrease in oocyte quality. .
TLR5 is another metabolic syndrome related gene that was found to be over 20 times
higher in the control oocytes. This gene is well known to be involved in activating an
immune response and other inflammatory related genes. It has also been shown that mice
deficient in this gene had increased body and fat mass (Vijay-Kumar et al. 2010). These
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mice also had increased circulating levels of triglycerides, cholesterol, proinflammatory
cytokines, glucose and insulin. When these mice were fed a high fat diet, they showed
even higher increases in body and fat mass and showed signs that they had become
diabetic. Deficiency of TLR5 also led to alterations in the gut microbiota that most likely
was responsible for inducing the inflammatory response. It is evident that deficiencies of
this gene lead to many aspects of metabolic syndrome. It is unknown what role this gene
may have in the oocytes, but it is possible that a decreased expression could also lead to
increased levels of triglycerides, cholesterol, proinflammatory cytokines, glucose and
insulin within the oocyte, similar to what was observed at the whole animal level in the
study done by (Vijay-Kumar et al. 2010).
Oxidative stress levels are known to be increased in obese individuals and play a
critical role in many diseases, including diabetes (Furukawa et al. 2004). Since
glutathione is the main antioxidant used by cells to decrease levels of reactive oxygen
species, we hypothesized that oocytes from pigs fed the sTWD would have higher levels
of reactive oxygen species than oocytes from the control pigs, which would subsequently
result in the increased levels of glutathione levels in these oocytes. Even though our gene
expression analysis revealed that none of the genes related to the glutaredoxin pathway
were found to be differentially expressed in the oocytes, our cytochemistry analysis
revealed a significant difference in glutathione levels between CON and sTWD oocytes.
Glutathione (GSH) was found to be 1.5 fold higher (P=0.03) in the sTWD oocytes.
Reactive oxygen species were also measured but this effect was not found to be
significant. Oxidative stress plays critical roles in many diseases. Obesity and diabetes
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have been shown to induce oxidative stress, which may be responsible for impairing
glucose uptake and inducing insulin resistance (Furukawa et al. 2004). In order to
counteract oxidative stress and rising reactive oxygen species levels, glutathione levels
are increased either through the synthesis of GSH or through the reduction of glutathione
disulfide to glutathione by glutathione reductase (Krisher et al. 2007). Glutathione is thus
essential for reducing harmful reactive oxygen species and protecting against oxidative
stress. In oocytes, it has been demonstrated that a high level of GSH upsets redox
homeostasis, resulting in decreased developmental competence (Zhou et al. 2008; Yuan
et al. 2012). A balanced redox environment is essential for proper oocyte development,
which could indicate that the sTWD oocytes are of lesser quality due to their high
glutathione levels. One other thing to note is that many of the enzymes involved in the
glutaredoxin pathway are dependent on selenium. The sTWD is slightly higher in
selenium, which could influence the activity of the enzymes responsible for reducing
ROS and increasing glutathione levels. Selenium levels in the follicular fluid were not
found to be different, however.
There was only one gene that was found to be significantly different in the
cumulus cells. TNFAIP3 was found to be over 3 times higher in the sTWD cumulus cells.
This gene is part of the inflammatory response and is induced by tumor necrosis factor
(TNF), which could be indicative of higher inflammation due to the diet.
In conclusion, we have shown that the sTWD leads to an obese phenotype in pigs
after just 12 weeks of consuming the diet. Pigs that were on this diet gained significantly
more weight as a whole than the controls by nearly double and had elevated serum
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glucose levels. This diet also led to many genes being differentially expressed in the
oocytes, demonstrating that western dietary consumption patterns do in fact have a
significant effect on transcript abundances within the oocyte. Many of the genes that were
found to be differentially expressed are known to play roles in glucose and lipid
metabolism. Alterations to the abundance of these genes may lead to a multitude of
effects in these pigs including effects that are typically seen with metabolic syndrome,
such as glucose intolerance, insulin resistance, obesity and diabetes. We expect that this
data will lead to a better understanding to how the diet a female consumes before
conception plays an important role in dictating reproductive success by affecting oocyte
quality.
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Tables and Figures
Table 4-1. Porcine control diet guaranteed analysis
Ingredient
Total Amount
Crude Protein
16%
Lysine
0.70%
Methionine
0.30%
Crude Fat
2.50%
Crude Fiber
9%
Calcium
1%
Phosphorus
0.40%
Salt
1%
Selenium
0.3 ppm
Copper
10 ppm
Zinc
60 ppm
Manganese
50 ppm
Iodine
0.2 ppm
Vitamin A
5,000 IU/lb
Vitamin D
100 IU/lb
Vitamin E
50 IU/lb
INGREDIENTS
Processed Grain By-products, Grain Product, Plant Protein Products, Calcium Carbonate, Salt, Bleachable
Fancy Tallow, Zinc Sulfate, Zinc Amino Acid Chelate, Manganese Sulfate, Manganese Amino Acid
Chelate, Copper Sulfate, Copper Amino Acid Chelate, Ferrous Sulfate, Sodium Selenite, Ethylene Diamine
Dihydriodide, Cobalt Sulfate, Choline Chloride, Vitamin E Supplement, dl-Calcium Pantothenate, Niacin,
d-Biotin, Vitamin A Supplement, Riboflavin Supplement, Menadione Sodium Bisulfite Complex (Source
of Vitamin K3), Vitamin B12 Supplement, Pyridoxine Hydrochloride, Folic Acid, d-Activated Animal Sterol
(Source of Vitamin D3), Thiamine Mononitrate, Ground Rice Hulls, Mineral Oil, Selenium Yeast,
Chromium Tripecolinate, Yucca Shidigera Extract.
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Table 4-2. Porcine sTWD formulation
Total
Amount
(g/kg)

Ingredient
Corn
(ground,
yellow dent)

Protein
(g/kg)

Fat
(g/kg)

Fiber
(g/kg)

420

281.23

39.564

19.908

30.66

Sugar
Whey
protein
Concentrate
80

229.33

229.33

0

0

0

165

9.075

128.7

13.2

0

Soybean oil

31.4

0

0

31.4

0

28.47

0

0.24

23.1

0

Olive oil

28

0

0

28

0

Lard

28

0

0

28

0

24.8

0

0

24.8

0

35

4.0145

168.504

168.408

30.66

Butter

Beef tallow
Mineral mix
Calcium Carbonate CaCO3
Potassium Phosphate, monobasic
KH2PO4

2.11995

Potassium Citrate, monohydrate

2.50005

8.9999

Sodium Chloride NaCl

17.20005

Ferric Citrate

0.084

Zinc Carbonate

0.02401

Manganese Carbonate MnCO3

0.05495

Cupric Carbonate, Certified

0.0021

Potassium Iodate KIO3

0.000301

Sodium Selenate Anhydrous Na2SeO4

0.000385

Sucrose/Cane Sugar, Fine Ground

4.0145

Vitamin mix

10
Niacin

0.036

Calcium Pantothenate

0.017

Pyridoxine HCl

0.0038

Riboflavin

0.0035

Folic Acid

0.002

Biotin
Vitamin B12 in Mannitol (0.1%
trituration)
Vitamin E Acetate (DL-Alpha
Tocopheryl Acetate)-- (500 IU/g)
Vitamin A Palmitate (500,000 U/g),
DRY
Vitamin D3 (500,000 U/g)
cholecalciferol

0.0003

0.00046

Vitamin K (phylloquinone)

0.00013

0.013
0.02
0.007

1.4

Sucrose/Cane Sugar, Fine Ground

Total

8.49481

0.002

Thiamin HCl

Choline Bitartrate

8.49481

	
  

1000

	
  
	
  

Carbs
(g/kg)

532.14431

	
  
	
  

174	
  
Total kcal/kg

4318.27

	
  
	
  

2128.58

674.02

1515.67
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Table 4-3. Porcine diet compositions
Macronutrients

Control Diet

sTWD Diet

Carbohydrates (% kcal)
Protein (% kcal)
Fat (% kcal)
Total Energy (kcal/kg)

81.5
16
2.5
3180

49.3
15.6
35.1
4318

Micronutrients (% of requirement)1

Control Diet

sTWD Diet

Riboflavin
100%
137%
Niacin
100%
418%
B6
100%
283%
Folate
100%
451%
Choline
100%
152%
B12
100%
111%
Vit D
100%
205%
Vit E
100%
42%
Vit K
100%
71%
Calcium
100%
28%
Phosphorus
100%
46%
Magnesium
100%
28%
Iron
100%
42%
Zinc
100%
30%
Copper
100%
49%
Selenium
100%
112%
Potassium
100%
197%
Sodium
100%
298%
1
Nutrient Requirements are averages for pigs between 50-80 kg derived from
Nutrient Requirements for Swine, Eleventh Revised Edition (2012).
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Table 4-4. Statistical analysis of food intake and weight gain data

FOOD INTAKE
ENERGY INTAKE
BODY WEIGHT
GAIN
% BODY WEIGHT
GAIN
METABOLIC
EFFICIENCY

AVG. CON

SEM

AVG. sTWD

SEM

PVALUE

304.58
913734.06

25.64
76906.9

264.65
1164473.16

28.85
126955.23

0.3312
0.1296

54.2

5.02

83.6

9.87

0.029

40.25

3.44

61.13

6.46

0.0255

17057.96

1252.55

14120.24

631.19

0.0695

Analysis of each parameter was performed using a random nested design where pig was
considered a random factor nested within the diet treatment group. P values of the
differences are shown for each parameter among diet group. Both body weight gain and
percent body weight gain (relative to pig starting weight) are significant (P<0.05).
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Table 4-5. Mineral analysis for follicular fluid samples collected from CON and
sTWD pigs
CON
Average

SEM
CON

Concentration (ppm)

Ag
Al
As
B
Ba
Be
Ca
Cd
Co
Cr
Cu
Fe
K
Li
Mg
Mn
Mo
Na
Ni
P
Pb
Sb
Se
Si
Sn
Sr
Tl
V
Zn

0.001
0.0258
0.008
0.054
0.002
0.001
116.9843
0.001
0.0018
0.1888
1.564
1.786
655.832
0.0043
29.528
0.0063
0.0058
3298.8295
0.005
165.1975
0.001
0.001
0.147
13.173
0.001
0.0353
0.001
0.0223
0.956

0
0.002
0.0019
0.0069
0.0004
0
2.1056
0
0.0002
0.0063
0.0831
0.0865
34.7118
0.0002
1.2978
0.0004
0.001
62.6058
0
7.0622
0
0
0.0085
0.3279
0
0.0014
0
0.0024
0.0577

sTWD
Average

SEM
TWD

Fold
Difference

Concentration (ppm)

0.001
0.0318
0.0084
0.024
0.0016
0.001
116.6148
0.001
0.001
0.2002
1.8326
2.0844
697.3234
0.0034
29.6674
0.008
0.0036
3365.2138
0.0054
189.0286
0.001
0.001
0.1282
13.3838
0.001
0.0436
0.001
0.0282
1.0394

Physiological Levels
(normal pig serum)
Concentration (ppm)

0
0.0078
0.0004
0.0041
0.0002
0
3.4756
0
0
0.0056
0.1213
0.2272
30.9183
0.0004
0.6352
0.0007
0.0002
73.5124
0.0005
10.4692
0
0
0.0051
0.4663
0
0.003
0
0.0024
0.0357

	
  
	
  

P
Value

1
0.8097
0.9524
2.25
1.25
1
1.0032
1
1.75
0.9428
0.8534
0.8568
0.9405
1.25
0.9953
0.7813
1.5972
0.9803
0.9259
0.8739
1
1
1.1466
0.9842
1
0.8085
1
0.789
0.9198

0.5239
0.3242
0.0093
0.4071
0.9366
0.0112
0.2449
0.1399
0.3092
0.4312
0.1355
0.9286
0.0945
0.0854
0.5465
0.5113
0.1293
0.1124
0.7457
0.0591
0.144
0.2798

< 0.05
< 0.2
< 0.1
< 1.0
< 0.3
< 0.05
90 to 130
< 0.05
< 0.001 to 0.1
0.15 to 0.5
1.3 to 3.0
1.0 to 2.0
140 to 200
< 0.05
18 to 40
2800 to 3500
< 0.05
80 to 150
< 0.05
< 0.05
0.14 to 0.3
< 0.05
< 1.0
< 0.01
0.01 to 0.1
0.7 to 1.5
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Table 4-6. Genes tested for quantitative PCR and their functional gene categories
FUNCTIONAL GENE
CATEGORIES
1 CARBON METABOLISM

NUMBER OF
GENES
9

APOPTOSIS

7

ATM, BAD, BAX, BCLX, BID, CASP8, XIAP

CARBOHYDRATE
METABOLISM

8

AKT2, G6PC, G6PD, GCK, GPI, IGF1, IRS1,
PPAR-GAMMA

CHOLESTEROL
SYNTHESIS

7

ACO1, HMGCR, LDLR, LIPG, LPL, RXRG,
SREBF1

EPIGENETIC MODIFIERS

7

ASH2L, DMAP1, DNMT1, DNMT3A, EHMT2,
EZH2, TRDMT1

FATTY ACID OXIDATION

9

ACADL, ACADM, ACOX1, ASCL3, CPT1A,
CPT1B, FABP3, FADS1, FASN

GLUTAREDOXIN

11

GCLC, GLRX, GLRX2, GPX1, GPX4, GSR, GSS,
SOD1, SOD2, TXN, TXNRD1

GLYCOLYSIS

4

ENO1, GLUT4, HK1, HK2

INFLAMMATION

8

CRP, IL10, IL1A, IL1B, IL6, IL6R, TNFAIP3, TNFALPHA

METABOLIC SYNDROME

10

AMPK-ALPHA, DGAT2, MYD88, PCK1, PPARALPHA, PPAR-DELTA, TLR2, TLR4, TLR5, TLR9

OTHER

2

HYOU1, YBX2

PEROXIREDOXINS

3

PRDX3, PRDX5, PRDX6

PROTEIN METABOLISM

5

ACY1, ARG1, GLUD1, GLUL, OTC

HOUSEKEEPING

4

ACTB, EIF4A1, GAPDH, HSP90AA1

GENES TESTED
AHCY, ALDH1L1, DHFR, FOLH1, MAT1A,
MTHFD1, MTHFR, MTHFS, MTR
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Fig. 4-1. Feed intake and weight gain data in control or sTWD pigs. A. Mean food
intake per week +/- SEM is shown for control pigs or sTWD pigs. B. Mean energy intake
per week +/- SEM shown for control pigs or sTWD pigs. C. Mean body weight gain per
week +/- SEM is shown for control pigs or sTWD pigs. D. Percent body weight gain per
week +/- SEM is shown for control pigs or sTWD pigs. E. Body weight measured each
week +/- SEM is shown for control pigs or sTWD pigs. F. Mean metabolic efficiency
(calculated as weekly energy intake divided by weekly body weight gain) per week +/SEM is shown for control pigs or sTWD pigs. n=5 for all measurements.
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Fig. 4-2. Total feed intake and weight gain data for each diet for the duration of the
trial. A. Total food intake per week +/- SEM is shown for control pigs or sTWD pigs. B.
Total energy intake per week +/- SEM shown for control pigs or sTWD pigs. C. Total
percent body weight gain per week +/- SEM is shown for control pigs or sTWD pigs. D.
Total body weight gain per week +/- SEM is shown for control pigs or sTWD pigs. F.
Total metabolic efficiency (calculated as weekly energy intake divided by weekly body
weight gain) per week +/- SEM is shown for control pigs or sTWD pigs. n=5 for all
measurements.
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Fig. 4-3. Average fasting glucose levels for CON and sTWD pigs at the beginning,
middle, and end of the 12 week trial. Glucose levels were statistically higher in serum
from sTWD pigs at the midpoint and endpoint measurements (P<0.05). Different letters
indicate that treatment groups and/or time points are significantly different as determined
by two-way ANOVA.
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Fig. 4-4. Log2 ratios of every gene for the one carbon metabolism functional gene
category tested by qPCR. A. Three of the five transcripts that were evaluated in the
oocytes were found to be differentially expressed. B. None of the genes were found to be
differentially expressed in the cumulus cells. * = P < 0.05. Data are the mean + S.E.M.
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Fig. 4-5. Log2 ratios of every gene for the apoptosis functional gene category tested
by qPCR. A. There was one gene that was found to be differentially expressed in the
oocytes. B. None of the genes were found to be differentially expressed in the cumulus
cells. * = P < 0.05. Data are the mean + S.E.M.
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*

Fig. 4-6. Log2 ratios of every gene for the carbohydrate metabolism functional gene
category tested by qPCR. A. Two out of five genes tested related to carbohydrate
metabolism was found to be differentially expressed in the oocytes. B. None of the genes
were found to be differentially expressed in the cumulus cells. * = P < 0.05. Data are the
mean + S.E.M.
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Fig. 4-7. Log2 ratios of every gene for the cholesterol synthesis functional gene
category tested by qPCR. A. Two genes were found to be differentially expressed in the
oocytes. B. None of the genes were found to be differentially expressed in the cumulus
cells. * = P < 0.05. Data are the mean + S.E.M.
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Fig. 4-8. Log2 ratios of every gene for the fatty acid oxidation functional gene
category tested by qPCR. A. One out of three fatty acid oxidation related genes were
found to be differentially expressed in the oocytes. B. None of the genes were found to be
differentially expressed in the cumulus cells. * = P < 0.05. Data are the mean + S.E.M.
	
  
	
  

	
  
	
  

187	
  

Fig. 4-9. Log2 ratios of every gene for the glutaredoxin functional gene category
tested by qPCR. A. None of the seven genes were found to be differentially expressed in
the oocytes. B. None of the genes were found to be differentially expressed in the
cumulus cells. * = P < 0.05. Data are the mean + S.E.M.
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Fig. 4-10. Log2 ratios of every gene for the glycolysis functional gene category tested
by qPCR. A. One gene related to glycolysis was found to be differentially expressed in
the oocytes. B. None of the genes were found to be differentially expressed in the
cumulus cells. * = P < 0.05. Data are the mean + S.E.M.
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Fig. 4-11. Log2 ratios of every gene for the inflammation functional gene category
tested by qPCR. A. None of the inflammation related genes were found to be
differentially expressed in the oocytes. B. One of the inflammation related genes was
found to be differentially expressed in the cumulus cells. * = P < 0.05. Data are the mean
+ S.E.M.
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Fig. 4-12. Log2 ratios of every gene for the metabolic syndrome functional gene
category tested by qPCR. A. Two of the five metabolic syndrome related genes tested
were found to be differentially expressed in the oocytes. B. None of the genes were found
to be differentially expressed in the cumulus cells. * = P < 0.05. Data are the mean +
S.E.M.
	
  
	
  

	
  
	
  

191	
  

Fig. 4-13. Log2 ratios of every gene for the peroxiredoxin functional gene category
tested by qPCR. A. None of the genes were found to be differentially expressed in the
oocytes. B. None of the genes were found to be differentially expressed in the cumulus
cells. * = P < 0.05. Data are the mean + S.E.M.
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Fig. 4-14. Log2 ratios of every gene for the epigenetic modifiers functional gene
category tested by qPCR. A. None of the genes were found to be differentially
expressed in the oocytes. B. None of the genes were found to be differentially expressed
in the cumulus cells. * = P < 0.05. Data are the mean + S.E.M.
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Fig. 4-15. Log2 ratios of every gene for the protein metabolism functional gene
category tested by qPCR. A. None of the genes were found to be differentially
expressed in the oocytes. B. None of the genes were found to be differentially expressed
in the cumulus cells. * = P < 0.05. Data are the mean + S.E.M.
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Fig. 4-16. Unsupervised bidirectional hierarchical cluster graph of the individual
oocytes tested for 56 genes with quantitative PCR using the complete Spearman
Correlation. Samples and genes are segregated and clustered together based on
similarity in expression pattern.
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Fig. 4-17. Cytochemistry analysis to evaluate levels of glutathione and reactive
oxygen species in oocytes. A. Average pixel intensity representing the amount of
fluorescence, which is indicative to glutathione levels in the oocytes. Each of the three
oocytes collected from CON (n=4) and sTWD (n=5) pigs are represented. Glutathione
was found to be 1.5 fold significantly higher (P=0.03) in the sTWD oocytes. B. Average
pixel intensity representing the amount of fluorescence, which is indicative to reactive
oxygen species levels in the oocytes. Each of the three oocytes collected from CON (n=4)
and sTWD (n=5) pigs are represented. The amount of reactive oxygen species was not
significantly different (P=0.37). * = P < 0.05. Data are the mean + S.E.M.
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Supplementary Table 4-1. Gene names, corresponding accession
numbers, and forward and reverse primer sequences utilized for quantitative
PCR.

GENE
SYMBOL

FUNCTIONAL
CATEGORY

DESIGN
REFSEQ

5'-FORWARD PRIMER-3'

3'-REVERSE PRIMER-5'

ACADL

FATTY ACID
OXIDATION

NM_213897.1

GTTAAGGGGCGAAAGCT
ACA

CTGGCAACCGTACATCTTC
A

ACADM

FATTY ACID
OXIDATION

NM_214039.1

GTGAGGGAGCAGGTTTC
AAAA

AAAGCTCTTTGTGCGAGTC
C

ACO1

CHOLESTEROL
SYNTHESIS

XM_003357729.2

TTGTGGGCACAGATTCA
CAC

GACAGCTTCTGCTTCGATA
CC

ACOX1

FATTY ACID
OXIDATION

NM_001101028.1

CTTCATTGTCCCTATCCG
GGAA

CCAATGTCCCCGACGGTAA
TA

ACY1

PROTEIN
METABOLISM

NM_213896.1

TCTTGCTCAACTCCCACA
CA

TGTAGCCATCTGCATCCTT
GAA

AHCY

1 CARBON
METABOLISM

NM_001011727.1

GGAGGGCAACATCTTTG
TCA

CACGATGGCGTCATCTTTC
A

AKT2

CARBOHYDRATE
METABOLISM

NM_001256779.1

TTGTCTCGGCTCTGGAGT
AC

TTGTCCAGCATGAGGTTTT
CC

ALDH1L1

1 CARBON
METABOLISM

NM_001244647.1

TTGGCAGACCTCATGGA
ACA

TTCAGGGCCAGTGTGTAGA
C

AMPK-α

METABOLIC
SYNDROME

NM_001167633.1

GTCGACGTCTCTTCCAAC
AA

CCACCATATGCCTGTGACA
A

ARG1

PROTEIN
METABOLISM

NM_214048.2

ATCATCGGAGCTCCTTTC
TCC

AGCAGACCAGCCTTTCTCA
A

ASCL3

FATTY ACID
OXIDATION

XM_003129388.2

CCCCTGAGCAGGATCAG
AA

CTCGAGCCTGTAACGACCA
A

ASH2L

EPIGENETIC
MODIFIER

NM_001243568.1

TTTCCGGCCATCTCACTG
TA

TCCTTCGGCGGATACTTGA
A

ATM

APOPTOSIS

NM_001123080.1

TTAAGAGCTTGGGCTCT
GGAA

TGGTACAGCGAGATCACAC
A

BAD

APOPTOSIS

XM_003122573.3

GCTCCGGAGGATGAGTG
AC

CTTCGGGCGAGGAAGTCC

BAX

APOPTOSIS

XM_003127290.3

GCGCTTTTCTACTTTGCC
AGTA

GCCGATCTCGAAGGAAGTC
C

BCLX

APOPTOSIS

NM_214285.1

AGCGTAGACAAGGAGAT
GCA

TTCAGGTAAGTGGCCATCC
A

BID

APOPTOSIS

NM_001030535.1

CCGCACAGTTCAGGAAC
CA

TCTGGCCAGGAGCATAGTC
A

CASP8

APOPTOSIS

NM_001031779.2

AGAGTGAGCTTCGGATA
CCA

TTCAATTCCGACCTGGTCA
C

CPT1A

FATTY ACID
OXIDATION

NM_001129805.1

GGGGTAATCGCCAAGAT
CAA

GAACAGGACGCCACTGAC

CPT1B

FATTY ACID
OXIDATION

NM_001007191.1

TGCACGGCAACTGCTAC
AA

CCCAGCTGGCCATTCTTGA
A

CRP

INFLAMMATION

NM_213844.2

TGTCTCCTGGTCATCATT
AGCC

CCGACTCTTTGGGGAAGAC
A
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DGAT2

METABOLIC
SYNDROME

NM_001160080.1

CACCTGGCTCAATAGGT
CCAA

AGCACGAGGAAAGACAGG
AC

DHFR

1 CARBON
METABOLISM

NM_001244064.1

CAAAGAATGACCACAAC
CTCTTCA

TCTTCTCCGGAATGGAGAA
CC

DMAP1

EPIGENETIC
MODIFIER

NM_001243640.1

GACGGAGCCATGTTCTT
CCA

ACCTGCACCGTCTTGTTGA
A

DNMT1

EPIGENETIC
MODIFIER

NM_001032355.1

AAAGGCGCTCATAGGCT
TCA

ACGCTGAACAGTGGTGCAT
A

DNMT3A

EPIGENETIC
MODIFIER

NM_001097437.1

ATGACCTCTCCATCGTCA
ACC

CAGGAGGCGGTAGAACTC
AAA

EHMT2

EPIGENETIC
MODIFIER

NM_001101823.1

ACTTCAGCCTCTACTACG
ATTCC

GTTCAGCCAGAGCTTCAAC
C

ENO1

GLYCOLYSIS

XM_005664974.1

ACAATGACAAGACGCGC
TAC

GGGCAGGCGCAATAGTTTT
A

EZH2

EPIGENETIC
MODIFIER

NM_001244309.1

CGAAGGATCCAGCCTGT
TCA

ACGGGATGACTTGTGTTGG
AA

FABP3

FATTY ACID
OXIDATION

NM_001099931.1

CTGGAAGCTAGTGGACA
GCAA

ACCTGCCTGGTGGCAAAA

FADS1

FATTY ACID
OXIDATION

NM_001113041.1

ATCCCCATGCACATCGA
TCA

GGCCACTGAACCAATCATT
GAA

FASN

FATTY ACID
OXIDATION

NM_001099930.1

TGGAGGGGCTATTGCAT
CAA

TGCTTACACTCTTCCCAGG
AC

FOLH1

1 CARBON
METABOLISM

NM_214384.1

CTCGCCCCAACTACATCT
CA

CCAGGAGGAGGTGGTTCAA
ATA

G6PC

CARBOHYDRATE
METABOLISM

NM_001113445.1

GGAGGGAATGAACCTTC
TCC

AATCCTGGGAGTCCTGGTA
A

G6PD

CARBOHYDRATE
METABOLISM

XM_003360515.3

GTCTGGTGGCCATGGAG
AA

CCTCTGAGATGCACTTCAA
CAC

GCK

CARBOHYDRATE
METABOLISM

XM_003134883.1

CCAAGCACCAGATGTAC
TCC

TGCACTCGGAGATGTAGTC
A

GCLC

GLUTAREDOXIN

XM_003128335.4

ACATGGAGGTGGATGTA
GACAC

TCCATCTGGCAACTGTCAT
CA

GLRX

GLUTAREDOXIN

NM_214233.1

CAGTGACACCAACGAGA
TTCA

ACCGATAAAGACCCGAGGT
AC

GLRX2

GLUTAREDOXIN

NM_001243717.1

GACGCTCTTTGCACAAT
GACA

TGTCCATTGCGCCTCCAAT
A

GLUD1

PROTEIN
METABOLISM

NM_001244501.1

AGTGAGAAGCAGCTGAC
CAA

TGGTCCATTGGCACCTTCA

GLUL

PROTEIN
METABOLISM

NM_213909.1

CATGTTTCGGGACCCTTT
CC

TCCGTTTACAGGTGTGCCT
TA

GLUT4

GLYCOLYSIS

NM_001128433.1

CCGTCGGGCTTCCAACA

GAGAAGACGGCGAGGACA
A

GPI

CARBOHYDRATE
METABOLISM

NM_214330.1

TGGGACCCACATTGCCA
AAA

ATGGTCTCCTGGGTGGTGA
A

GPX1

GLUTAREDOXIN

NM_214201.1

CGGGACTACACCCAGAT
GAA

TCCCCATTCTTGGCATTTTC
C

GPX4

GLUTAREDOXIN

NM_214407.1

GCTTTAGCCGCCTGTTCC

TCGATGTCCTTGGCTGAGA
A
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GSR

GLUTAREDOXIN

XM_003483635.2

TGAATGTCGGATGTGTA
CCC

CAACTCTGAAAGCCATAGT
CAAC

GSS

GLUTAREDOXIN

NM_001244625.1

GGCCATTGCTGCCCCTA

CCAAGGCCTGTACCATCTC
C

HK1

GLYCOLYSIS

NM_001243184.1

CTGGCCTATTACTTCACC
GAAC

AGCCGCATGGCATAGAGAT
A

HK2

GLYCOLYSIS

NM_001122987.1

TGGTCACACTGCTGAAG
GAA

AGTCCCAACCGTGTCATTC
A

HMGCR

CHOLESTEROL
SYNTHESIS

NM_001122988.1

AAAGTTTGCCCTCAGCTC
CA

GTGGGACCTAAAATTGCCA
TTCC

IGF1

CARBOHYDRATE
METABOLISM

NM_214256.1

TTCAGTTCGTGTGCGGA
GAC

CGGAAGCAGCACTCATCCA

IL10

INFLAMMATION

NM_214041.1

GGAGAAGCTGAAGACCC
TCA

CGGCCTTGCTCTTGTTTTCA

IL1A

INFLAMMATION

NM_214029.1

TCCCTGACCTCTTTGAAG
ACC

CAGAGAGAGATGGTCGAT
ATCAGAA

IL1B

INFLAMMATION

NM_214055.1

TGGCCCACACATGCTGA
A

CCTTGCACAAAGCTCATGC
A

IL6

INFLAMMATION

NM_214399.1

AGGAACCCAGCTATGAA
CTCC

AGTAGCCATCACCAGAAGC
A

IL6R

INFLAMMATION

NM_214403.1

GGACAACGCCACCATTC
AC

TGCACGGACTTCAGAAGCA

IRS1

CARBOHYDRATE
METABOLISM

NM_001244489.1

CCGTCAGTAGCTCAACT
GGA

TGTGAGGTCCTGGTTGTGA
AT

LDLR

CHOLESTEROL
SYNTHESIS

NM_001206354.2

GAGGGGCCCAACAAGTT
CA

TCCCTGACTGAGTTGCACA
C

LIPG

CHOLESTEROL
SYNTHESIS

NM_001243029.1

TTTACGGCACCAATGCA
GAC

GAAGGTGTTGGTGGCATTC
A

LPL

CHOLESTEROL
SYNTHESIS

NM_214286.1

GTCCCCAGATGGAGAGC
AAA

CTTCGCGGGAGACGATCA

MAT1A

1 CARBON
METABOLISM

NM_001243187.1

GGTGGTCAGAGACACCA
TCAA

CAGCACATTGCAGGTCTTG
AA

MTHFD1

1 CARBON
METABOLISM

XM_001924329.3

ACCCAAAGGATGCTTGG
AAC

TTTTACTGCGCCCGATCAC

MTHFR

1 CARBON
METABOLISM

XM_003127574.2

CCCAGGAGTGGGATGAA
TTCC

GTAGTCCTTCAGCTCCCCA
AA

MTHFS

1 CARBON
METABOLISM

XM_005656266.1

CAGGTCCCCATGGATGA
ACA

GACGCTGGGGAGTCTTCAT
AA

MTR

1 CARBON
METABOLISM

XM_001927058.2

ACCAAGTGCTTACCGGC
ATA

CACATCACCTTTAACGGTA
GCC

MYD88

METABOLIC
SYNDROME

NM_001099923.1

TGCGTCTGGTCCATTGCT
A

TCAGAGACAACCACTACCA
TCC

OTC

PROTEIN
METABOLISM

NM_001164002.2

GCCCTTAGACACAGTCA
CAA

GACCCTTCAGCTGCACTTT
A

PCK1

METABOLIC
SYNDROME

NM_001123158.1

GGACTTCGAGAAAGCCT
TCA

GCTGAACGGGATGACATAC
A

PPAR-γ

CARBOHYDRATE
METABOLISM

NM_214379.1

ACAGCGACCTGGCGATA
TTTA

TGGGCTTCACATTCAGCAA
AC
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PPARα

METABOLIC
SYNDROME

NM_001044526.1

TCGGCTAAAGCTGGTCT
ATGAC

GCATGCGCCCAAATCGAA

PPARδ

METABOLIC
SYNDROME

NM_001130241.2

AGGCATCAGGCTTCCAC
TAC

CACTTCTCGTACTCCAGCTT
CA

PRDX2

PEROXIREDOXINS

NM_001244474.1

GTCTCCGTTGACTCTCAG
TTCA

CCAAGCCTCCCTCCTTCC

PRDX3

PEROXIREDOXINS

NM_001244531.1

GTGAAGTTGTTGCCGTGT
CA

ATGTTCATGTGGCCCAAAC
C

PRDX5

PEROXIREDOXINS

NM_214144.1

GAGTCCCTGGGGCCTTT
AC

CTGCTCCACAAACCCTGGA
A

PRDX6

PEROXIREDOXINS

NM_214408.1

CCAACTTCGAAGCCAAT
ACTACC

CCGAGGGTGGGAGAAAAG
AA

RXRG

CHOLESTEROL
SYNTHESIS

NM_001130213.1

TCCCCACTTCTCTGACCT
CA

AGGAGGCGATCAGCAATTC
A

SOD1

GLUTAREDOXIN

NM_001190422.1

ATGGTGGGCCAAAGGAT
CA

GATGTACACAGTGGCCACA
C

SOD2

GLUTAREDOXIN

NM_214127.2

GCTTGTTCTAACCAGGAT
CCC

TAATACGCATGCTCCCACA
C

SREBF1

CHOLESTEROL
SYNTHESIS

NM_214157.1

ACTGTGACCTCGCAGAT
CCA

GGGTCCCCATGTCTGTTTTC
A

TLR2

METABOLIC
SYNDROME

NM_213761.1

CGGCTTCCAAGGATGGA
GAA

AGACCCATGCTGTCCACAA
A

TLR4

METABOLIC
SYNDROME

NM_001113039.1

TGGTGTCCCAGCACTTCA
TA

CGGCATGACTCCTCAGAAA
C

TLR5

METABOLIC
SYNDROME

NM_001123202.1

CCAGTACAGCGACCAAA
ACA

TGTTGCTGATGCGATCTTC
C

TLR9

METABOLIC
SYNDROME

NM_213958.1

CAGCCAGACCCTTTGGA
GAA

CACCTGCACCAGGAGAGA
AA

TNF-α

INFLAMMATION

NM_214022.1

CTGGCCCCTTGAGCATC
A

GGGCTTATCTGAGGTTTGA
GAC

TNFAIP3

INFLAMMATION

NM_001267890.1

AGGAAGCTTGTGGCACT
GAA

TCCTGAACACCCCACATGT
AC

TRDMT1

EPIGENETIC
MODIFIER

NM_001162885.1

AGCTTGAAACTGCAGGA
GAA

GCATTTGCACAGAGAGATC
AC

TXN

GLUTAREDOXIN

NM_214313.2

GGGCCTTGCAAAATGAT
CAA

CCTGACAGTCATCCACATC
TAC

TXNRD1

GLUTAREDOXIN

NM_214154.3

AGGCCACTAACAGTGAC
GAA

TTCTTGTGCAAGCATCTCTT
CC

XIAP

APOPTOSIS

NM_001097436.1

GAGTGCTCAGAAAGACA
ATGCA

CCTCAGCTGTTCTTCAGCA
CTA
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Supplemental Figure 4-1. Feed intake and weight gain data per animal on each diet.
A. Mean food intake per pig week is shown for control and sTWD pigs. B. Mean energy
intake per pig per week shown for control pigs and sTWD pigs. C. Mean body weight
gain per pig week is shown for control pigs and sTWD pigs. D. Percent body weight gain
per pig per week is shown for control pigs and sTWD pigs. E. Mean body weight
measured each week per pig is shown for control pigs and sTWD pigs. E. Mean
metabolic efficiency (calculated as weekly energy intake divided by weekly body weight
gain) per pig per week is shown for control pigs and sTWD pigs.
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Supplemental Figure 4-2. Total feed intake and weight gain data per animal on each
diet for the duration of the trial. A. Total food intake per pig week is shown for control
pigs and sTWD pigs. B. Total energy intake per pig per week shown for control pigs and
sTWD pigs. C. Total percent body weight gain per pig week is shown for control pigs
and sTWD pigs. D. Total body weight gain per pig per week is shown for control pigs
and sTWD pigs. E. Total metabolic efficiency (calculated as weekly energy intake
divided by weekly body weight gain) per pig per week is shown for control pigs and
sTWD pigs. 	
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CHAPTER 5
SUMMARY
Oocyte quality has been shown to be a main contributor to many of the infertility

issues in the US. The intrinsic quality of the oocyte primarily determines whether a
zygote has the potential to progress through pregnancy (Roberts 2005). Oocyte
development is a complex process in which each stage must be completed successfully in
order for the oocyte to be developmentally competent. Any alterations during oocyte
development can lead to decreased oocyte quality and have long lasting affects on
development. The environment surrounding the oocyte can directly influence whether the
oocyte has to ability to acquire developmental competence (Katz-Jaffe et al. 2009). The
oocyte is very sensitive to perturbations to its environment and any changes to this
environment can lead to alterations to the quality of the oocyte (Leroy et al. 2011). The
experiments described herein have demonstrated that oocyte quality is indeed affected by
alterations to the environment it is surrounded by. Transcript abundances of specific
genes can be altered due to maturation culture conditions, maternal age, and a total
western diet that reflects the poor eating habits of the United States.
In a study looking at the effects in vitro maturation culture conditions have on the
gene expression profiles of oocytes, many transcripts were determined to be differentially
expressed. Majority of these transcripts were found to be more abundant in the IVM
oocytes by both RNA sequencing and qPCR analysis. An overall higher abundance of
transcripts in the IVM oocytes would directly impact the quality of these oocytes and
would most likely contribute to their decreased developmental competence. This
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discrepancy in transcript abundance between IVM and IVV oocytes could be due to
alterations to the mechanisms that are responsible for the normal pattern of transcript
silencing that occurs during oocyte development. An increase in transcript abundance
could also be caused by perturbations to mechanisms that are responsible for degrading
majority of transcripts at the end of oocyte development. If any of these mechanisms are
perturbed in the IVM oocytes, they could be a plausible explanation for the overall
increase in transcript abundance that was observed. qPCR analysis revealed that
transcripts for apoptosis inhibitors and epigenetic modifiers are all significantly more
abundant in IVV oocytes. EHMT2 is a histone methyltransferase that is responsible for
condensing chromatin structure in order to silence gene expression, which normally
occurs in the oocyte at the end of development. The lower abundance of this transcript in
the IVM oocytes could indicate that genes aren’t getting silenced properly, which could
contribute to the overall increase in transcript abundance in these oocytes. In vitro
maturation could be altering the establishment and/or maintenance of epigenetic marks.
IVM oocytes are aspirated immaturely and are subsequently forced to quickly complete
their growth and maturation process, which could be preventing these oocytes from
appropriately acquiring epigenetic marks. Inappropriate amounts of epigenetic marks,
specifically methylation marks, could lead to the improper silencing of genes, and thus an
overall increase in transcript abundance. Discrepancies in transcript abundance and
epigenetic marks would undoubtedly lead to a decrease in oocyte quality and
developmental competence. These experiments also suggest that RNA degradation and
chromatin remodeling pathways may be perturbed in IVM oocytes. One of the transcripts
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that code for the poly(A) binding proteins (PABPC4) was determined to be more
abundant in the IVM oocytes. Since these proteins are responsible for shielding mRNAs
from undergoing deadenylation, it is likely they are also protecting mRNAs from being
degraded which could be another plausible explanation for why overall transcript
abundance is higher in the IVM oocytes. In vitro maturation can evidently have profound
effects on transcript populations of metaphase-II oocytes with the most obvious effect
being increased transcript abundance. We expect that this data will lead to a better
understanding of how we can improve the quality of oocytes that are matured in vitro by
either altering the culture conditions or the expression of specific transcripts in order to
allow the IVM oocyte to be more similar to the IVV oocyte.
In a study examining the effects of maternal age on oocyte quality, age-related
differences in gene expression was observed in equine cumulus-oocyte complexes, which
may plausibly be associated with the lower quality and decreased developmental
competence of oocytes from aged mares. This decreased competence in aged oocytes
could be caused by increased rates of oxidative stress and subsequent DNA damage.
Oxidative stress can directly impact many processes in the oocyte, including
mitochondrial dysfunction and compromised chromosomal segregation. Three genes
involved in cellular mechanisms to combat increasing levels of oxidative stress were
found to be more abundant in oocytes and/or cumulus cells from aged mares. Further
evaluation to examine the rates of oxidative stress and reactive oxygen species would
provide better insight to determine if this mechanism is indeed contributing to the a
decrease in oocyte quality due to aging. Higher incidences of apoptosis in the cumulus
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cells from aged mares may also be a possibility, which would further impact the
developmental competence of the oocyte. Cumulus cells are in direct contact with the
oocyte and facilitate proper oocyte development. Any deleterious effects on the cumulus
cells could disrupt essential interactions between the cumulus cells and oocyte, ultimately
affecting oocyte quality. Since apoptosis in the cumulus cells has previously been shown
to decrease oocyte quality (Nakahara et al 1997; Kaneko et al 2000; Pocar et al 2005),
evaluating the incidence of apoptosis in the aged cumulus cells would be insightful and
would help to explain for the decreased oocyte quality due to aging. Even though we did
not observe any alterations to the expression profiles of genes related to aneuploidy,
higher incidences of aneuploidy have been shown to be correlated with advancing
maternal age. Further examination of genes that are involved in meiotic spindle formation
and chromosomal alignment could provide better insight into whether there is an
increased incidence of aneuploidy in mare oocytes due to aging. There is a possibility
that changes in, and abnormal activity of, the pathways described could result in an
environment that leads to an increased incidence of meiotic spindle and chromosomal
alignment defects, ultimately decreasing the quality of the oocyte. Identification of how
the oocyte is altered due to age will ultimately help to improve fertility regardless of a
female’s age.
The swine total western diet is a calorie-rich, micronutrient-deficient diet that was
formulated to be more representative of the diet consumed by majority of Americans. In
this last study, the sTWD was shown to lead to an obese phenotype in pigs after just 12
weeks of consuming this diet. Pigs that were on this diet significantly gained more weight
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as a whole than the controls by nearly double. These pigs also had increased levels of
serum glucose levels. The sTWD led to many genes being differentially expressed in the
oocytes, demonstrating that western dietary consumption patterns have a significant
effect on the oocyte. Many of the genes found to be differentially expressed are known to
play roles in glucose and lipid metabolism. Alterations to the abundance of these genes
have been shown to lead to effects seen with metabolic syndrome, such as glucose
intolerance, insulin resistance, obesity and diabetes. For example, decreased expression
of AKT2 was observed in the sTWD oocytes. A lower expression of this gene has been
shown to be caused by oxidative stress and leads to increased glucose levels, resulting in
impaired glucose tolerance and insulin resistance (Cho et al 2001; Furukawa et al 2004;
Garofalo et al 2003; McClung et al 2004). Further examination of the roles AKT2 may
have in these oocytes as well as evaluating oxidative stress levels would be useful to
determine if this is a possible mechanism for the decrease in oocyte quality due to
nutrition. Both LDLR and RXRG are involved in maintaining lipid homeostasis. A
decreased abundance of these genes in the sTWD oocytes could be contributing to the
obese phenotype that was observed in these pigs. Three of the genes involved in the one
carbon metabolism pathway were found to be differentially expressed and lower in the
sTWD oocytes. Deficiencies in factors related to this pathway have been shown to lead to
epigenetic alterations in genes that regulate key developmental processes (Xu and
Sinclair 2015) due to the utilization of folate and methionine within this pathway. Further
evaluation of the one carbon metabolism pathway would be useful to evaluate whether
alterations to this pathway could decrease oocyte quality. Glutathione levels were
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measured in both CON and sTWD oocytes and were found to be higher in the sTWD
oocytes. Glutathione is essential for reducing harmful reactive oxygen species, which
could indicate an increased need for such mechanisms to combat oxidative stress in the
sTWD oocytes. This is another indicator that oxidative stress could be contributing to the
decrease in oocyte quality. We expect that this data will lead to a better understanding to
how the diet a woman consumes before conception plays an important role in dictating
reproductive success by affecting oocyte quality.
Alterations to the oocyte can have long lasting effects on development, so it is
essential to determine how we can improve the quality of oocytes that may develop under
less than ideal circumstances and/or in unnatural environments. The experiments
described herein have aimed to determine how oocyte quality may be affected by
alterations to the environment it is surrounded by. Evaluating oocyte quality for various
environmental factors has revealed several correlations, all of which could help in
determining what makes a good quality oocyte. Oxidative stress has been shown to be a
common theme that occurs in oocytes of presumed lesser quality. Genes that play a role
in combating and reducing oxidative stress were shown to be elevated in IVM, aged, and
sTWD oocytes, which could indicate increased rates of oxidative stress in oocytes due to
an altered environment. Experiments to evaluate oxidative stress, including amounts of
reactive oxygen species would help to determine if this is a shared mechanism that is
altered among varying environmental factors. Another common theme that occurs due to
an altered environment is alterations within the cumulus cells, at least among those
environmental factors in which the cumulus cells were tested here. Apoptosis in the
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cumulus cells may occur due to an altered environment and could be impacting the
quality of the oocyte. Genes that are involved in the apoptosis pathway were shown to be
altered due to the environment in both the oocytes and cumulus cells. Assays to evaluate
the incidence of apoptosis in both the cumulus cells and oocytes would appropriately
evaluate whether this pathway is indeed affected by an altered environment. There were
other genes that were evaluated that were also shown to be altered in the cumulus cells,
which could contribute to oocyte quality. The cumulus cells are essential companion cells
to the oocyte and help to confer developmental competence. Alterations to gene
expression profiles in the cumulus cells could lead to a decrease in their ability to
appropriately provide the growth factors and biosynthetic substrates that are necessary for
proper oocyte development. Another affected pathway that was observed due to the
various environmental factors was transcript silencing and degradation. An altered
environment may affect mechanisms that are responsible for silencing transcripts and
turning off gene expression, such as methylation. Evaluating the methylation status of
these oocytes would provide further details in determining if this pathway is commonly
affected by poor environmental conditions. The oocyte must synthesize and store a large
amount of mRNA transcripts that are necessary for oocyte maturation and sustaining
early embryo development. Differences in mRNA profiles and transcript abundance can
definitely influence oocyte competence. Degradation of mRNA transcripts during
maturation is just as crucial of transcript accumulation. Both aberrant degradation as well
as maintenance of transcripts during oocyte maturation could be deleterious to oocyte
quality. Further evaluation of both of these mechanisms could provide several markers
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that would be indicative of oocyte quality that could be used to identify what truly makes
an oocyte of good quality.
Ultimately, we hope this work provide a better understanding of oocyte quality in
order to delineate appropriate markers of oocyte quality that will successfully allow the
identification of oocytes that have achieved developmental competence. Identification of
such markers will help to explain how the oocyte’s environment can be altered in order to
improve the quality of the oocytes exposed to various environmental factors such as
culture conditions, advancing age, or poor nutrition. Any pathways that have been shown
to be affected across all the environmental factors could provide several markers that are
indicative of oocyte quality. In addition, by thoroughly examining the transcript profiles
of oocytes exposed to such factors, it may be possible to identify treatment regimens that
can be utilized through RNA or protein injection into the oocytes in order to improve
fertility in these circumstances.
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APPENDIX A. The complete data set for all of the biological processes found to be
significantly enriched in IVM or IVV oocytes.
Table A-1. Biological processes found to be active in IVM oocytes using the
mvGST package in Bioconductor
GO ID

Term

GO:0009887 organ morphogenesis
GO:0007417 central nervous system development
GO:0006417 regulation of translation
transforming growth factor beta receptor
GO:0007179 signaling pathway
GO:0009791 post-embryonic development
GO:0006665 sphingolipid metabolic process
GO:0006812 cation transport
GO:0007565 female pregnancy
GO:0001503 ossification
GO:0030336 negative regulation of cell migration
regulation of sequence-specific DNA binding
GO:0051090 transcription factor activity
GO:0030521 androgen receptor signaling pathway
GO:0016197 endosome transport
GO:0031100 organ regeneration
GO:0001843 neural tube closure
GO:0051216 cartilage development
GO:0010923 negative regulation of phosphatase activity
GO:0042475 odontogenesis of dentin-containing tooth
GO:0060337 type I interferon-mediated signaling pathway
GO:0006898 receptor-mediated endocytosis
GO:0030509 BMP signaling pathway
GO:0070936 protein K48-linked ubiquitination
GO:0007269 neurotransmitter secretion
GO:0010468 regulation of gene expression
GO:0006952 defense response
positive regulation of neuron projection
GO:0010976 development
GO:0051591 response to cAMP
GO:0030326 embryonic limb morphogenesis
GO:0030155 regulation of cell adhesion
GO:0045786 negative regulation of cell cycle
GO:0019432 triglyceride biosynthetic process

	
  

Adjusted P-Value
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0006488
GO:0050680
GO:0007368
GO:0017148
GO:0045727
GO:0045740
GO:0071300
GO:0042733
GO:0048538
GO:0001657
GO:0006833
GO:0008643
GO:0030148
GO:0070979
GO:0007131
GO:0007566
GO:0043407
GO:0006749
GO:0007586
GO:0006090
GO:0042552
GO:0048146
GO:0042147
GO:0030178
GO:0032956
GO:0042771
GO:0043086
GO:0007346
GO:0035116
GO:0046677
GO:0001656
GO:0001658
GO:0001837
GO:0007224
GO:0042476
GO:0051017

	
  

dolichol-linked oligosaccharide biosynthetic
process
negative regulation of epithelial cell
proliferation
determination of left/right symmetry
negative regulation of translation
positive regulation of translation
positive regulation of DNA replication
cellular response to retinoic acid
embryonic digit morphogenesis
thymus development
ureteric bud development
water transport
carbohydrate transport
sphingolipid biosynthetic process
protein K11-linked ubiquitination
reciprocal meiotic recombination
embryo implantation
negative regulation of MAP kinase activity
glutathione metabolic process
digestion
pyruvate metabolic process
myelination
positive regulation of fibroblast proliferation
retrograde transport; endosome to Golgi
negative regulation of Wnt receptor signaling
pathway
regulation of actin cytoskeleton organization
DNA damage response; signal transduction by
p53 class mediator resulting in induction of
apoptosis
negative regulation of catalytic activity
regulation of mitotic cell cycle
embryonic hindlimb morphogenesis
response to antibiotic
metanephros development
branching involved in ureteric bud
morphogenesis
epithelial to mesenchymal transition
smoothened signaling pathway
odontogenesis
actin filament bundle assembly

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0051496 positive regulation of stress fiber assembly
G-protein signaling; coupled to cAMP
GO:0007188 nucleotide second messenger
GO:0007422 peripheral nervous system development
GO:0030325 adrenal gland development
GO:0042327 positive regulation of phosphorylation
GO:0071479 cellular response to ionizing radiation
GO:0001890 placenta development
GO:0009954 proximal/distal pattern formation
positive regulation of cAMP biosynthetic
GO:0030819 process
GO:0048536 spleen development
GO:0006270 DNA-dependent DNA replication initiation
GO:0035338 long-chain fatty-acyl-CoA biosynthetic process
GO:0046847 filopodium assembly
GO:0001707 mesoderm formation
GO:0006306 DNA methylation
GO:0007492 endoderm development
GO:0070373 negative regulation of ERK1 and ERK2 cascade
GO:0006337 nucleosome disassembly
GO:0009880 embryonic pattern specification
GO:0045930 negative regulation of mitotic cell cycle
GO:0046907 intracellular transport
GO:0006904 vesicle docking involved in exocytosis
GO:0009987 cellular process
GO:0042246 tissue regeneration
GO:0045732 positive regulation of protein catabolic process
GO:0045765 regulation of angiogenesis
GO:0050714 positive regulation of protein secretion
positive regulation of reactive oxygen species
GO:2000379 metabolic process
GO:0000070 mitotic sister chromatid segregation
GO:0001702 gastrulation with mouth forming second
GO:0001894 tissue homeostasis
GO:0006171 cAMP biosynthetic process
GO:0008406 gonad development
GO:0030099 myeloid cell differentiation
GO:0034504 protein localization to nucleus
GO:0034644 cellular response to UV
GO:0048701 embryonic cranial skeleton morphogenesis
GO:0006401 RNA catabolic process

	
  

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000

	
  
	
  

220	
  

GO:0006978
GO:0007608
GO:0016486
GO:0030866
GO:0045648
GO:0045859
GO:0046627
GO:0048565
GO:0001654
GO:0006612
GO:0007026
GO:0007528
GO:0010718
GO:0030041
GO:0030048
GO:0060326
GO:0060334
GO:0001944
GO:0006471
GO:0007052
GO:0016573
GO:0030513
GO:0034605
GO:0046676
GO:0046697
GO:0048485
GO:0048839
GO:0050766
GO:0060444
GO:0070371
GO:0006259
GO:0010942
GO:0014003
GO:0014047
GO:0021537
	
  

DNA damage response; signal transduction by
p53 class mediator resulting in transcription of
p21 class mediator
sensory perception of smell
peptide hormone processing
cortical actin cytoskeleton organization
positive regulation of erythrocyte differentiation
regulation of protein kinase activity
negative regulation of insulin receptor signaling
pathway
digestive tract development
eye development
protein targeting to membrane
negative regulation of microtubule
depolymerization
neuromuscular junction development
positive regulation of epithelial to mesenchymal
transition
actin filament polymerization
actin filament-based movement
cell chemotaxis
regulation of interferon-gamma-mediated
signaling pathway
vasculature development
protein ADP-ribosylation
mitotic spindle organization
histone acetylation
positive regulation of BMP signaling pathway
cellular response to heat
negative regulation of insulin secretion
decidualization
sympathetic nervous system development
inner ear development
positive regulation of phagocytosis
branching involved in mammary gland duct
morphogenesis
ERK1 and ERK2 cascade
DNA metabolic process
positive regulation of cell death
oligodendrocyte development
glutamate secretion
telencephalon development

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0035329
GO:0042744
GO:0048745
GO:0071158
GO:0006661
GO:0010862
GO:0017144
GO:0019216
GO:0030010
GO:0030111
GO:0042130
GO:0043923
GO:0048025
GO:0048557
GO:0006996
GO:0009268
GO:0009755
GO:0010510
GO:0014065
GO:0019827
GO:0030316
GO:0032886
GO:0033280
GO:0045807
GO:0045947
GO:0048566
GO:0050771
GO:0060395
GO:0072659
GO:0090398
GO:0009416
GO:0021510
GO:0030518
GO:0032855
GO:0034614
GO:0046579
GO:0048384

	
  

hippo signaling cascade
hydrogen peroxide catabolic process
smooth muscle tissue development
positive regulation of cell cycle arrest
phosphatidylinositol biosynthetic process
positive regulation of pathway-restricted SMAD
protein phosphorylation
drug metabolic process
regulation of lipid metabolic process
establishment of cell polarity
regulation of Wnt receptor signaling pathway
negative regulation of T cell proliferation
positive regulation by host of viral transcription
negative regulation of nuclear mRNA splicing;
via spliceosome
embryonic digestive tract morphogenesis
organelle organization
response to pH
hormone-mediated signaling pathway
regulation of acetyl-CoA biosynthetic process
from pyruvate
phosphatidylinositol 3-kinase cascade
stem cell maintenance
osteoclast differentiation
regulation of microtubule-based process
response to vitamin D
positive regulation of endocytosis
negative regulation of translational initiation
embryonic digestive tract development
negative regulation of axonogenesis
SMAD protein signal transduction
protein localization in plasma membrane
cellular senescence
response to light stimulus
spinal cord development
intracellular steroid hormone receptor signaling
pathway
positive regulation of Rac GTPase activity
cellular response to reactive oxygen species
positive regulation of Ras protein signal
transduction
retinoic acid receptor signaling pathway

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0051457
GO:0002244
GO:0006476
GO:0006750
GO:0006940
GO:0007004
GO:0021854
GO:0031214
GO:0032438
GO:0046513
GO:0048009
GO:0048646
GO:0061036
GO:0070935
GO:0071285
GO:0071902
GO:0090103
GO:2001238
GO:0001823
GO:0002076
GO:0006275
GO:0009303
GO:0015701
GO:0032270
GO:0042640
GO:0048663
GO:0051974
GO:0055003
GO:0060412
GO:0070372
GO:0001736
GO:0001953
GO:0007043
GO:0010226
GO:0030502
GO:0031065
GO:0033365

	
  

maintenance of protein location in nucleus
hemopoietic progenitor cell differentiation
protein deacetylation
glutathione biosynthetic process
regulation of smooth muscle contraction
telomere maintenance via telomerase
hypothalamus development
biomineral tissue development
melanosome organization
ceramide biosynthetic process
insulin-like growth factor receptor signaling
pathway
anatomical structure formation involved in
morphogenesis
positive regulation of cartilage development
3'-UTR-mediated mRNA stabilization
cellular response to lithium ion
positive regulation of protein serine/threonine
kinase activity
cochlea morphogenesis
positive regulation of extrinsic apoptotic
signaling pathway
mesonephros development
osteoblast development
regulation of DNA replication
rRNA transcription
bicarbonate transport
positive regulation of cellular protein metabolic
process
anagen
neuron fate commitment
negative regulation of telomerase activity
cardiac myofibril assembly
ventricular septum morphogenesis
regulation of ERK1 and ERK2 cascade
establishment of planar polarity
negative regulation of cell-matrix adhesion
cell-cell junction assembly
response to lithium ion
negative regulation of bone mineralization
positive regulation of histone deacetylation
protein localization to organelle

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0034968
GO:0051593
GO:0001706
GO:0006342
GO:0006622
GO:0006885
GO:0007184
GO:0008272
GO:0010524
GO:0022409
GO:0031290
GO:0031396
GO:0031668
GO:0032211
GO:0035121
GO:0042592
GO:0042921
GO:0043589
GO:0045662
GO:0045778
GO:0048738
GO:0051775
GO:0055008
GO:0060402
GO:0070989
GO:0080111
GO:0090136
GO:0002548
GO:0006596
GO:0008210
GO:0009086
GO:0010863
GO:0010886
GO:0022407
GO:0030854
GO:0031571
GO:0032094
GO:0032148

	
  

histone lysine methylation
response to folic acid
endoderm formation
chromatin silencing
protein targeting to lysosome
regulation of pH
SMAD protein import into nucleus
sulfate transport
positive regulation of calcium ion transport into
cytosol
positive regulation of cell-cell adhesion
retinal ganglion cell axon guidance
regulation of protein ubiquitination
cellular response to extracellular stimulus
negative regulation of telomere maintenance via
telomerase
tail morphogenesis
homeostatic process
glucocorticoid receptor signaling pathway
skin morphogenesis
negative regulation of myoblast differentiation
positive regulation of ossification
cardiac muscle tissue development
response to redox state
cardiac muscle tissue morphogenesis
calcium ion transport into cytosol
oxidative demethylation
DNA demethylation
epithelial cell-cell adhesion
monocyte chemotaxis
polyamine biosynthetic process
estrogen metabolic process
methionine biosynthetic process
positive regulation of phospholipase C activity
positive regulation of cholesterol storage
regulation of cell-cell adhesion
positive regulation of granulocyte differentiation
mitotic cell cycle G1/S transition DNA damage
checkpoint
response to food
activation of protein kinase B activity

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0034453 microtubule anchoring
GO:0043206 fibril organization
negative regulation of DNA damage response;
GO:0043518 signal transduction by p53 class mediator
GO:0045671 negative regulation of osteoclast differentiation
negative regulation of oligodendrocyte
GO:0048715 differentiation
GO:0048863 stem cell differentiation
GO:0050877 neurological system process
GO:0051016 barbed-end actin filament capping
pathway-restricted SMAD protein
GO:0060389 phosphorylation
positive regulation of SMAD protein import into
GO:0060391 nucleus
planar cell polarity pathway involved in neural
GO:0090179 tube closure
negative regulation of cytokine-mediated
GO:0001960 signaling pathway
GO:0007096 regulation of exit from mitosis
GO:0007140 male meiosis
activation of adenylate cyclase activity by
GO:0007191 dopamine receptor signaling pathway
GO:0008366 axon ensheathment
GO:0015804 neutral amino acid transport
GO:0022408 negative regulation of cell-cell adhesion
GO:0042491 auditory receptor cell differentiation
GO:0042761 very long-chain fatty acid biosynthetic process
GO:0043116 negative regulation of vascular permeability
negative regulation of striated muscle tissue
GO:0045843 development
chromatin-mediated maintenance of
GO:0048096 transcription
GO:0048598 embryonic morphogenesis
GO:0050909 sensory perception of taste
positive regulation of histone H3-K4
GO:0051571 methylation
GO:0060484 lung-associated mesenchyme development
GO:0070723 response to cholesterol
GO:0000281 cytokinesis after mitosis
GO:0001523 retinoid metabolic process
GO:0003197 endocardial cushion development
GO:0006518 peptide metabolic process

	
  

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0006835
GO:0007097
GO:0009062
GO:0030578
GO:0031076
GO:0031589
GO:0032469
GO:0032926
GO:0040037
GO:0048843
GO:0048853
GO:0048935
GO:0050665
GO:0050868
GO:0050872
GO:0050953
GO:0051642
GO:0051926
GO:0060231
GO:0060425
GO:0071514
GO:2000045
GO:2000059
GO:0001779
GO:0002238
GO:0003337
GO:0006002
GO:0006998
GO:0007182
GO:0007606
GO:0009792
GO:0009798
GO:0021675
GO:0023014

	
  

dicarboxylic acid transport
nuclear migration
fatty acid catabolic process
PML body organization
embryonic camera-type eye development
cell-substrate adhesion
endoplasmic reticulum calcium ion homeostasis
negative regulation of activin receptor signaling
pathway
negative regulation of fibroblast growth factor
receptor signaling pathway
negative regulation of axon extension involved
in axon guidance
forebrain morphogenesis
peripheral nervous system neuron development
hydrogen peroxide biosynthetic process
negative regulation of T cell activation
white fat cell differentiation
sensory perception of light stimulus
centrosome localization
negative regulation of calcium ion transport
mesenchymal to epithelial transition
lung morphogenesis
genetic imprinting
regulation of G1/S transition of mitotic cell
cycle
negative regulation of protein ubiquitination
involved in ubiquitin-dependent protein
catabolic process
natural killer cell differentiation
response to molecule of fungal origin
mesenchymal to epithelial transition involved in
metanephros morphogenesis
fructose 6-phosphate metabolic process
nuclear envelope organization
common-partner SMAD protein phosphorylation
sensory perception of chemical stimulus
embryo development ending in birth or egg
hatching
axis specification
nerve development
signal transduction by phosphorylation

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0030206
GO:0030240
GO:0030510
GO:0030850
GO:0031929
GO:0032940
GO:0033598
GO:0034374
GO:0035308
GO:0035518
GO:0035725
GO:0043068
GO:0043523
GO:0046835
GO:0048193
GO:0048387
GO:0048711
GO:0048747
GO:0048806
GO:0050910
GO:0060026
GO:0060124
GO:0060157
GO:0060707
GO:0071310
GO:0071353
GO:0090344
GO:0002064
GO:0002446
GO:0003215
GO:0006285
GO:0006307
GO:0006516
GO:0006893
GO:0006999
GO:0010975
GO:0016202
GO:0019367
GO:0022417

	
  

chondroitin sulfate biosynthetic process
skeletal muscle thin filament assembly
regulation of BMP signaling pathway
prostate gland development
TOR signaling cascade
secretion by cell
mammary gland epithelial cell proliferation
low-density lipoprotein particle remodeling
negative regulation of protein dephosphorylation
histone H2A monoubiquitination
sodium ion transmembrane transport
positive regulation of programmed cell death
regulation of neuron apoptosis
carbohydrate phosphorylation
Golgi vesicle transport
negative regulation of retinoic acid receptor
signaling pathway
positive regulation of astrocyte differentiation
muscle fiber development
genitalia development
detection of mechanical stimulus involved in
sensory perception of sound
convergent extension
positive regulation of growth hormone secretion
urinary bladder development
trophoblast giant cell differentiation
cellular response to organic substance
cellular response to interleukin-4
negative regulation of cell aging
epithelial cell development
neutrophil mediated immunity
cardiac right ventricle morphogenesis
base-excision repair; AP site formation
DNA dealkylation involved in DNA repair
glycoprotein catabolic process
Golgi to plasma membrane transport
nuclear pore organization
regulation of neuron projection development
regulation of striated muscle tissue development
fatty acid elongation; saturated fatty acid
protein maturation by protein folding

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0030241
GO:0030278
GO:0031054
GO:0032455
GO:0033674
GO:0034063
GO:0043011
GO:0043586
GO:0045647
GO:0045719
GO:0045839
GO:0046325
GO:0046470
GO:0046578
GO:0048541
GO:0050778
GO:0051014
GO:0051488
GO:0060710
GO:0070507
GO:0072075
GO:0072205
GO:0090181
GO:0090286
GO:0090400
GO:0001895
GO:0006475
GO:0009404
GO:0015671
GO:0015760
GO:0021861
GO:0021879
GO:0032502
GO:0032516
GO:0032713
GO:0033085
GO:0033088

	
  

skeletal muscle myosin thick filament assembly
regulation of ossification
pre-miRNA processing
nerve growth factor processing
positive regulation of kinase activity
stress granule assembly
myeloid dendritic cell differentiation
tongue development
negative regulation of erythrocyte differentiation
negative regulation of glycogen biosynthetic
process
negative regulation of mitosis
negative regulation of glucose import
phosphatidylcholine metabolic process
regulation of Ras protein signal transduction
Peyer's patch development
positive regulation of immune response
actin filament severing
activation of anaphase-promoting complex
activity
chorio-allantoic fusion
regulation of microtubule cytoskeleton
organization
metanephric mesenchyme development
metanephric collecting duct development
regulation of cholesterol metabolic process
cytoskeletal anchoring at nuclear membrane
stress-induced premature senescence
retina homeostasis
internal protein amino acid acetylation
toxin metabolic process
oxygen transport
glucose-6-phosphate transport
forebrain radial glial cell differentiation
forebrain neuron differentiation
developmental process
positive regulation of phosphoprotein
phosphatase activity
negative regulation of interleukin-4 production
negative regulation of T cell differentiation in
thymus
negative regulation of immature T cell

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0033153
GO:0034626
GO:0035022
GO:0040020
GO:0042117
GO:0043248
GO:0043353
GO:0045617
GO:0045945
GO:0048769
GO:0048846
GO:0050765
GO:0050957
GO:0051492
GO:0051574
GO:0055098
GO:0060529
GO:0070365
GO:0070887
GO:0090370
GO:0000059
GO:0002043
GO:0003166
GO:0006636
GO:0006725
GO:0006868
GO:0007212
GO:0010614
GO:0010950
GO:0014074
GO:0018022
GO:0032233

	
  

proliferation in thymus
T cell receptor V(D)J recombination
fatty acid elongation; polyunsaturated fatty acid
positive regulation of Rac protein signal
transduction
regulation of meiosis
monocyte activation
proteasome assembly
enucleate erythrocyte differentiation
negative regulation of keratinocyte
differentiation
positive regulation of transcription from RNA
polymerase III promoter
sarcomerogenesis
axon extension involved in axon guidance
negative regulation of phagocytosis
equilibrioception
regulation of stress fiber assembly
positive regulation of histone H3-K9
methylation
response to low-density lipoprotein particle
stimulus
squamous basal epithelial stem cell
differentiation involved in prostate gland acinus
development
hepatocyte differentiation
cellular response to chemical stimulus
negative regulation of cholesterol efflux
protein import into nucleus; docking
blood vessel endothelial cell proliferation
involved in sprouting angiogenesis
bundle of His development
unsaturated fatty acid biosynthetic process
cellular aromatic compound metabolic process
glutamine transport
dopamine receptor signaling pathway
negative regulation of cardiac muscle
hypertrophy
positive regulation of endopeptidase activity
response to purine-containing compound
peptidyl-lysine methylation
positive regulation of actin filament bundle

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0033158
GO:0042760
GO:0045343
GO:0045651
GO:0046499
GO:0048069
GO:0048341
GO:0048807
GO:0048861
GO:0050482
GO:0051534
GO:0051546
GO:0051572
GO:0060033
GO:0060513
GO:0060561
GO:0061047
GO:0061153
GO:0070265
GO:0072001
GO:0090068
GO:0090292
GO:2000678
GO:0002320
GO:0002686
GO:0003130
GO:0003229
GO:0006348
GO:0007143
GO:0007196
GO:0007379
GO:0007386
GO:0009649

	
  

assembly
regulation of protein import into nucleus;
translocation
very long-chain fatty acid catabolic process
regulation of MHC class I biosynthetic process
positive regulation of macrophage differentiation
S-adenosylmethioninamine metabolic process
eye pigmentation
paraxial mesoderm formation
female genitalia morphogenesis
leukemia inhibitory factor signaling pathway
arachidonic acid secretion
negative regulation of NFAT protein import into
nucleus
keratinocyte migration
negative regulation of histone H3-K4
methylation
anatomical structure regression
prostatic bud formation
apoptosis involved in morphogenesis
positive regulation of branching involved in lung
morphogenesis
trachea gland development
necrotic cell death
renal system development
positive regulation of cell cycle process
nuclear matrix anchoring at nuclear membrane
negative regulation of transcription regulatory
region DNA binding
lymphoid progenitor cell differentiation
negative regulation of leukocyte migration
BMP signaling pathway involved in heart
induction
ventricular cardiac muscle tissue development
chromatin silencing at telomere
female meiosis
inhibition of adenylate cyclase activity by Gprotein coupled glutamate receptor signaling
pathway
segment specification
compartment pattern specification
entrainment of circadian clock

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0009812
GO:0010447
GO:0015840
GO:0015853
GO:0016082
GO:0017055
GO:0021873
GO:0021943
GO:0030323
GO:0031022
GO:0031123
GO:0032696
GO:0032714
GO:0032902
GO:0035284
GO:0035993
GO:0042074
GO:0042904
GO:0043243
GO:0043462
GO:0045007
GO:0045063
GO:0045085
GO:0045218
GO:0045578
GO:0045750
GO:0045793
GO:0048048
GO:0048496
GO:0050832
GO:0051138
GO:0051208
GO:0051901
GO:0051964
GO:0055075
GO:0055078
GO:0060122

	
  

flavonoid metabolic process
response to acidity
urea transport
adenine transport
synaptic vesicle priming
negative regulation of RNA polymerase II
transcriptional preinitiation complex assembly
forebrain neuroblast division
formation of radial glial scaffolds
respiratory tube development
nuclear migration along microfilament
RNA 3'-end processing
negative regulation of interleukin-13 production
negative regulation of interleukin-5 production
nerve growth factor production
brain segmentation
deltoid tuberosity development
cell migration involved in gastrulation
9-cis-retinoic acid biosynthetic process
positive regulation of protein complex
disassembly
regulation of ATPase activity
depurination
T-helper 1 cell differentiation
negative regulation of interleukin-2 biosynthetic
process
zonula adherens maintenance
negative regulation of B cell differentiation
positive regulation of S phase of mitotic cell
cycle
positive regulation of cell size
embryonic eye morphogenesis
maintenance of organ identity
defense response to fungus
positive regulation of NK T cell differentiation
sequestering of calcium ion
positive regulation of mitochondrial
depolarization
negative regulation of synapse assembly
potassium ion homeostasis
sodium ion homeostasis
inner ear receptor stereocilium organization

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0060393
GO:0060421
GO:0060438
GO:0060763
GO:0071499
GO:0071603
GO:0071899
GO:0072112
GO:0072368
GO:2000810
GO:0000019
GO:0002521
GO:0003279
GO:0003401
GO:0006481
GO:0007356
GO:0007423
GO:0009051
GO:0009308
GO:0009804
GO:0015891
GO:0018076
GO:0022028
GO:0030223
GO:0030718
GO:0031343
GO:0033144
GO:0034389
GO:0040023
GO:0043049
GO:0045198
GO:0046322
GO:0051054
GO:0060197
GO:0060536
GO:0061298

	
  

regulation of pathway-restricted SMAD protein
phosphorylation
positive regulation of heart growth
trachea development
mammary duct terminal end bud growth
cellular response to laminar fluid shear stress
endothelial cell-cell adhesion
negative regulation of estrogen receptor binding
glomerular visceral epithelial cell differentiation
regulation of lipid transport by negative
regulation of transcription from RNA
polymerase II promoter
regulation of tight junction assembly
regulation of mitotic recombination
leukocyte differentiation
cardiac septum development
axis elongation
C-terminal protein methylation
thorax and anterior abdomen determination
sensory organ development
pentose-phosphate shunt; oxidative branch
amine metabolic process
coumarin metabolic process
siderophore transport
N-terminal peptidyl-lysine acetylation
tangential migration from the subventricular
zone to the olfactory bulb
neutrophil differentiation
germ-line stem cell maintenance
positive regulation of cell killing
negative regulation of intracellular steroid
hormone receptor signaling pathway
lipid particle organization
establishment of nucleus localization
otic placode formation
establishment of epithelial cell apical/basal
polarity
negative regulation of fatty acid oxidation
positive regulation of DNA metabolic process
cloacal septation
cartilage morphogenesis
retina vasculature development in camera-type

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0065001
GO:0070171
GO:0072104
GO:0072125
GO:0072193
GO:0090191
GO:2001076
GO:0000738
GO:0002074
GO:0002666
GO:0002682
GO:0003179
GO:0006431
GO:0006982
GO:0010041
GO:0010587
GO:0015980
GO:0019322
GO:0021881
GO:0021978
GO:0030046
GO:0032218
GO:0032431
GO:0035104
GO:0035814
GO:0035990
GO:0042488
GO:0042633
GO:0044240
GO:0045656
GO:0045686
GO:0046340
GO:0048295

	
  

eye
specification of axis polarity
negative regulation of tooth mineralization
glomerular capillary formation
negative regulation of glomerular mesangial cell
proliferation
ureter smooth muscle cell differentiation
negative regulation of branching involved in
ureteric bud morphogenesis
positive regulation of metanephric ureteric bud
development
DNA catabolic process; exonucleolytic
extraocular skeletal muscle development
positive regulation of T cell tolerance induction
regulation of immune system process
heart valve morphogenesis
methionyl-tRNA aminoacylation
response to lipid hydroperoxide
response to iron(III) ion
miRNA catabolic process
energy derivation by oxidation of organic
compounds
pentose biosynthetic process
Wnt receptor signaling pathway involved in
forebrain neuron fate commitment
telencephalon regionalization
parallel actin filament bundle assembly
riboflavin transport
activation of phospholipase A2 activity
positive regulation of transcription via sterol
regulatory element binding
negative regulation of renal sodium excretion
tendon cell differentiation
positive regulation of odontogenesis of dentincontaining tooth
hair cycle
multicellular organismal lipid catabolic process
negative regulation of monocyte differentiation
negative regulation of glial cell differentiation
diacylglycerol catabolic process
positive regulation of isotype switching to IgE
isotypes

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0048635
GO:0048871
GO:0051799
GO:0060965
GO:0060972
GO:0061030
GO:0070946
GO:0071248
GO:0071394
GO:0009624
GO:0021571
GO:0061031
GO:0006354
GO:0010830
GO:0060315
GO:0048680
GO:0010701
GO:0044058
GO:0060455
GO:0006929
GO:0042596
GO:0042045
GO:0045918
GO:0032957
GO:0001516
GO:0060316
GO:0050732
GO:0021545
GO:0045773
GO:0016322
GO:0043171
GO:0051938
GO:0000042
GO:0061351
GO:0000212
GO:0060996

	
  

negative regulation of muscle organ
development
multicellular organismal homeostasis
negative regulation of hair follicle development
negative regulation of gene silencing by miRNA
left/right pattern formation
epithelial cell differentiation involved in
mammary gland alveolus development
neutrophil mediated killing of gram-positive
bacterium
cellular response to metal ion
cellular response to testosterone stimulus
response to nematode
rhombomere 5 development
endodermal digestive tract morphogenesis
transcription elongation; DNA-dependent
regulation of myotube differentiation
negative regulation of ryanodine-sensitive
calcium-release channel activity
positive regulation of axon regeneration
positive regulation of norepinephrine secretion
regulation of digestive system process
negative regulation of gastric acid secretion
substrate-dependent cell migration
fear response
epithelial fluid transport
negative regulation of cytolysis
inositol trisphosphate metabolic process
prostaglandin biosynthetic process
positive regulation of ryanodine-sensitive
calcium-release channel activity
negative regulation of peptidyl-tyrosine
phosphorylation
cranial nerve development
positive regulation of axon extension
neuron remodeling
peptide catabolic process
L-glutamate import
protein targeting to Golgi
neural precursor cell proliferation
meiotic spindle organization
dendritic spine development

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.001
0.001
0.001
0.001
0.001
0.002
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GO:0022614 membrane to membrane docking
positive regulation of protein kinase A signaling
GO:0010739 cascade
GO:0060900 embryonic camera-type eye formation
GO:0007172 signal complex assembly
GO:0051965 positive regulation of synapse assembly
GO:0034499 late endosome to Golgi transport
GO:0055088 lipid homeostasis
GO:0007406 negative regulation of neuroblast proliferation
protein import into mitochondrial outer
GO:0045040 membrane
GO:0035640 exploration behavior
GO:0072015 glomerular visceral epithelial cell development
GO:0021702 cerebellar Purkinje cell differentiation
GO:0034067 protein localization in Golgi apparatus
GO:0070779 D-aspartate import
GO:2000147 positive regulation of cell motility
GO:0045577 regulation of B cell differentiation
GO:0019222 regulation of metabolic process
GO:0012501 programmed cell death
activation of MAPK activity by adrenergic
GO:0071883 receptor signaling pathway
positive regulation of fatty acid biosynthetic
GO:0045723 process
GO:0051353 positive regulation of oxidoreductase activity
GO:0046219 indolalkylamine biosynthetic process
GO:0042149 cellular response to glucose starvation
GO:0046488 phosphatidylinositol metabolic process
GO:0045821 positive regulation of glycolysis
GO:0048143 astrocyte activation
GO:0060708 spongiotrophoblast differentiation
negative regulation of calcium ion transport via
GO:0051927 voltage-gated calcium channel activity
GO:0035630 bone mineralization involved in bone maturation
GO:0060426 lung vasculature development
chondroitin sulfate proteoglycan biosynthetic
GO:0050650 process
GO:0006820 anion transport
GO:0003143 embryonic heart tube morphogenesis
GO:0060074 synapse maturation
GO:0006851 mitochondrial calcium ion transport
GO:0003417 growth plate cartilage development

	
  

0.002
0.003
0.003
0.003
0.004
0.004
0.004
0.004
0.005
0.005
0.006
0.006
0.007
0.007
0.007
0.007
0.007
0.007
0.011
0.012
0.012
0.013
0.014
0.014
0.014
0.014
0.015
0.018
0.019
0.020
0.020
0.020
0.020
0.021
0.022
0.024
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GO:0000715
GO:0031023
GO:2001240
GO:0070831
GO:0065004
GO:0021551
GO:0060527
GO:0061045
GO:0015677
GO:0060003
GO:0006111
GO:0042427
GO:0016480
GO:0042711
GO:0000430
GO:0019086
GO:0031117
GO:0014912
GO:0006997
GO:0043029
GO:0032000
GO:0051246
GO:0021696
GO:0035067
GO:0015833
GO:0007028
GO:0033687

	
  

nucleotide-excision repair; DNA damage
recognition
microtubule organizing center organization
negative regulation of extrinsic apoptotic
signaling pathway in absence of ligand
basement membrane assembly
protein-DNA complex assembly
central nervous system morphogenesis
prostate epithelial cord arborization involved in
prostate glandular acinus morphogenesis
negative regulation of wound healing
copper ion import
copper ion export
regulation of gluconeogenesis
serotonin biosynthetic process
negative regulation of transcription from RNA
polymerase III promoter
maternal behavior
regulation of transcription from RNA
polymerase II promoter by glucose
late viral mRNA transcription
positive regulation of microtubule
depolymerization
negative regulation of smooth muscle cell
migration
nucleus organization
T cell homeostasis
positive regulation of fatty acid beta-oxidation
regulation of protein metabolic process
cerebellar cortex morphogenesis
negative regulation of histone acetylation
peptide transport
cytoplasm organization
osteoblast proliferation

0.024
0.025
0.025
0.025
0.025
0.026
0.027
0.027
0.028
0.028
0.029
0.029
0.029
0.032
0.033
0.033
0.033
0.035
0.036
0.037
0.041
0.043
0.044
0.045
0.045
0.048
0.049
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Table A-2. Biological processes found to be active in IVV oocytes using the
mvGST package in Bioconductor
GO ID

Term

GO:0000002
GO:0000045
GO:0000050
GO:0000053
GO:0000076
GO:0000085
GO:0000089
GO:0000090
GO:0000132
GO:0000165
GO:0000209
GO:0000245
GO:0000266
GO:0000303
GO:0000375

mitochondrial genome maintenance
autophagic vacuole assembly
urea cycle
argininosuccinate metabolic process
DNA replication checkpoint
G2 phase of mitotic cell cycle
mitotic metaphase
mitotic anaphase
establishment of mitotic spindle orientation
MAPK cascade
protein polyubiquitination
spliceosome assembly
mitochondrial fission
response to superoxide
RNA splicing; via transesterification reactions
regulation of alternative nuclear mRNA splicing;
via spliceosome
spliceosomal snRNP assembly
nuclear mRNA 3'-splice site recognition
endonucleolytic cleavage in ITS1 to separate
SSU-rRNA from 5.8S rRNA and LSU-rRNA
from tricistronic rRNA transcript (SSU-rRNA;
5.8S rRNA; LSU-rRNA)
endonucleolytic cleavage to generate mature 3'end of SSU-rRNA from (SSU-rRNA; 5.8S
rRNA; LSU-rRNA)
nucleotide-excision repair; DNA damage
pyrimidine
removal dimer repair by nucleotide-excision
repair double-strand break processing
DNA
DNA strand renaturation
response to acid
replicative cell aging
age-dependent response to oxidative stress
detection of chemical stimulus involved in
sensory perception of sweet taste

GO:0000381
GO:0000387
GO:0000389

GO:0000447

GO:0000461
GO:0000718
GO:0000720
GO:0000729
GO:0000733
GO:0001101
GO:0001302
GO:0001306
GO:0001582

	
  

Adjusted P-Value
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000

0.000

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0001662
GO:0001675
GO:0001754
GO:0001782
GO:0001816
GO:0001817
GO:0001821
GO:0001836
GO:0001841
GO:0001916
GO:0001933
GO:0001937
GO:0001945
GO:0001947
GO:0002001
GO:0002027
GO:0002031
GO:0002086
GO:0002088
GO:0002089
GO:0002118
GO:0002224
GO:0002248
GO:0002309
GO:0002331
GO:0002407
GO:0002467
GO:0002504
GO:0002540
GO:0002542
GO:0002553
GO:0002634
GO:0002687

	
  

behavioral fear response
acrosome assembly
eye photoreceptor cell differentiation
B cell homeostasis
cytokine production
regulation of cytokine production
histamine secretion
release of cytochrome c from mitochondria
neural tube formation
positive regulation of T cell mediated
negative
regulation of protein phosphorylation
cytotoxicity
negative regulation of endothelial cell
lymph
vessel development
proliferation
heart looping
renin secretion into blood stream
regulation of heart rate
G-protein coupled receptor internalization
diaphragm contraction
lens development in camera-type eye
lens morphogenesis in camera-type eye
aggressive behavior
toll-like receptor signaling pathway
connective tissue replacement involved in
inflammatory response wound healing
T cell proliferation involved in immune response
pre-B cell allelic exclusion
dendritic cell chemotaxis
germinal center formation
antigen processing and presentation of peptide or
polysaccharide antigen via MHC class II
leukotriene production involved in inflammatory
response
Factor XII activation
histamine secretion by mast cell
regulation of germinal center formation
positive regulation of leukocyte migration

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000

GO:0002755

MyD88-dependent toll-like receptor signaling
pathway

0.000

GO:0002756

MyD88-independent toll-like receptor signaling
pathway

0.000
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GO:0002827 positive regulation of T-helper 1 type immune
response
GO:0002860 positive regulation of natural killer cell mediated
negative
regulation
inflammatory
response
cytotoxicity
directedofagainst
tumor cell
target to
GO:0002862
antigenic stimulus

0.000

GO:0003014
GO:0003094
GO:0003105
GO:0003151
GO:0003211
GO:0005977
GO:0005978
GO:0005979
GO:0005980
GO:0005981
GO:0006000
GO:0006004
GO:0006007
GO:0006011
GO:0006015
GO:0006027
GO:0006069
GO:0006071
GO:0006082
GO:0006084
GO:0006085
GO:0006099
GO:0006101
GO:0006103

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000

GO:0006122
GO:0006139
GO:0006144
GO:0006164
GO:0006165
GO:0006166
GO:0006172
GO:0006183
GO:0006195
GO:0006206
GO:0006220
	
  

renal system process
glomerular filtration
negative regulation of glomerular filtration
outflow tract morphogenesis
cardiac ventricle formation
glycogen metabolic process
glycogen biosynthetic process
regulation of glycogen biosynthetic process
glycogen catabolic process
regulation of glycogen catabolic process
fructose metabolic process
fucose metabolic process
glucose catabolic process
UDP-glucose metabolic process
5-phosphoribose 1-diphosphate biosynthetic
glycosaminoglycan
catabolic process
process
ethanol oxidation
glycerol metabolic process
organic acid metabolic process
acetyl-CoA metabolic process
acetyl-CoA biosynthetic process
tricarboxylic acid cycle
citrate metabolic process
2-oxoglutarate metabolic process
mitochondrial electron transport; ubiquinol to
cytochrome c
nucleobase-containing compound metabolic
purine
processbase metabolic process
purine nucleotide biosynthetic process
nucleoside diphosphate phosphorylation
purine ribonucleoside salvage
ADP biosynthetic process
GTP biosynthetic process
purine nucleotide catabolic process
pyrimidine base metabolic process
pyrimidine nucleotide metabolic process

0.000
0.000

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0006221
GO:0006228
GO:0006233
GO:0006241
GO:0006264
GO:0006271
GO:0006290
GO:0006295
GO:0006296
GO:0006312
GO:0006313
GO:0006325
GO:0006333
GO:0006356
GO:0006360
GO:0006361
GO:0006362
GO:0006363
GO:0006379
GO:0006383
GO:0006385
GO:0006386
GO:0006388
GO:0006407
GO:0006424
GO:0006433
GO:0006477
GO:0006479
GO:0006486
GO:0006493
GO:0006501
GO:0006506
GO:0006520
GO:0006526
GO:0006527

	
  

pyrimidine nucleotide biosynthetic process
UTP biosynthetic process
dTDP biosynthetic process
CTP biosynthetic process
mitochondrial DNA replication
DNA strand elongation involved in DNA
pyrimidine
replication dimer repair
nucleotide-excision repair; DNA incision; 3'-to
nucleotide-excision
repair; DNA incision; 5'-to
lesion
mitotic
lesion recombination
transposition; DNA-mediated
chromatin organization
chromatin assembly or disassembly
regulation of transcription from RNA
polymerase I promoter
transcription from RNA polymerase I promoter
transcription initiation from RNA polymerase I
promoter
transcription elongation from RNA polymerase I
promoter
termination of RNA polymerase I transcription
mRNA cleavage
transcription from RNA polymerase III promoter
transcription elongation from RNA polymerase
III promoter
termination of RNA polymerase III transcription
tRNA splicing; via endonucleolytic cleavage and
ligation
rRNA export from nucleus
glutamyl-tRNA aminoacylation
prolyl-tRNA aminoacylation
protein sulfation
protein methylation
protein glycosylation
protein O-linked glycosylation
C-terminal protein lipidation
GPI anchor biosynthetic process
cellular amino acid metabolic process
arginine biosynthetic process
arginine catabolic process

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0006531
GO:0006532
GO:0006533
GO:0006536
GO:0006564
GO:0006621
GO:0006641
GO:0006654
GO:0006656
GO:0006662
GO:0006690
GO:0006691
GO:0006695
GO:0006699
GO:0006700
GO:0006701
GO:0006702
GO:0006707
GO:0006754
GO:0006766
GO:0006767
GO:0006771
GO:0006777
GO:0006779
GO:0006783
GO:0006790
GO:0006796
GO:0006801
GO:0006821
GO:0006825
GO:0006826
GO:0006829
GO:0006855
GO:0006869
GO:0006879
GO:0006882
GO:0006887
GO:0006888
GO:0006890
GO:0006891
GO:0006897

	
  

aspartate metabolic process
aspartate biosynthetic process
aspartate catabolic process
glutamate metabolic process
L-serine biosynthetic process
protein retention in ER lumen
triglyceride metabolic process
phosphatidic acid biosynthetic process
phosphatidylcholine biosynthetic process
glycerol ether metabolic process
icosanoid metabolic process
leukotriene metabolic process
cholesterol biosynthetic process
bile acid biosynthetic process
C21-steroid hormone biosynthetic process
progesterone biosynthetic process
androgen biosynthetic process
cholesterol catabolic process
ATP biosynthetic process
vitamin metabolic process
water-soluble vitamin metabolic process
riboflavin metabolic process
Mo-molybdopterin cofactor biosynthetic process
porphyrin-containing compound biosynthetic
heme
biosynthetic process
process
sulfur compound metabolic process
phosphate-containing compound metabolic
superoxide
metabolic process
process
chloride transport
copper ion transport
iron ion transport
zinc ion transport
drug transmembrane transport
lipid transport
cellular iron ion homeostasis
cellular zinc ion homeostasis
exocytosis
ER to Golgi vesicle-mediated transport
retrograde vesicle-mediated transport; Golgi to
intra-Golgi
vesicle-mediated transport
ER
endocytosis

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0006909
GO:0006914
GO:0006928
GO:0006930
GO:0006937
GO:0006939
GO:0006949
GO:0006956
GO:0006958
GO:0006959
GO:0006968
GO:0006991
GO:0007005
GO:0007016
GO:0007017
GO:0007031
GO:0007059
GO:0007062
GO:0007080
GO:0007088
GO:0007089
GO:0007093
GO:0007094
GO:0007095
GO:0007098
GO:0007141
GO:0007156

	
  

phagocytosis
autophagy
cellular component movement
substrate-dependent cell migration; cell
regulation
extension of muscle contraction
smooth muscle contraction
syncytium formation
complement activation
complement activation; classical pathway
humoral immune response
cellular defense response
response to sterol depletion
mitochondrion organization
cytoskeletal anchoring at plasma membrane
microtubule-based process
peroxisome organization
chromosome segregation
sister chromatid cohesion
mitotic metaphase plate congression
regulation of mitosis
traversing start control point of mitotic cell cycle
mitotic cell cycle checkpoint
mitotic cell cycle spindle assembly checkpoint
mitotic cell cycle G2/M transition DNA damage
centrosome
checkpoint cycle
male meiosis I
homophilic cell adhesion
activation of transmembrane receptor protein
GO:0007171
tyrosine kinase activity
G-protein signaling; coupled to cyclic nucleotide
GO:0007187 second messenger

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000

GO:0007189 activation of adenylate cyclase activity by Gprotein signaling pathway
GO:0007193 inhibition of adenylate cyclase activity by Gprotein signaling pathway
activation of phospholipase C activity by Gprotein coupled receptor protein signaling
GO:0007200
pathway coupled to IP3 second messenger
GO:0007202 activation of phospholipase C activity
GO:0007214 gamma-aminobutyric acid signaling pathway

0.000

0.000
0.000

0.000

0.000
0.000
0.000
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GO:0007229
GO:0007256
GO:0007259
GO:0007260
GO:0007262
GO:0007263
GO:0007286
GO:0007292
GO:0007339
GO:0007405
GO:0007494
GO:0007501
GO:0007518
GO:0007521
GO:0007529
GO:0007595
GO:0007597
GO:0007611
GO:0007616
GO:0007617
GO:0007625
GO:0007628
GO:0008015
GO:0008033
GO:0008037
GO:0008206
GO:0008209
GO:0008217
GO:0008306
GO:0008340
GO:0008344
GO:0008347
GO:0008354
GO:0008608
GO:0008615
GO:0008633
GO:0008634
GO:0008654

	
  

integrin-mediated signaling pathway
activation of JNKK activity
JAK-STAT cascade
tyrosine phosphorylation of STAT protein
STAT protein import into nucleus
nitric oxide mediated signal transduction
spermatid development
female gamete generation
binding of sperm to zona pellucida
neuroblast proliferation
midgut development
mesodermal cell fate specification
myoblast cell fate determination
muscle cell fate determination
establishment of synaptic specificity at
neuromuscular junction
lactation
blood coagulation; intrinsic pathway
learning or memory
long-term memory
mating behavior
grooming behavior
adult walking behavior
blood circulation
tRNA processing
cell recognition
bile acid metabolic process
androgen metabolic process
regulation of blood pressure
associative learning
determination of adult lifespan
adult locomotory behavior
glial cell migration
germ cell migration
attachment of spindle microtubules to
pyridoxine
kinetochorebiosynthetic process
activation of pro-apoptotic gene products
negative regulation of survival gene product
expression
phospholipid biosynthetic process

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0009052
GO:0009083
GO:0009116
GO:0009117
GO:0009142
GO:0009156
GO:0009165
GO:0009186
GO:0009263
GO:0009311
GO:0009314
GO:0009566
GO:0009607
GO:0009612
GO:0009628
GO:0009650
GO:0009651
GO:0009744
GO:0009749
GO:0009888
GO:0009966
GO:0009968
GO:0010039
GO:0010042
GO:0010043
GO:0010046
GO:0010212
GO:0010224
GO:0010390
GO:0010457
GO:0010469
GO:0010535
GO:0010569
GO:0010574
GO:0010596
GO:0010608
GO:0010613

	
  

pentose-phosphate shunt; non-oxidative branch
branched chain family amino acid catabolic
nucleoside
metabolic process
process
nucleotide metabolic process
nucleoside triphosphate biosynthetic process
ribonucleoside monophosphate biosynthetic
nucleotide
process biosynthetic process
deoxyribonucleoside diphosphate metabolic
deoxyribonucleotide
biosynthetic process
process
oligosaccharide metabolic process
response to radiation
fertilization
response to biotic stimulus
response to mechanical stimulus
response to abiotic stimulus
UV protection
response to salt stress
response to sucrose stimulus
response to glucose stimulus
tissue development
regulation of signal transduction
negative regulation of signal transduction
response to iron ion
response to manganese ion
response to zinc ion
response to mycotoxin
response to ionizing radiation
response to UV-B
histone monoubiquitination
centriole-centriole cohesion
regulation of receptor activity
positive regulation of activation of JAK2 kinase
activity
regulation of double-strand break repair via
homologous recombination
regulation of vascular endothelial growth factor
production
negative regulation of endothelial cell migration
posttranscriptional regulation of gene expression
positive regulation of cardiac muscle
hypertrophy
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0.000
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0.000
0.000
0.000
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GO:0010667
GO:0010669
GO:0010694
GO:0010700
GO:0010724
GO:0010738
GO:0010740
GO:0010756
GO:0010820
GO:0010826
GO:0010881
GO:0010884
GO:0010891
GO:0010894
GO:0010898
GO:0010909
GO:0010951
GO:0010952
GO:0010956
GO:0010963
GO:0010977
GO:0010991
GO:0014032
GO:0014033
GO:0014037
GO:0014059
GO:0014075
GO:0014706
GO:0014824
GO:0014827
GO:0014829
GO:0014850
GO:0014902
GO:0014911
GO:0015074

	
  

negative regulation of cardiac muscle cell
epithelial
apoptosis structure maintenance
positive regulation of alkaline phosphatase
negative
activity regulation of norepinephrine secretion
regulation of definitive erythrocyte
regulation
of protein kinase A signaling cascade
differentiation
positive regulation of intracellular protein kinase
cascade
positive regulation of plasminogen activation
positive regulation of T cell chemotaxis
negative regulation of centrosome duplication
regulation of cardiac muscle contraction by
regulation of the release of sequestered calcium
positive
regulation of lipid storage
ion
negative regulation of sequestering of
negative
regulation of steroid biosynthetic
triglyceride
positive
process regulation of triglyceride catabolic
positive
process regulation of heparan sulfate
proteoglycan biosynthetic process
negative regulation of endopeptidase activity
positive regulation of peptidase activity
negative regulation of calcidiol 1monooxygenase activity
regulation of L-arginine import
negative regulation of neuron projection
negative
regulation of SMAD protein complex
development
assembly
neural crest cell development
neural crest cell differentiation
Schwann cell differentiation
regulation of dopamine secretion
response to amine stimulus
striated muscle tissue development
artery smooth muscle contraction
intestine smooth muscle contraction
vascular smooth muscle contraction
response to muscle activity
myotube differentiation
positive regulation of smooth muscle cell
DNA
integration
migration
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0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
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GO:0015697
GO:0015711
GO:0015721
GO:0015879
GO:0015884
GO:0015893
GO:0015914
GO:0015949
GO:0015991
GO:0015993
GO:0016236
GO:0016254
GO:0016265
GO:0016311
GO:0016338
GO:0016339
GO:0016540
GO:0016559
GO:0016576
GO:0016601
GO:0016925
GO:0016973
GO:0016998
GO:0017085
GO:0017156
GO:0017157
GO:0018193
GO:0018401
GO:0018879
GO:0018894
GO:0018958
GO:0018963
GO:0019059
GO:0019079
GO:0019226
GO:0019233
GO:0019254
GO:0019255
GO:0019550

	
  

quaternary ammonium group transport
organic anion transport
bile acid and bile salt transport
carnitine transport
folic acid transport
drug transport
phospholipid transport
nucleobase-containing small molecule
ATP
hydrolysis coupled proton transport
interconversion
molecular hydrogen transport
macroautophagy
preassembly of GPI anchor in ER membrane
death
dephosphorylation
calcium-independent cell-cell adhesion
calcium-dependent cell-cell adhesion
protein autoprocessing
peroxisome fission
histone dephosphorylation
Rac protein signal transduction
protein sumoylation
poly(A)+ mRNA export from nucleus
cell wall macromolecule catabolic process
response to insecticide
calcium ion-dependent exocytosis
regulation of exocytosis
peptidyl-amino acid modification
peptidyl-proline hydroxylation to 4-hydroxy-Lproline
biphenyl metabolic process
dibenzo-p-dioxin metabolic process
phenol-containing compound metabolic process
phthalate metabolic process
initiation of viral infection
viral genome replication
transmission of nerve impulse
sensory perception of pain
carnitine metabolic process; CoA-linked
glucose 1-phosphate metabolic process
glutamate catabolic process to aspartate

0.000
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GO:0019551 glutamate catabolic process to 2-oxoglutarate
GO:0019725 cellular homeostasis
peptide cross-linking via chondroitin 4-sulfate
GO:0019800
glycosaminoglycan

0.000
0.000

GO:0019852
GO:0019933
GO:0019953
GO:0021516
GO:0021549

0.000
0.000
0.000
0.000
0.000

GO:0021740
GO:0021766
GO:0021819
GO:0021846
GO:0021895
GO:0021960
GO:0021987
GO:0022604
GO:0030001
GO:0030091
GO:0030100
GO:0030101
GO:0030166
GO:0030177
GO:0030183
GO:0030193
GO:0030194
GO:0030198
GO:0030199
GO:0030216
GO:0030217
GO:0030220
GO:0030239
GO:0030260
GO:0030279
GO:0030301
GO:0030318
GO:0030330

	
  

L-ascorbic acid metabolic process
cAMP-mediated signaling
sexual reproduction
dorsal spinal cord development
cerebellum development
principal sensory nucleus of trigeminal nerve
development
hippocampus development
layer formation in cerebral cortex
cell proliferation in forebrain
cerebral cortex neuron differentiation
anterior commissure morphogenesis
cerebral cortex development
regulation of cell morphogenesis
metal ion transport
protein repair
regulation of endocytosis
natural killer cell activation
proteoglycan biosynthetic process
positive regulation of Wnt receptor signaling
pathway
B cell differentiation
regulation of blood coagulation
positive regulation of blood coagulation
extracellular matrix organization
collagen fibril organization
keratinocyte differentiation
T cell differentiation
platelet formation
myofibril assembly
entry into host cell
negative regulation of ossification
cholesterol transport
melanocyte differentiation
DNA damage response; signal transduction by
p53 class mediator

0.000
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GO:0030500 regulation of bone mineralization
GO:0030512 negative regulation of transforming growth
factor beta receptor signaling pathway
GO:0030520 intracellular estrogen receptor signaling pathway
GO:0030534 adult behavior
GO:0030539 male genitalia development
GO:0030574 collagen catabolic process
GO:0030818 negative regulation of cAMP biosynthetic
GO:0030901 midbrain
process development
GO:0030902 hindbrain development
GO:0030951 establishment or maintenance of microtubule
cytoskeleton polarity
GO:0030967 ER-nuclear sterol response pathway
GO:0031016 pancreas development

0.000

GO:0031018 endocrine pancreas development
GO:0031077 post-embryonic camera-type eye development
GO:0031146 SCF-dependent proteasomal ubiquitin-dependent
protein catabolic process
GO:0031297 replication fork processing
GO:0031424 keratinization
GO:0031573 intra-S DNA damage checkpoint
GO:0031584 activation of phospholipase D activity
GO:0031622 positive regulation of fever generation
GO:0031638 zymogen activation
GO:0031639 plasminogen activation
GO:0031663 lipopolysaccharide-mediated signaling pathway
GO:0031667 response to nutrient levels
GO:0031998 regulation of fatty acid beta-oxidation
GO:0032008 positive regulation of TOR signaling cascade
GO:0032060 bleb assembly
GO:0032071 regulation of endodeoxyribonuclease activity
negative regulation of NF-kappaB transcription
GO:0032088
factor activity
GO:0032091 negative regulation of protein binding
GO:0032092 positive regulation of protein binding
GO:0032205 negative regulation of telomere maintenance
GO:0032227 negative regulation of synaptic transmission;
dopaminergic
GO:0032229 negative regulation of synaptic transmission;
GABAergic
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GO:0032269 negative regulation of cellular protein metabolic
process
GO:0032313 regulation of Rab GTPase activity
GO:0032314 regulation of Rac GTPase activity
GO:0032364 oxygen homeostasis
GO:0032375 negative regulation of cholesterol transport
GO:0032400 melanosome localization
GO:0032402 melanosome transport
GO:0032436 positive regulation of proteasomal ubiquitindependent protein catabolic process
GO:0032463 negative regulation of protein
GO:0032480 negative
regulation of type I interferon
homooligomerization
GO:0032507 maintenance
production of protein location in cell
GO:0032651 regulation of interleukin-1 beta production
GO:0032693 negative regulation of interleukin-10 production
GO:0032700 negative regulation of interleukin-17 production
GO:0032725 positive regulation of granulocyte macrophage
colony-stimulating factor production
GO:0032728 positive regulation of interferon-beta production
GO:0032729 positive regulation of interferon-gamma
GO:0032733 positive
regulation of interleukin-10 production
production
GO:0032735 positive regulation of interleukin-12 production
GO:0032740 positive regulation of interleukin-17 production
GO:0032743 positive regulation of interleukin-2 production
GO:0032760 positive regulation of tumor necrosis factor
productionof transcription elongation; DNAGO:0032784 regulation
dependent
GO:0032786 positive regulation of transcription elongation;
DNA-dependent
GO:0032790 ribosome disassembly
GO:0032793 positive regulation of CREB transcription factor
activity
GO:0032816 positive regulation of natural killer cell
GO:0032819 positive
regulation of natural killer cell
activation
GO:0032851 positive
regulation of Rab GTPase activity
proliferation
GO:0032872 regulation of stress-activated MAPK cascade
GO:0032963 collagen metabolic process
GO:0032964 collagen biosynthetic process
GO:0033014 tetrapyrrole biosynthetic process
GO:0033077 T cell differentiation in thymus
GO:0033133 positive regulation of glucokinase activity
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GO:0033138 positive regulation of peptidyl-serine
positive regulation of intracellular estrogen
GO:0033148 phosphorylation
receptor signaling pathway
GO:0033151 V(D)J recombination
GO:0033169 histone H3-K9 demethylation
GO:0033197 response to vitamin E
GO:0033209 tumor necrosis factor-mediated signaling
GO:0033327 Leydig
pathwaycell differentiation
GO:0033554 cellular response to stress
GO:0033591 response to L-ascorbic acid
GO:0033683 nucleotide-excision repair; DNA incision
GO:0033689 negative regulation of osteoblast proliferation
GO:0034080 CenH3-containing nucleosome assembly at
centromere
GO:0034105 positive regulation of tissue remodeling
GO:0034109 homotypic cell-cell adhesion
GO:0034130 toll-like receptor 1 signaling pathway
GO:0034134 toll-like receptor 2 signaling pathway
GO:0034138 toll-like receptor 3 signaling pathway
GO:0034142 toll-like receptor 4 signaling pathway
GO:0034220 ion transmembrane transport
GO:0034372 very-low-density lipoprotein particle remodeling
GO:0034375 high-density lipoprotein particle remodeling
GO:0034393 positive regulation of smooth muscle cell
GO:0034418 urate
biosynthetic process
apoptosis
GO:0034435 cholesterol esterification
GO:0034446 substrate adhesion-dependent cell spreading
GO:0034498 early endosome to Golgi transport
GO:0034501 protein localization to kinetochore
GO:0034599 cellular response to oxidative stress
GO:0034616 response to laminar fluid shear stress
GO:0034660 ncRNA metabolic process
GO:0035019 somatic stem cell maintenance
GO:0035025 positive regulation of Rho protein signal
GO:0035108 limb
morphogenesis
transduction
GO:0035166 post-embryonic hemopoiesis
GO:0035176 social behavior
GO:0035434 copper ion transmembrane transport
GO:0035582 sequestering of BMP in extracellular matrix
GO:0035583 sequestering of TGFbeta in extracellular matrix
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GO:0035666 TRIF-dependent toll-like receptor signaling
GO:0035690 cellular
pathwayresponse to drug
GO:0035767 endothelial cell chemotaxis
positive regulation of insulin secretion involved
GO:0035774
in cellular response to glucose stimulus
GO:0035872 nucleotide-binding domain; leucine rich repeat
containing receptor signaling pathway
GO:0035970 peptidyl-threonine dephosphorylation
GO:0038061 NIK/NF-kappaB cascade
GO:0040012 regulation of locomotion
GO:0040014 regulation of multicellular organism growth
GO:0040036 regulation of fibroblast growth factor receptor
signaling pathway
GO:0042058 regulation of epidermal growth factor receptor
signaling pathway
GO:0042088 T-helper 1 type immune response
GO:0042093 T-helper cell differentiation
GO:0042095 interferon-gamma biosynthetic process
GO:0042098 T cell proliferation
GO:0042102 positive regulation of T cell proliferation
GO:0042104 positive regulation of activated T cell
GO:0042129 regulation
of T cell proliferation
proliferation
GO:0042157 lipoprotein metabolic process
GO:0042158 lipoprotein biosynthetic process
GO:0042178 xenobiotic catabolic process
GO:0042220 response to cocaine
GO:0042221 response to chemical stimulus
GO:0042254 ribosome biogenesis
GO:0042255 ribosome assembly
GO:0042256 mature ribosome assembly
GO:0042262 DNA protection
GO:0042271 susceptibility to natural killer cell mediated
cytotoxicity
GO:0042273 ribosomal large subunit biogenesis
GO:0042305 specification of segmental identity; mandibular
segment
GO:0042310 vasoconstriction
GO:0042312 regulation of vasodilation
GO:0042346 positive regulation of NF-kappaB import into
GO:0042462 eye
photoreceptor cell development
nucleus
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GO:0042474 middle ear morphogenesis
GO:0042482 positive regulation of odontogenesis
GO:0042510 regulation of tyrosine phosphorylation of Stat1
protein
GO:0042517 positive regulation of tyrosine phosphorylation
of Stat3 protein
GO:0042520 positive regulation of tyrosine phosphorylation
of Stat4 protein
positive regulation of tyrosine phosphorylation
GO:0042523
of Stat5 protein

0.000
0.000

GO:0042531 positive regulation of tyrosine phosphorylation
of STAT protein
GO:0042535 positive regulation of tumor necrosis factor
biosynthetic process
GO:0042541 hemoglobin biosynthetic process
GO:0042554 superoxide anion generation
GO:0042632 cholesterol homeostasis
GO:0042699 follicle-stimulating hormone signaling pathway
GO:0042743 hydrogen peroxide metabolic process
GO:0042755 eating behavior
GO:0042756 drinking behavior
GO:0042773 ATP synthesis coupled electron transport
GO:0042775 mitochondrial ATP synthesis coupled electron
transport
GO:0042776 mitochondrial ATP synthesis coupled proton
transport
GO:0042832 defense response to protozoan
GO:0042987 amyloid precursor protein catabolic process
GO:0043084 penile erection
GO:0043097 pyrimidine nucleoside salvage
GO:0043101 purine-containing compound salvage
GO:0043117 positive regulation of vascular permeability
GO:0043122 regulation of I-kappaB kinase/NF-kappaB
negative
cascade regulation of I-kappaB kinase/NFGO:0043124
kappaB cascade
GO:0043129 surfactant homeostasis
GO:0043149 stress fiber assembly
GO:0043163 cell envelope organization
GO:0043200 response to amino acid stimulus
GO:0043249 erythrocyte maturation

0.000
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GO:0043252
GO:0043270
GO:0043279
GO:0043320
GO:0043368
GO:0043382
GO:0043405
GO:0043434
GO:0043473
GO:0043484
GO:0043496
GO:0043497
GO:0043517
GO:0043524
GO:0043525
GO:0043570
GO:0043587
GO:0043615
GO:0043666
GO:0043691
GO:0043931
GO:0043984
GO:0044237
GO:0044249
GO:0044262
GO:0044334
GO:0044342
GO:0044344
GO:0045022
GO:0045039
GO:0045058
GO:0045078
GO:0045086
GO:0045089
GO:0045104

	
  

sodium-independent organic anion transport
positive regulation of ion transport
response to alkaloid
natural killer cell degranulation
positive T cell selection
positive regulation of memory T cell
regulation
of MAP kinase activity
differentiation
response to peptide hormone stimulus
pigmentation
regulation of RNA splicing
regulation of protein homodimerization activity
regulation of protein heterodimerization activity
positive regulation of DNA damage response;
signal transduction by p53 class mediator
negative regulation of neuron apoptosis
positive regulation of neuron apoptosis
maintenance of DNA repeat elements
tongue morphogenesis
astrocyte cell migration
regulation of phosphoprotein phosphatase
reverse
activity cholesterol transport
ossification involved in bone maturation
histone H4-K16 acetylation
cellular metabolic process
cellular biosynthetic process
cellular carbohydrate metabolic process
canonical Wnt receptor signaling pathway
involved in positive regulation of epithelial to
mesenchymal transition
type B pancreatic cell proliferation
cellular response to fibroblast growth factor
early
endosome to late endosome transport
stimulus
protein import into mitochondrial inner
T
cell selection
membrane
positive regulation of interferon-gamma
biosynthetic process
positive regulation of interleukin-2 biosynthetic
process
positive regulation of innate immune response
intermediate filament cytoskeleton organization

0.000
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GO:0045116
GO:0045190
GO:0045217
GO:0045329
GO:0045333
GO:0045444
GO:0045579
GO:0045582
GO:0045597
GO:0045599
GO:0045616
GO:0045618
GO:0045652
GO:0045663
GO:0045667
GO:0045682
GO:0045716
GO:0045725
GO:0045730
GO:0045739
GO:0045743
GO:0045749
GO:0045767
GO:0045776
GO:0045779
GO:0045879
GO:0045885
GO:0045900
GO:0045907
GO:0045910
GO:0045950
GO:0045987
GO:0046005
GO:0046034
GO:0046134
GO:0046135
GO:0046329

	
  

protein neddylation
isotype switching
cell-cell junction maintenance
carnitine biosynthetic process
cellular respiration
fat cell differentiation
positive regulation of B cell differentiation
positive regulation of T cell differentiation
positive regulation of cell differentiation
negative regulation of fat cell differentiation
regulation of keratinocyte differentiation
positive regulation of keratinocyte
regulation
of megakaryocyte differentiation
differentiation
positive regulation of myoblast differentiation
regulation of osteoblast differentiation
regulation of epidermis development
positive regulation of low-density lipoprotein
particle receptor biosynthetic process
positive regulation of glycogen biosynthetic
respiratory
burst
process
positive regulation of DNA repair
positive regulation of fibroblast growth factor
receptor signaling pathway
negative regulation of S phase of mitotic cell
regulation
of anti-apoptosis
cycle
negative regulation of blood pressure
negative regulation of bone resorption
negative regulation of smoothened signaling
positive
pathwayregulation of survival gene product
negative
regulation of translational elongation
expression
positive regulation of vasoconstriction
negative regulation of DNA recombination
negative regulation of mitotic recombination
positive regulation of smooth muscle contraction
positive regulation of circadian sleep/wake
cycle; REM sleep
ATP metabolic process
pyrimidine nucleoside biosynthetic process
pyrimidine nucleoside catabolic process
negative regulation of JNK cascade
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GO:0046427
GO:0046487
GO:0046500
GO:0046599
GO:0046641
GO:0046686
GO:0046689
GO:0046822
GO:0046827
GO:0046849
GO:0046887
GO:0046889
GO:0046898
GO:0046902
GO:0046928
GO:0046931
GO:0046950
GO:0046951
GO:0046952
GO:0047497
GO:0048008
GO:0048012
GO:0048041
GO:0048144
GO:0048168
GO:0048205
GO:0048245
GO:0048260
GO:0048311
GO:0048477
GO:0048478
GO:0048511
GO:0048568
GO:0048593
GO:0048625
GO:0048643
GO:0048659
GO:0048660
GO:0048662
GO:0048705
GO:0048708

	
  

positive regulation of JAK-STAT cascade
glyoxylate metabolic process
S-adenosylmethionine metabolic process
regulation of centriole replication
positive regulation of alpha-beta T cell
response
to cadmium ion
proliferation
response to mercury ion
regulation of nucleocytoplasmic transport
positive regulation of protein export from
bone
remodeling
nucleus
positive regulation of hormone secretion
positive regulation of lipid biosynthetic process
response to cycloheximide
regulation of mitochondrial membrane
regulation
of neurotransmitter secretion
permeability
pore complex assembly
cellular ketone body metabolic process
ketone body biosynthetic process
ketone body catabolic process
mitochondrion transport along microtubule
platelet-derived growth factor receptor signaling
hepatocyte
pathway growth factor receptor signaling
focal
adhesion assembly
pathway
fibroblast proliferation
regulation of neuronal synaptic plasticity
COPI coating of Golgi vesicle
eosinophil chemotaxis
positive regulation of receptor-mediated
mitochondrion
endocytosis distribution
oogenesis
replication fork protection
rhythmic process
embryonic organ development
camera-type eye morphogenesis
myoblast cell fate commitment
positive regulation of skeletal muscle tissue
smooth
muscle cell proliferation
development
regulation of smooth muscle cell proliferation
negative regulation of smooth muscle cell
skeletal
system morphogenesis
proliferation
astrocyte differentiation
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GO:0048712
GO:0048808
GO:0048813
GO:0048814
GO:0048844
GO:0050658
GO:0050671
GO:0050673
GO:0050678
GO:0050715
GO:0050727
GO:0050731
GO:0050773
GO:0050776
GO:0050805
GO:0050819
GO:0050829
GO:0050850
GO:0050851
GO:0050853
GO:0050863
GO:0050870
GO:0050873
GO:0050884
GO:0050912
GO:0050916
GO:0050917
GO:0050920
GO:0050927
GO:0050930
GO:0051006
GO:0051048
GO:0051084
GO:0051085

negative regulation of astrocyte differentiation
male genitalia morphogenesis
dendrite morphogenesis
regulation of dendrite morphogenesis
artery morphogenesis
RNA transport
positive regulation of lymphocyte proliferation
epithelial cell proliferation
regulation of epithelial cell proliferation
positive regulation of cytokine secretion
regulation of inflammatory response
positive regulation of peptidyl-tyrosine
regulation
of dendrite development
phosphorylation
regulation of immune response
negative regulation of synaptic transmission
negative regulation of coagulation
defense response to Gram-negative bacterium
positive regulation of calcium-mediated
antigen
signalingreceptor-mediated signaling pathway
B cell receptor signaling pathway
regulation of T cell activation
positive regulation of T cell activation
brown fat cell differentiation
neuromuscular process controlling posture
detection of chemical stimulus involved in
sensory perception of taste
sensory perception of sweet taste
sensory perception of umami taste
regulation of chemotaxis
positive regulation of positive chemotaxis
induction of positive chemotaxis
positive regulation of lipoprotein lipase activity
negative regulation of secretion
'de novo' posttranslational protein folding
chaperone mediated protein folding requiring
cofactor

GO:0051091 positive regulation of sequence-specific DNA
binding transcription factor activity
GO:0051098 regulation of binding
GO:0051100 negative regulation of binding
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GO:0051128
GO:0051135
GO:0051142
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positive regulation of muscle cell differentiation
positive regulation of striated muscle cell
protein
tetramerization
differentiation
positive regulation of cellular component
chromosome
movement organization
positive regulation of release of sequestered
calcium ion into cytosol
response to mineralocorticoid stimulus
stress-activated MAPK cascade
intracellular pH reduction
elevation of cytosolic calcium ion concentration
regulation
cytoskeleton
organization
involved inofG-protein
signaling
coupled to IP3
histone
H3-K4
methylation
second messenger
dopamine uptake
response to methylmercury
proteolysis involved in cellular protein catabolic
process
detection of stimulus
defense response to virus
localization within membrane
actin filament capping
regulation of cell cycle
positive regulation of cell division
negative regulation of cell division
response to misfolded protein
positive regulation of hair follicle development
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regulation of mitochondrial membrane potential
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GO:0055005 ventricular cardiac myofibril development
GO:0055010 ventricular cardiac muscle tissue morphogenesis
GO:0055012 ventricular cardiac muscle cell differentiation
GO:0055086 nucleobase-containing small molecule metabolic
process
GO:0055096 low-density lipoprotein particle mediated
GO:0060019 radial
glial cell differentiation
signaling
GO:0060041 retina development in camera-type eye
GO:0060044 negative regulation of cardiac muscle cell
GO:0060045 positive
regulation of cardiac muscle cell
proliferation
GO:0060081 membrane
hyperpolarization
proliferation
GO:0060119 inner ear receptor cell development
GO:0060134 prepulse inhibition
GO:0060135 maternal process involved in female pregnancy
cellular process regulating host cell cycle in
GO:0060154
response to virus
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regulation of timing of neuron differentiation
ciliary cell motility
flagellar cell motility
long-term synaptic potentiation
regulation of ryanodine-sensitive calciumrelease channel activity
primitive erythrocyte differentiation
head development
cranial suture morphogenesis
innervation
growth hormone receptor signaling pathway
JAK-STAT cascade involved in growth
hormone signaling pathway
positive regulation of penile erection
response to growth hormone stimulus
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Type I pneumocyte differentiation
Type II pneumocyte differentiation
spongiotrophoblast layer development
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regulation of androgen receptor signaling
pathway

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000

	
  
	
  

258	
  
GO:0060849 regulation of transcription involved in lymphatic
endothelial cell fate commitment
GO:0060992 response to fungicide
GO:0061077 chaperone-mediated protein folding
GO:0061098 positive regulation of protein tyrosine kinase
GO:0061099 negative
activity regulation of protein tyrosine kinase
GO:0061136 regulation
activity of proteasomal protein catabolic
GO:0061141 lung
ciliated cell differentiation
process
GO:0061178 regulation of insulin secretion involved in
cellular response to glucose stimulus
GO:0061333 renal tubule morphogenesis
GO:0061337 cardiac conduction
GO:0061370 testosterone biosynthetic process
GO:0061383 trabecula morphogenesis
GO:0070098 chemokine-mediated signaling pathway
GO:0070102 interleukin-6-mediated signaling pathway
GO:0070207 protein homotrimerization
GO:0070286 axonemal dynein complex assembly
GO:0070301 cellular response to hydrogen peroxide
GO:0070374 positive regulation of ERK1 and ERK2 cascade
GO:0070375 ERK5 cascade
GO:0070389 chaperone cofactor-dependent protein refolding
GO:0070493 thrombin receptor signaling pathway
GO:0070509 calcium ion import
GO:0070536 protein K63-linked deubiquitination
GO:0070542 response to fatty acid
GO:0070584 mitochondrion morphogenesis
GO:0070633 transepithelial transport
GO:0070830 tight junction assembly
GO:0070848 response to growth factor stimulus
GO:0070857 regulation of bile acid biosynthetic process
GO:0071157 negative regulation of cell cycle arrest
GO:0071222 cellular response to lipopolysaccharide
GO:0071230 cellular response to amino acid stimulus
GO:0071236 cellular response to antibiotic
GO:0071242 cellular response to ammonium ion
GO:0071243 cellular response to arsenic-containing substance
GO:0071277 cellular response to calcium ion
GO:0071312 cellular response to alkaloid
GO:0071316 cellular response to nicotine
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cellular response to cAMP
cellular response to interferon-gamma
cellular response to interleukin-1
cellular response to tumor necrosis factor
cellular response to growth factor stimulus
cellular response to gonadotropin stimulus
cellular response to follicle-stimulating hormone
cellular
stimulusresponse to parathyroid hormone
cellular
stimulusresponse to peptide hormone stimulus
cellular response to lipid
cellular response to oleic acid
cellular response to hypoxia
cellular response to salt stress
cellular response to gamma radiation
cellular response to fluid shear stress
cellular response to temperature stimulus
semaphorin-plexin signaling pathway
cellular response to dexamethasone stimulus
cellular response to transforming growth factor
beta stimulus
zinc ion transmembrane transport
zinc ion import
commissural neuron axon guidance
mitotic cell cycle G2/M transition checkpoint
glomerulus morphogenesis
glomerular mesangial cell development
nephron tubule epithelial cell differentiation
signal transduction by p53 class mediator
regulation
lipid transport
by positive
resulting inofinduction
of apoptosis
regulation of transcription from RNA
reactive
oxygen
species metabolic process
polymerase
II promoter
protein localization in membrane
positive regulation of establishment of protein
localization in plasma membrane
negative regulation of establishment of protein
localization in plasma membrane
primitive streak formation
positive regulation of neutrophil chemotaxis
positive regulation of protein kinase C signaling
cascade
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GO:0090050 positive regulation of cell migration involved in
sprouting angiogenesis
GO:0090073 positive regulation of protein homodimerization
activity
GO:0090084 negative regulation of inclusion body assembly
GO:0090102 cochlea development
GO:0090166 Golgi disassembly
GO:0090190 positive regulation of branching involved in
ureteric bud morphogenesis
GO:0090200 positive regulation of release of cytochrome c
from mitochondria
GO:0090201 negative regulation of release of cytochrome c
from mitochondria
GO:0090265 positive regulation of immune complex
clearance by monocytes and macrophages
GO:0097191 extrinsic apoptotic signaling pathway
GO:2000060 positive regulation of protein ubiquitination
involved in ubiquitin-dependent protein
catabolicregulation
process of type B pancreatic cell
GO:2000078 positive
development
GO:2000111 positive regulation of macrophage apoptosis
GO:2000134 negative regulation of G1/S transition of mitotic
cell cycle
positive regulation of neural precursor cell
GO:2000179
proliferation
GO:2000318 positive regulation of T-helper 17 type immune
response
GO:2000330 positive regulation of T-helper 17 cell lineage
commitment
GO:2000484 positive regulation of interleukin-8 secretion
GO:2000543 positive regulation of gastrulation
GO:2000727 positive regulation of cardiac muscle cell
GO:2000778 positive
regulation of interleukin-6 secretion
differentiation
negative
regulation of mesenchymal cell
GO:2000791
proliferation involved in lung development
GO:2000795 negative regulation of epithelial cell
proliferation involved in lung morphogenesis
GO:2001013 epithelial cell proliferation involve in renal
tubule morphogenesis
GO:2001014 regulation of skeletal muscle cell differentiation
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GO:2001237 negative regulation of extrinsic apoptotic
signaling pathway
GO:2001243 negative regulation of intrinsic apoptotic
signaling pathway
GO:2001244 positive regulation of intrinsic apoptotic
signaling pathway
GO:0016052 carbohydrate catabolic process
GO:0035313 wound healing; spreading of epidermal cells
GO:0008611 ether lipid biosynthetic process
GO:0002740 negative regulation of cytokine secretion
involved in immune response
GO:0001831 trophectodermal cellular morphogenesis
GO:0032800 receptor biosynthetic process
GO:0060547 negative regulation of necrotic cell death
GO:2001141 regulation of RNA biosynthetic process
GO:0001678 cellular glucose homeostasis
GO:0006032 chitin catabolic process
GO:0001919 regulation of receptor recycling
GO:0031328 positive regulation of cellular biosynthetic
GO:0009301 snRNA
process transcription
GO:0046826 negative regulation of protein export from
GO:0016446 somatic
nucleus hypermutation of immunoglobulin
GO:0016584 nucleosome
positioning
genes
GO:0021587 cerebellum morphogenesis
GO:0055119 relaxation of cardiac muscle
GO:0006880 intracellular sequestering of iron ion
GO:0000279 M phase
GO:0031575 mitotic cell cycle G1/S transition checkpoint
GO:0010803 regulation of tumor necrosis factor-mediated
GO:0010944 negative
signalingregulation
pathway of transcription by
GO:0003278 apoptosis
involved
in heart
morphogenesis
competitive
promoter
binding
GO:0035195 gene silencing by miRNA
GO:0021695 cerebellar cortex development
GO:0045348 positive regulation of MHC class II biosynthetic
GO:0016239 positive
process regulation of macroautophagy
GO:0051354 negative regulation of oxidoreductase activity
GO:0014066 regulation of phosphatidylinositol 3-kinase
GO:0033136 serine
cascadephosphorylation of STAT3 protein
GO:0015867 ATP transport
GO:0003350 pulmonary myocardium development
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negative regulation of myotube differentiation
L-cysteine catabolic process
negative regulation of epidermal growth factornegative
of B cell proliferation
activatedregulation
receptor activity
positive regulation of arachidonic acid secretion
protein localization to chromatin
positive regulation of receptor activity
positive regulation of actin cytoskeleton
regulation
of RIG-I signaling pathway
reorganization
regulation of cysteine-type endopeptidase
cellular
activity response to nutrient
synaptic transmission; dopaminergic
regulation of cardiac muscle contraction
citrulline biosynthetic process
anion homeostasis
cell proliferation in midbrain
DNA recombinase assembly
regulation of cohesin localization to chromatin
fever generation
histone H3-T11 phosphorylation
cytosolic calcium ion transport
protein processing involved in protein targeting
negative
regulation of reactive oxygen species
to mitochondrion
sterol
transport
metabolic
process
positive regulation of cardiac muscle contraction
camera-type eye photoreceptor cell
eye
morphogenesis
differentiation
iris morphogenesis
chronic inflammatory response to antigenic
positive
stimulusregulation of calcidiol 1visual
learning activity
monooxygenase
regulation of vascular permeability
positive regulation of mitotic cell cycle
nuclear fragmentation involved in apoptotic
behavioral
response to cocaine
nuclear change
type 2 immune response
regulation of isotype switching
regulation of systemic arterial blood pressure by
neurotransmitter
renin-angiotensinbiosynthetic process
endosome to lysosome transport
negative regulation of anti-apoptosis
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cellular triglyceride homeostasis
sperm chromatin condensation
complement activation; lectin pathway
trigeminal nerve development
regulation of potassium ion transport
regulation of lipid kinase activity
positive regulation of G0 to G1 transition
negative regulation of transcription from RNA
cellular
response
to interferon-beta
polymerase
II promoter
involved in smooth
C21-steroid
hormone
metabolic
process
muscle cell differentiation
negative regulation of tumor necrosis factor
stem
cell division
biosynthetic
process
vagina development
progesterone receptor signaling pathway
histone H3 deacetylation
L-fucose catabolic process
axonogenesis involved in innervation
regulation of blood vessel size
regulation of DNA repair
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APPENDIX B. License to publish Chapter 3 from Reproduction, Fertility, and
Development
The Copyright/License to Publish agreement that the authors have signed allows them to
include their papers in part or in full in their thesis, provided it is for non-commercial
purposes and on the condition that it is clearly indicated that the paper has been published
in Reproduction, Fertility and Development(provide complete citation if already
published). Full acknowledgement of the source must also be made as well as cite the
URL link to our website. For the online version of the thesis, creating a direct link back
to our website would be appreciated.
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